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SUMMARY
The hepatitis B virus nucleocapsid, or core particle, forms the major internal 
structural component of the infectious viral Dane particle. Core particles play essential 
roles in the morphogenesis of the virion and in reverse transcription of pregenomic RNA, 
one of the initial steps in genome replication. The 183 amino acid core protein is the sole 
component of the core particle. In a disulphide-bonded dimeric form, the core protein 
accumulates to reach a critical threshold concentration leading to the co-operative core 
particle assembly process. The core protein consists of two domains: the N-terminal 140 
amino acids and the C-terminal 43 amino acids. The latter region can be removed without 
affecting particle assembly. This region also contains a high proportion of basic residues 
and is tethered in the particle interior, where it interacts with the viral genome. The core 
protein is also an important immunological target during HBV infection. It contains B- 
and T-cell epitopes throughout its length and the core-specific helper T-cell response is 
thought to be an important factor in resolution of infection.
During HBV infection subpopulations of viral variants arise with mutations in their 
nucleotide sequences. Variants with deletions in genomic regions are also detected, with 
deletions within the core gene being the most common. Determination of the functional 
ability of these variants was important as they are proposed to represent immune escape 
variants in patients and, as such, may be responsible for the chronic hepatitis observed.
To allow detection of core deletion proteins with the immunodominant B-cell 
epitope (amino acids 74-89) removed, a ten amino acid epitope tag was inserted at the C- 
terminus of all proteins. The tag sequence did not affect particle assembly by full-length 
protein and allowed detection of bacterially-expressed core deletion proteins A84-109, 
A 81-121, A60-117 and A79-125 (numbers indicate the residues deleted). Although, after 
sucrose gradient centrifugation, core deletion proteins were present in regions of the 
gradient where particles were expected, no particulate structures were detectable by 
electron microscopy. It was concluded that these deletion proteins were incapable of 
stable particle assembly and, instead, only formed large non-specific aggregates. Similar 
results were obtained when samples used for electron microscopy were tested in an 
agarose gel assay for core particles. The inability of the four core deletion proteins to 
assemble into core particles was not due to a failure of the proteins to dimerise, which is 
the first step of the particle assembly pathway.
The deleted region of the A81-121 gene was replaced by an identical-sized region 
from the HBV surface gene and the resulting Acore-surface hybrid protein purified by 
density gradient centrifugation. This protein was also unable to form stable particles, 
indicating that the central region of the core protein is important for the formation of core 
particles.
Step-wise replacement of the original core gene sequence to the A81-121 core gene 
deletion, from both the 5' and 3’ ends of the deleted sequence, was carried out. This gave 
two sets of genes encoding three ’fill-in’ proteins (5’FIO, 20, 30 and 3’FIO, 20, 30) with 
decreasing deletions (31 amino acids to 11 amino acids). However, all proteins were 
unable to form stable particles when purified as before.
Results published during this project showed that central deletions of the core 
protein disrupted a motif consisting of a heptad repeat of hydrophobic residues. These 
results showed that even small disturbances of, or within, this motif prevented core 
particle assembly.
As viral variants with core gene deletions are found co-existing with wild-type virus 
the possibility that both forms of protein could co-assemble to form novel mixed particles 
was examined. Density gradient purification of extracts from cells co-expressing full- 
length protein and the A84-109 or A81-121 proteins showed that both proteins were 
present in the same fractions, with a gradient profile similar to that of particles formed 
from full-length protein. These profiles were also different to those obtained for A84-109 
and A81-121 proteins expressed in isolation. Therefore it seemed that mixed particles 
were able to assemble. In experiments where full-length and 5’F30 proteins were co­
expressed similar results were not obtained, suggesting that mixed particles were unable 
to form, despite the smaller size of the deletion.
In mammalian cells, core protein shows a cell-cycle dependent cellular localisation. 
The protein is present in the nucleus during the G, and G 0 phases of the cell cycle and in 
the cytoplasm during S phase. Although the mechanism and function of this cell cycle- 
dependent localisation are unknown, a decision was made to investigate whether or not 
the core deletion proteins were subject to the same regulation. Using aphidicolin to arrest 
cells at the G,/S boundary, the location of the core deletion proteins in transfected HepG2 
cells was examined by immunofluorescence. All four core deletion proteins displayed a 
localisation which was both nuclear and cytoplasmic within the same cell. This altered 
pattern was probably due to the presence of the deletion upstream to the nuclear 
localisation signal in the C-terminus of the core protein. The significance of this result is 
unknown at present, but may be relevant to the disease state observed in these patients.
Sequencing of full-length core genes from viral DNA extracted from the serum of a 
chronic active hepatitis patient with core gene deletions (supplied by Dr. N. Naoumov) 
was carried out to examine whether or not the full-length viral subpopulation was 
responsible for the nature of the infection. The ten clones isolated showed a number of 
mutations throughout the pre-core and core regions, but these did not cluster in 
immunologically important epitopes.
The results from this project have shown that HBV variants with core gene 
deletions are not functionally viable by themselves. However, the interactions between 
core deletion proteins and full-length protein require further study, as does the
significance of the altered core deletion protein localisation. Results from these studies 
may explain the disease severity observed in the affected patients. Alternatively, further 
studies on the functional differences displayed by full-length core protein variants will 
yield more information on the mechanism of chronic hepatitis development. Studies on 
the structures of the core particle and the core protein published recently should also allow 
a more rational and directed approach to identifying regions of the core protein required 
for core particle assembly.
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CHAPTER 1 INTRODUCTION
1A THE HEPADNA V I R I D A E
1A1 Hepatitis B Virus
1) D iscovery an d  characterisation
The characterisation of the hepatitis B virus (HBV) followed the detection of the 
’Australia antigen' (AuAg) in serum from an Australian aborigine and in patients with 
acute leukaemia (Blumberg et al., 1965). Detection of the antigen in cases of viral and 
post-transfusion hepatitis led to the proposal that it was associated with the causative 
agent (Blumberg et al., 1967; Prince, 1968; Bayer et al., 1968; Giles et a l., 1969; Gocke 
and Kavey, 1969). This antigen was subsequently shown to be present in the serum of 
acute and chronic hepatitis B patients, as single or aggregated 20nm diameter particles 
(either spheres or long filaments). Electron microscopic studies (Dane et al., 1970; 
Jokelainen et al., 1970) using sera from AuAg-positive hepatitis patients, showed that 
these 20nm diameter spheres and filaments aggregated with larger 42nm diameter particles 
when incubated with antiserum. The 42nm particle, known as the Dane particle, was 
proposed to be the hepatitis B virion and was shown to have a greater density than the 
smaller particles, probably due to the presence of the viral DNA. The particle possessed a 
7nm thick outer envelope which surrounded a 28nm icosahedral inner core (see Figure 
1A 1). Virions and the smaller particles aggregated due to the presence of a common 
protein (or proteins) in their outer layers and the 20nm particles were proposed to 
represent non-infectious particles composed of surplus virion envelope proteins.
In 1973, Kaplan et al. discovered an endogenous DNA polymerase activity associated 
with 28nm core particles of the virion, which was either released from virions 
spontaneously or by NP40 treatment. This provided further evidence that the Dane 
particle was the HBV virion and that the inner core particles probably represented viral 
nucleocapsids. Conclusive evidence was provided by Robinson and Greenman (1974), 
who showed that this polymerase activity could be immunoprecipitated by antisera 
specific for the viral surface protein (anti-HBs) but not by antisera specific for the core 
protein (anti-HBc) before NP40 treatment of purified virions and by anti-HBc but not 
anti-HBs antisera after NP40 treatment. The structure of the viral DNA was initially 
determined by electron microscopic studies to be exclusively circular double-stranded 
DNA, smaller in size than any other double-stranded DNA virus and probably with a very 
limited coding capacity (Robinson et al., 1974). Using both molecular biological and 
electron microscopic studies the nature of the viral DNA was further elucidated and was 
shown to contain a single-stranded region, which was converted to a fully double­
stranded region by the endogenous polymerase reaction (Summers et al., 1975; Hruska et
1
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Nucleocapsid
DNA
Lipid biiayer
1-------  PreS2
(PreS2/S = M )
DNA polymerase —  
(Reverse transcriptase) HBsAg
( =  S)
DNA terminal 
protein ~  PreS1 
(PreS1/PreS2/S = L)
Figure 1A1: Structural organisation of the HBV virion
The infectious virion consists of an outer membrane containing the three surface gene 
products: SHBs (HBsAg), MHBs (PreS2+HBsAg) and LHBs (PreS1+preS2+HBsAg). 
The internal nucleocapsid, or core particle, consists entirely of core protein dimers and 
encloses the partially double-stranded circular DNA genome and the polymerase, 
covalently linked to the minus-strand DNA via its terminal protein domain. (Taken from 
Nassal and Schaller, 1993)
al., 1977). By convention, the full length strand, being complementary to the viral 
transcripts, is termed the minus-strand and the shorter strand is termed the plus-strand. 
This single-stranded region was observed in >99% of genomes examined and, although 
variable in size, had a favoured minimum length of 650-700 nucleotides (Delius et al., 
1983). In contrast to its 3' end, the 5' end of the plus-strand was fixed in position with 
respect to a unique Eco RI site in the genome and a nick present in the minus-strand. The 
partial duplex nature of the genome was maintained by a cohesive region of approximately 
210-310bp at the 5' termini of both DNA strands (Sattler and Robinson, 1979; Siddiqui et 
al., 1979). In addition to differing in length, the two DNA strands differed in the nature 
of their 5' termini. The minus-strand was shown to have a protein bound to its 5 ' 
terminus, explaining the extraction of viral DNA to the organic phase upon phenol 
extraction (Gerlich and Robinson, 1980). After treatment of the protein:DNA complex 
with 0 .1M NaOH or by heating with SDS to 90°C this attachment remained, suggesting a 
covalent linkage. Both strands of the DNA were unable to be phosphorylated by 
polynucleotide kinase, the minus-strand because of the attached protein. However, no 
protein was detected at the 5' terminus of the plus-strand. This puzzle was solved when it 
was shown that a small capped oligoribonucleotide approximately 17 nucleotides long
2
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was attached to this terminus (Will et al., 1987). These two different attachments were 
later shown to result from the viral replication mechanism (See section 1B2).
2) Genomic Organisation
The cloning of Dane particle-extracted HBV DNA allowed complete determination of 
the nucleotide sequence (Galibert et al., 1979; Pasek et al., 1979; Ono et al., 1983; see 
Figure 1A2). Although the plus-strand was predicted to contain several small open 
reading frames (ORFs), no protein products have ever been detected. The minus-strand 
was shown to have four major ORFs, one of which covered approximately 80% of the 
genome. The other ORFs had multiple in-frame start codons and were presumed to code 
for more than one protein.
ORF S was identified as coding for the surface proteins of the virus, present in the 
virion envelope. This was achieved by comparison of both the molecular weight and 
partial amino acid sequence of the surface protein with the predicted translated nucleotide 
sequence of the ORF. The gene had three in-frame start codons and a single stop codon, 
with the sequences upstream of the small surface gene named pre-S 1 and pre-S2.
The core, or C, ORF was identified by the similarity in molecular weights of the core 
protein and the calculated molecular weight of the ORF C product. When this genomic 
region was expressed in E.coli and injected into rabbits, the sera reacted in 
immunodiffusion assays with human HBcAg isolated from human liver (Pasek et al., 
1979; Burrell et al., 1979).
The largest open reading frame, ORF P, gave a protein of predicted molecular weight 
of approximately 90kDa. This was within the correct molecular weight range expected for 
a DNA polymerase or reverse transcriptase, thus putatively identifying this gene as coding 
for the viral polymerase.
The smallest open reading frame was designated ORF X, with a predicted size of 
17kDa. No viral protein of this size has yet been identified in infected cells. This may be 
due to different sized proteins being produced from this ORF (Kwee et al., 1992). The 
precise role of ORF X and its possible related products in the viral lifecycle is still 
unclear, but a number of functions have been suggested (see sections 1B3.3 and 1B4.2).
All four ORFs overlap to some extent: the surface gene is contained entirely within the 
region of the polymerase gene, although is in a different reading frame. The regulatory 
elements for transcription are also present within coding sequences, allowing further 
genomic compactness.
Two repeats of an 11 bp sequence, termed DR1 (nucleotides 1590-1600) and DR2, 
(nucleotides 1824-1834) were identified at the ends of the viral genome. These direct 
repeats have significance for both the viral replicative mechanism and in specific 
integration of viral DNA into chromosomal DNA in hepatocellular carcinoma (Dejean et 
al., 1984).
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Figure 1A2: Genomic organisation of HBV
The outer lines represent the different classes of transcripts and the bold inner circles the 
DNA genome, as found in the virion. The oligoribonucleotide primer found at the 5' end of 
the plus-strand DNA is shown as a wavy line and the polymerase/terminal protein at the 
minus-strand terminus as a triangle. Encapsidation signal (e) sequences are represented 
by a hatched rectangle. The four major ORFs (C, S, X and P) are indicated in the centre. 
The numbering system shown in this diagram differs from that used in the rest of this 
thesis, which follows the system of Ono et al., (1983) where position 1 is identified as 
the first T nucleotide in the unique Eco Rl site, at the 5' end of the pre-S2 region 
(nucleotide 1322 in the above diagram). (Taken from Nassal and Schaller, 1993)
1A2 W oodchuck Hepatitis Virus
The woodchuck hepatitis virus was the second hepadnavirus discovered shortly after 
the isolation of HBV. The existence of this virus was suggested by the high incidence of 
severe chronic hepatitis and primary hepatocellular carcinoma in a colony of woodchucks
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in Penrose Research Facility at Philadelphia Zoo (Summers et al., 1978). The serum of 
these animals contained large amounts of excess viral envelope proteins in the form of 
approximately 25nm diameter spheres or filamentous particles, similar to those described 
in humans. These particles displayed weak serological cross-reactivity with the analogous 
HBsAg particles, whilst core particles isolated from livers in the two species showed 
higher levels of cross-reactivity (Werner et al., 1979). Many double-layered 55nm 
particles were also detected which contained DNA and a DNA polymerase activity 
analogous to that of the human virion. These particles were presumed to be woodchuck 
hepatitis B virus (WHV) virions. The viral genome showed significant cross­
hybridisation to the HBV genome. Sequencing of full-length cloned genomes showed that 
the number and sizes of the open reading frames, along with their location relative to the 
nick in the minus-strand, were also similar to the HBV genome structure. Comparison of 
HBV and W HV nucleotide sequences showed 62-70% homology. The least homologous 
region was that surrounding the unique Eco RI site, corresponding to sequences common 
to the pre-S region and the polymerase gene (Galibert et al., 1982). A region 
corresponding to the 3' end of the X gene also showed a lower homology. Viral genomes 
were predominantly found in the liver, although smaller quantities of viral DNA and RNA 
were detected in peripheral blood leukocytes, spleen and kidney (Summers et al., 1978; 
Korba et al., 1986).
1A3 Ground Squirrel Hepatitis Virus
A vims similar to HBV was isolated from seemingly healthy Beechey ground squirrels 
(Marion et al., 1980). The virus showed marked hepatotropism and a narrow host range, 
with rats, mice, guinea pigs and hamsters showing no detectable antigenemia after 
parenteral administration of the virus (Ganem et al., 1982a). Despite high serum titres of 
viral surface proteins and 47nm virions, no pathology was observed in infected ground 
squirrels (Marion et al., 1980; Ganem et al., 1982a). Using hybridisation studies, 
physical mapping and complete genome sequencing, the genome showed extensive 
homology to both HBV (55% nucleotide homology) and WHV (82% nucleotide 
homology). The number and arrangement of the ORFs was also very similar to both HBV 
and WHV (Siddiqui eta l., 1981; Ganem et al., 1982b; Seeger et al., 1984). The surface 
and core proteins were shown to be cross-reactive with and biochemically related to 
analogous HBV and WHV proteins (Cote and Gerin, 1983; Feitelson et al., 1982).
Similar hepadnaviruses have also been isolated from Arctic ground squirrels (Testut et 
al., 1996) and gibbons (Norder et al., 1996), although these are less well characterised.
1A4 Avian Hepadnaviruses
HBV-like viruses have been discovered in Pekin Ducks, in some instances only one 
day after birth, suggesting viral infection and multiplication in embryonic eggs (Mason et
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al., 1980). Virions of the same size and appearance as HBV were detected in sera from 
these birds, which preferentially localised to the liver.
Determination of the nucleotide sequence of the viral DNA by Mandart et a l  (1984) 
showed the genome to be 3021 nucleotides in length, which is comparable in size to 
HBV. However, compared with HBV, a lower homology was shown (<40% for the 
largest part of the sequence). Also, the genome of duck hepatitis B virus (DHBV) has a 
different organisation, lacking a homologue of the mammalian hepadnaviral X gene. 
Instead only a larger, novel core gene was present with C-terminal basic amino acid 
repeats which are similar to those found in the mammalian hepadnaviral core proteins. 
The surface gene homologue was found to be approximately fifty amino acids shorter 
than the HBV protein, due to the deletion of a region corresponding to amino acids 105- 
155. The 40nm virion particle co-migrated on CsCl gradients with a DNA polymerase 
activity (Mason et a l ,  1980), suggesting that DHBV also possessed an endogenous DNA 
polymerase. Amino acid sequence comparisons showed the predicted polymerase protein 
was related to the equivalent protein in HBV and WHV (Mandart et a l ,  1984).
Another recently characterised avian hepadnavirus, heron HBV (HHBV), was isolated 
from grey herons in Germany. HHBV showed similar virion morphology, genome size 
and core and surface protein sizes when compared to DHBV (Sprengel et a l ,  1988). 
Sequencing of the genome showed a high homology to DHBV (78.5%) and a similar 
organisation, with the mammalian hepadnaviral X gene missing and a larger core gene 
present instead. The differing genomic organisation and lower sequence homology for 
avian hepadnaviruses, compared to the mammalian viruses, suggests that these viruses 
form a distinct group, but still with specific host ranges, as HHBV was found to be non- 
infectious to Pekin Ducks (Sprengel et a l ,  1988).
IB VIRAL LIFECYCLE 
1B1 Hepatocyte Binding
To initiate infection, a virus must attach to a host cell receptor via proteins present on 
the virion surface (see Figure 1B1). The exact identity of these proteins and the 
mechanism of virus attachment and subsequent penetration into human hepatocytes in the 
lifecycle of HBV are unknown. The large, middle and small surface proteins (LH Bs, 
MHBs and SHBs, respectively (see Figure 1 A l and Section 1B4.4)) are all present in the 
virion but it is unclear as to which particular region/s of these proteins are important for 
hepatocyte binding. However, candidate host cell proteins which bind to all three virion 
surface proteins have been identified.
The pre-Sl region of LHBs has been reported to bind to hepatocyte plasma 
membranes through specific interactions involving residues between amino acids 21-47
6
Chapter 1 Introduction
Infectious 
HBV virion
Receptor
Endo'plasmic
reticulum
•Strand
DNA
•Strand
DNA
I protein
3.5 kb RNA 
pregenome
+ precore 
proteins
Figure 1B1: Basic life-cycle of HBV
(1) Attachment to and (2) penetration of the host cell. (3) Uncoating and transport of the 
viral genome to the nucleus. (4) Conversion into covalently-closed circular (ccc) DNA as 
the template for transcription. (5) RNA synthesis and transport to the cytoplasm. (6) 
Translation of the gene products. (7) Nucleocapsid assembly and encapsidation of 
pgRNA. (8) Reverse transcription of pgRNA and DNA synthesis. (9) Export from the cell 
as enveloped virions. Alternatively, the nucleic acid can be reimported to the nucleus for 
amplification of cccDNA (10). (Taken from Nassal and Schaller, 1993)
7
Chapter 1 Introduction
(Neurath et al., 1986; Pontisso et al., 1989a; Petit et al., 1991). Interacting host cell 
membrane proteins have been detected which may have a role in the initial stages of viral 
infection. A region of the IgA a-1 chain, with limited amino acid similarity to pre-Sl 
amino acids 21-47, competed with pre-Sl residues for liver plasma membrane binding, 
suggesting the presence of a common receptor (Pontisso et al., 1992). The use of anti- 
idiotypic antibodies to pre-Sl residues identified several liver cell membrane proteins 
which may function as HBV receptors (Petit et al., 1992). The liver membrane 
asialoglycoprotein receptor was also shown to bind virions, with binding completely 
inhibited by anti-pre-Sl, but not anti-pre-S2 monoclonal antibodies (Treichel et al., 
1994).
Pre-S2 residues do not mediate binding to hepatocyte membranes by themselves, but 
binding was possible in the presence of polymerised human serum albumin (pHSA), 
which also binds liver cell membranes (Pontisso et al., 1989b). However conflicting 
reports occur as to the relevance of pre-S2:pHSA-mediated hepatocyte binding: pre-S2 
residues corresponding to the pHSA binding site are inaccessible to monoclonal 
antibodies when present in virions (Petit et al., 1987) and the occurrence of 
gluteraldehyde-linked pHSA, the most efficient polymerised form for binding (Yu et al., 
1985), in vivo  seems unlikely. In contrast to these findings which cast doubt on the 
relevance of pre-S2-mediated hepatocyte binding, pre-S2 residues were shown to be 
capable of generating neutralising and protecting antibodies (Neurath et al., 1986; Itoh et 
al., 1983).
Although early reports suggested SHBs was unable to bind to hepatocytes, or that 
these interactions were irrelevant, recent experiments by the group of Yap have shown 
this may not be the case. SHBs particles (see Section 1B4.4) bound to intact human 
hepatocytes (Leenders et al., 1990) through specific interactions with endonexin II 
(annexin V), a 34kDa member of Ca2+-dependent phospholipid binding proteins (Hertogs 
et al., 1993). The production of anti-idiotypic anti-HBs antibodies in rabbits immunised 
with human liver endonexin II gave evidence for the ligand:receptor nature of this 
interaction (Hertogs et al., 1994).
In order to reconcile these seemingly conflicting results, it is not unreasonable to 
suggest that more than one surface/pre-S protein region is required for efficient organ- 
and species-specific vims attachment. This process may involve a number of steps, each 
utilising a different surface protein region (Leenders et al., 1990). SHBs protein may be a 
more likely candidate for hepatocyte binding, with pre-S regions providing species- 
specific interactions due to their low cross-species homology. Alternatively, vims 
attachment and entry into cells may occur by a non-specific process, despite the 
observation of these specific interactions between surface proteins and hepatocyte 
membrane proteins. If this was the case, though, the efficiency would have to be very 
high to allow successful propagation of a small inoculum of virus. Also, another
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explanation would be required to explain the organ- and species-specificity of the 
hepadnaviruses.
The entry of enveloped viruses into cells often requires proteolysis of the envelope 
proteins to expose a fusion domain. This domain enables the fusion of viral membranes 
with either host cell membranes or endosome membranes if virions are endocytosed. In 
studies with staphylococcal V8 protease-treated virions, Lu et al. (1996) showed that at 
acid pH, virus particles were able to infect normally non-susceptible HepG2 cells. The V8 
protease treatment exposed a putative consensus fusion domain between amino acids 182- 
188 of pre-Sl protein: FLGXLLV. The pre-Sl residues required for attachment, as 
described before, did not seem to be necessary for these experiments; V8 protease 
treatment removes essentially all pre-S residues from the virion. Surface residues were 
also the only requirement for entry of SHBs particles into primary human hepatocytes via 
endonexin II attachments (de Bruin et al., 1995). After incubation with gold-conjugated 
SHBs particles at 4°C, cells warmed to 37°C showed invagination of plasma membrane 
coated pit regions at SHBs binding sites and formation of endocytotic vesicles. With the 
different mechanisms for viral entry inferred by both sets of results, fusion peptide- 
mediated and receptor-mediated endocytosis respectively, the problem remains unsolved.
Less still is known about the processes that occur following virion entry into host 
cells. The precise mechanism allowing delivery of the viral genome to the nucleus remains 
undetermined, although clues have come from an in vitro model derived from WHV 
(Kann et al., 1997). In this model the polymerase:DNA complex was efficiently 
transported into the nucleus after release from core particles. These possibly disassemble 
before reaching the nuclear membrane (Bock et al., 1996), as core particles themselves do 
not cross intact nuclear membranes (Guidotti et al., 1994a). In addition, phosphorylation 
of core protein C-terminal serine residues by encapsidated protein kinase C (Kann et al., 
1993) may act to destabilise the core particle and allow virion genome release (Kann and 
Gerlich, 1994).
1B2 Viral Replication
The unusual structure of the HBV genome is a consequence of the mode of replication 
employed by the virus. HBV utilises a reverse transcription step to synthesise minus- 
strand DNA, in contrast to almost all other DNA viruses (Summers and M ason, 1982). 
HBV replication occurs in four main stages, which are listed and described below:
1) formation of covalently-closed circular DNA (cccDNA)
2) production of pregenomic RNA (pgRNA)
3) minus-strand DNA synthesis, by reverse transcription
4) plus-strand DNA synthesis
Stages 1 and 2 occur in the host cell nucleus, whereas stages 3 and 4 occur after the
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Figure 1B2: Model for HBV replication
(1) Encapsidation and initiation of minus-strand DNA synthesis. The dotted line 
represents pgRNA; boxes 1 and 2 represent DR1 and DR2, respectively. The 
polymerase (oval shape) binds the 5' e stem loop and facilitates pgRNA encapsidation. 
Four nucleotides of minus-strand DNA are synthesised (solid line) from the bulge region.
(2) Minus-strand template switch. The polymerase-tetranucleotide complex switches to 
complementary sequences in the 3' copy of DR1 and minus-strand DNA synthesis 
continues. (3 and 4) Synthesis of minus-strand DNA. As minus-strand DNA (solid line) is 
synthesised, pgRNA is degraded by the RNase H activity of the polymerase. (5) 
Completion of minus-strand DNA synthesis and generation of plus-strand RNA primer. 
The final RNase H cleavage generates the plus-strand primer, which is derived from the 
first 18 nucleotides of the pgRNA (from cap structure to 3' of DR1). (6) Translocation of 
the plus-strand primer. The primer anneals to complementary DNA sequences in DR2, 
which is juxtaposed to DR1 upon completion of minus-strand synthesis. (7) Initiation 
and elongation of plus-strand DNA synthesis. Approximately 50 nucleotides of plus- 
strand DNA is synthesised. The minus-strand DNA terminal redundancy is labelled Y. 
(8) Intra-strand template switch and elongation of plus-strand DNA. Plus-strand DNA 
synthesis switches templates from the 5' to 3' end of minus-strand DNA, facilitated b y 
the terminal redundancy V. Plus-strand DNA elongation continues. (9) Elongation and 
completion of plus-strand DNA synthesis results in a relaxed circular DNA. (10 and 11) 
In situ priming of plus-strand DNA synthesis. A fraction of plus-strands may not initiate 
at DR2, but at DR1 instead, due to plus-strand primer not being translocated. Elongation 
results in duplex, linear DNA. (Taken from Loeb et al., 1997)
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production of pgRNA, which is complexed to the viral polymerase and is encapsidated 
into an assembling core particle (see Section 1B5). A summary diagram of HBV 
replication is shown in Figure 1B2.
1) Form ation o f cccDNA
Several modifications to both strands of the virion DNA are required before it can be 
used as a transcriptional template: the protein must be dissociated from the 5' end of the 
minus-strand; eight terminally redundant nucleotides removed from the 5' end of the 
minus-strand and the 5' and 3' ends ligated; the 17-mer oligoribonucleotide must be 
removed from the 5' end of the plus-strand and plus-strand synthesis completed. The 
resulting circular supercoiled molecule is termed cccDNA. Host cell enzymes are thought 
to be responsible for all these stages, but this has only been demonstrated experimentally 
for the last stage mentioned (Kock and Schlicht, 1993). Amplification of cccDNA occurs 
through an intracellular pathway and this form of DNA accumulates in the nucleus (Miller 
and Robinson, 1984; Tuttleman et al., 1986).
2) Production o f pregenom ic RNA
The 3.5kb pregenomic RNA (pgRNA) represents one of the major polyadenylated 
transcripts found in infected hepatocytes (Cattaneo et al., 1984). It is transcribed from one 
region of the core promoter by host cell RNA polymerase II and, in addition to its role in 
viral replication, also acts as the template for translation of core and polymerase proteins. 
The 5' end of this transcript was mapped to the pre-core region nucleotide 1818, five 
nucleotides downstream of the pre-core ATG; this explains why this transcript does not 
code for e antigen. The transcript terminates at the common site for all hepadnaviral 
mRNAs, approximately twenty nucleotides downstream of the conserved hexanucleotide 
UAUAAA. This transcription termination signal is read-through at the first pass, leaving 
the pgRNA with a terminal redundancy of approximately 120 nucleotides (Will et al., 
1987). An 85 nucleotide sequence at the 5' end of pgRNA was identified as being 
necessary for efficient encapsidation of pgRNA into core particles, following interaction 
of the RNA with the viral polymerase (Junker-Niepmann et al., 1990; see Section 1B5). 
This cis-acting encapsidation signal was termed £ and contained several inverted repeat 
sequences suggesting a high degree of secondary structure. These repeat sequences were 
similar in all hepadnaviruses. The secondary structure of £ was determined by RNase and 
nuclease probing and shown to be a bipartite stem-loop structure, with lower and upper 
stems interrupted by a six nucleotide bulge. The upper stem contained a single unpaired U 
and a six nucleotide loop (Knaus and Nassal, 1993; Pollack and Ganem, 1993; see Figure 
1D2). Due to the terminal redundancy, two copies of £ and the DR1 repeat are present in 
pgRNA.
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3) M inus-strand DNA synthesis by reverse transcription
Recently the e encapsidation signal has also been shown to be involved in the initial 
stages of minus-strand DNA synthesis. From the results of primer extension analysis it 
was previously believed that minus-strand DNA synthesis initiated at the 3' copy of DR1 
(DR1*) and proceeded in a continuous manner, without the need of a template switch 
(Will et al., 1987). However, experiments with DHBV polymerase expressed in a yeast 
TY1 retrotransposon system (Tavis and Ganem, 1993) showed that the minus-strand 
origin mapped within the stem-loop of e. This origin had been previously described as a 
cryptic site which was used when DR1* was deleted from pgRNA (Condreay et al.,
1992). As the 3' copy of e and the 5' copy of DR1 were functionally silenced in pgRNA 
(Seeger and M aragos, 1990), the hypothesised mechanism for minus strand synthesis 
involved a template switch by nascent minus-strand DNA from the 5' copy of e to DR1*. 
This mechanism has now been demonstrated for both DHBV (Wang and Seeger, 1993; 
Tavis et a l ,  1994) and HBV (Rieger and Nassal, 1996). The replication origin was more 
precisely mapped to the six nucleotide bulge of e and particularly to the four distal 
nucleotides UUCA (Nassal and Rieger, 1996).
Evidence from studies on DHBV replication indicated that reverse transcription was 
initiated via a mechanism unique to hepadnaviruses: the reaction was primed by a protein 
molecule which remains covalently bound to the 5' end of minus-strand DNA throughout 
the viral lifecycle (Molnar-Kimber et a l,  1983). The initiation step involved the formation 
of a phosphodiester bond between the Tyr-96 residue in the terminal protein domain of 
the polymerase and, in the case of DHBV, a dGTP nucleotide (Bartenschlager and 
Schaller, 1988; Zoulim and Seeger, 1994; Weber et a l ,  1994). This nucleotide was 
specified by the 3' terminal nucleotide in the bulge of the £ sequence. The use of HBV 
polymerase expressed in insect cells has confirmed a similar mechanism for this stage of 
HBV replication. HBV polymerase was expressed in the presence of RNA containing £ 
and DR1 sequences to examine HBV minus-strand DNA initiation. The minus-strand 
DNA synthesised initiated with a dTTP nucleotide (Lanford et a l ,  1995), complementary 
to the 3' terminal nucleotide in the bulge of the HBV £ sequence. However, minus-strand 
transfer to the DR1 sequence was found to be more efficient than for DHBV. Another 
difference from DHBV replication was that Tyr-63 was the site of the DNA:polymerase 
linkage (Lanford et a l ,  1997).
After the addition of four nucleotides complementary to the bulge sequence, primer 
elongation halts, possibly because the polymerase encounters the structurally rigid lower 
stem of £. The polymerase-primer complex then translocates to a complementary 
tetranucleotide sequence in DR1* and minus-strand synthesis is completed in a 
continuous manner as initially hypothesised (Will et a l ,  1987). The sequence 
complementarity only partially explains the specificity of the translocation reaction, as the 
tetranucleotide sequence occurs eighteen times in a unit-length genome and sequences
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complementary by only two nucleotides are capable of translocating efficiently (Nassal 
and Rieger, 1996). In addition, when multiple complementary tetranucleotide sequences 
were introduced around DR1*, the original sequence was still used preferentially (Loeb 
and Tian, 1995). The conformation of the pgRNA may place the 5' e and DR1* 
sequences in close spatial proximity, presumably by adopting a circularised shape, 
bringing the ends of the pregenome together. This conformation may be stabilised by 
RNA:protein interactions, which could possibly involve additional polymerase binding 
sites (Seifer and Standring, 1995) or cellular proteins such as the 65kDa nuclear protein 
which binds pyrimidine-rich regions present at both ends of pgRNA in the terminally 
redundant sequences (Perri and Ganem, 1996). Kidd and Kidd-Ljunggren (1996) carried 
out computer-based modelling studies of the folding of the pgRNA template and predicted 
that the 3' end of pgRNA contained an RNA superstructure with DR1* exposed on a 
loop. This superstructure is not present at the 5' end of pgRNA and so may direct correct 
positioning of the translocating polymerase-primer complex. As the tetranucleotide 
translocation site for this complex in DR1* is located eight nucleotides downstream of the 
5' end of the pgRNA, this results in a terminal redundancy of eight nucleotides in the 
completed minus-strand DNA.
Digestion of the pgRNA occurs simultaneously with reverse transcription and is also 
catalysed by the viral polymerase. Mutational analysis of the polymerase protein showed 
that RNase H activity mapped to the C-terminal region, between amino acids 680-832 
(Radziwill et al., 1990).
4) P lus-strand synthesis
The 5' end of plus-strand DNA was found to contain a covalently-linked seventeen 
nucleotide long oligoribonucleotide with sequence identical to both DR1 and nucleotides 
5' of DR1 (Will et al., 1987; Seeger et al., 1986). This oligoribonucleotide was capped in 
the DHBV genome (Lien et al., 1986) and was proposed to be the undigested 5' end of 
the pgRNA. This would have been translocated to the DR2 sequence in the newly- 
synthesised minus-strand DNA, which is where the 5' end of plus-strand DNA was 
mapped. Again, the translocation mechanism is unknown, but the spatial conformation of 
the minus-strand is probably critical for correct positioning of the translocated 
oligoribonucleotide.
Oligoribonucleotide-primed plus-strand synthesis proceeds up to the 3' end of the 
minus-strand template after which an intra-molecular template switch must take place. 
This switch is facilitated by the eight nucleotide redundancy in the 5' and 3' ends of 
minus-strand DNA, but the exact mechanism remains to be determined. Recent studies on 
DHBV replication have suggested that factors other than the terminal redundancy are 
required for this template switch (Loeb et al., 1997).
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Plus-strand synthesis halts before completion resulting in the circular partially double­
stranded genome observed in virions. The reasons for this are unclear, but possibilities 
include spatial constraints within the nucleocapsid or an insufficient pool of available 
dNTPs after the mature virion is released into the extracellular medium.
1B3 HBV G ene E xpression
The subject of HBV gene expression results in the production of a large amount of 
literature, some of which can be difficult to integrate and may be contradictory. This 
section gives only a basic summary of the main points; further, more detailed information 
is available in recent reviews by both Schaller and Fischer (1991) and Yen (1993). The 
positions and lengths of the transcripts are represented in Figure 1A2, where the pgRNA 
is labelled 'C'.
1B3.1 T ranscrip ts
Viral messages are transcribed from the episomal cccDNA template (see Section 
1 B2( 1)) by the host cell transcriptional apparatus. Four classes of transcripts have been 
detected: 3.5kb, 2.4kb, 2.1 kb and 0.9kb. The transcripts are initiated from four viral 
promoters: the core promoter, the surface promoters Spl and SpII and the X promoter. 
All transcripts terminate downstream of the single polyadenylation site, UAUAAA, which 
is located after the core gene AUG start codon.
The core promoter gives rise to three different 3.5kb transcripts (Yaginuma et al., 
1987; Honigwachs et al., 1989). Two of these are the long pre-core mRNAs, initiated 20- 
30 nucleotides upstream of the pre-core ATG at 1783/4 and 1790± 1 and which encode e 
antigen. The third is a shorter, more abundant core mRNA, or pgRNA. This is initiated at 
1819± 1 and can be reverse transcribed or used as message for core and polymerase 
proteins. This promoter contains binding sites for the liver-enriched factors HNF3 and 
HNF4 (Johnson et al., 1995; Guo et al., 1993; Raney et al., 1997). However, a recent 
report by Yu and Mertz (1996) has shown that synthesis of pgRNA and pre-core mRNAs 
was actually under the control of two discrete promoters which, although partially 
overlapping, were genetically separable. The activities of the two promoters were also 
shown to be differentially regulated, which may explain the differing relative abundance 
of the pgRNA and pre-core transcripts in infected liver cells.
As these RNAs are all of supergenomic length, the polyadenylation signal must be 
ignored when first encountered by the RNA polymerase. Efficient recognition of the 
downstream polyadenylation signal, in the case of ground squirrel hepatitis virus (GSHV) 
at least, requires three sequences located in the 397 nucleotides upstream of the AAUAAA 
sequence (Russnak and Ganem, 1990). The inefficient usage of the signal on the first 
pass is a result of pgRNA containing only one of these regions between its 5' end and the
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polyadenylation signal.
The Spl promoter directs the synthesis of a single 2.4kb transcript (the pre-Sl 
transcript) which is initiated at nucleotide 2807 and encodes LHBs (Will et al., 1987). 
This is the only HBV promoter to contain an upstream TATA box, which explains the 
lack of heterogeneity of the 5' end of LHBs-encoding transcripts. The Spl promoter 
shows a strong preference for differentiated hepatocytes and contains binding sites for 
HNF1 and HNF3 (Chang et al., 1989; Raney et al., 1995).
The SpII promoter directs the synthesis of a number of mRNAs with start sites on 
either side of the pre-S2 ATG (Cattaneo et al., 1983, 1984; Standring et al., 1984; 
Yaginuma et al., 1987). Those mRNAs which initiate 5' to this ATG encode M HBs, 
while those initiating 3' to this ATG encode SHBs. Thus the SpII promoter is responsible 
for the production of both MHBs and SHBs proteins.
The X promoter directs the synthesis of viral mRNAs which encode the X protein. 
These transcripts have heterogeneous 5' termini and are approximately 0.7-0.9kb in 
length (Treinin and Laub, 1987). However, these transcripts have not been detected in 
HBV-infected liver cells, although the X protein has been detected in liver biopsies 
(Haruna et al., 1991; Wang et al., 1991a) and sera (Feitelson and Clayton, 1990) from 
HBV-infected patients.
The 3.5kb pgRNA transcript undergoes splicing to produce two separate mRNAs, 
approximately 2.2kb in size, which have been detected in infected liver cells and in 
HepG2 cells transfected with genomic constructs (Wu et al., 1991a). The 2.2kb mRNAs 
are either singly or doubly spliced: singly spliced transcripts have 1224 nucleotides 
removed and are predicted to encode a core protein lacking its terminal cysteine, an N- 
terminally truncated polymerase and smaller surface proteins. Doubly spliced transcripts 
contain a 282 nucleotide in-frame deletion from the middle of the core gene and a 1016 
nucleotide deletion from the terminal codon of the core gene. These splicing events would 
remove the C-terminal cysteine of the core protein and the N-terminus of SHBs, also 
producing a truncated polymerase. A 2.7kb spliced RNA has also been detected in 
transfected HepG2 cells with the same splice acceptor site as the 2.2kb RNA, but a splice 
donor site 500bp downstream of the 2.2kb donor site (Suzuki et al., 1990). The relevance 
of these splicing events is unclear as they seem to play no major role in the viral lifecycle, 
as determined by mutational inactivation of the donor and acceptor sites (Suzuki et al.,
1990). However as they seem to be more prominent in patients who have progressed 
from acute to chronic hepatitis, as compared to patients who recover from acute hepatitis, 
a role has been postulated for them in the cause of chronic HBV infection (Rosmorduc et 
al., 1995).
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1B3.2 T ranscriptional regulation by c /s-acting  elem ents
1) Enhancers
In addition to the four promoters and the polyadenylation site, the HBV genome also 
contains two enhancer elements, I and II, which regulate promoter activities. Enhancer I 
(nucleotides 1074 and 1234) is located in the upstream region of the X promoter, and can 
function in an orientation-independent manner (Shaul et al., 1985). Enhancer I sequences 
were capable of increasing the rate of transcription from the core and X promoters, but 
had little effect on the SpII promoter (Zhang et al., 1992; Raney et al., 1989). The 
mechanism of action of enhancer I is likely to contribute to the hepatotropism of HBV as 
it showed higher levels of activity in differentiated hepatocyte cell lines (Antonucci and 
Rutter, 1989; Honigwachs et al., 1989; Zhang et al., 1992). Both footprinting and gel 
retardation analyses have shown the presence of multiple binding sites in enhancer I for 
the liver-enriched factors HBLF, HNF3 and HNF4 (Trujillo et al., 1991; Chen et al.,
1994).
Enhancer II (nucleotides 1636-1741) is positioned upstream of the core promoter 
between DR1 and DR2 and can function in an orientation- and position-independent 
manner, with increased activity in differentiated liver cells (Yee, 1989). Enhancer II was 
capable of upregulating transcription from both the Spl and SpII promoters (Yuh and 
Ting, 1990). The functional ability of enhancer II is strictly dependent on a bipartite 
structure consisting of a 23bp box a  (1646-1668) and a 12bp box (3 (1704-1715) (Yuh 
and Ting, 1990; Yuh et al., 1992). Liver cell-specific proteins have been shown to bind to 
enhancer II, again explaining the high activity of enhancer II in hepatocytes, compared 
with other cell types (Yuh and Ting 1993).
The glucocorticoid response element, located approximately 730bp upstream to 
enhancer I, has been shown to bind purified glucocorticoid receptor and to augment the 
activity of enhancer I in the presence of dexamethasone (Tur-Kaspa et al., 1988). This 
may explain the increased expression of surface and core proteins observed in patients on 
corticosteroid treatment (Scullard et al., 1981; Wu et al., 1982; Ohtsu et al., 1991).
2) Negative regulation o f  transcription
In addition to the action of the enhancer elements, viral transcription is also negatively 
regulated by cA-acting elements. In transient transfection assays, 2.4kb surface gene 
transcripts were difficult to detect, in contrast to the abundant 2.1 kb surface mRNAs 
(Bulla and Siddiqui, 1989). This was due to differences in the levels of transcription from 
the Spl promoter and the SpII promoter. Deletion analysis of the surface gene regulatory 
region showed that the decreased Spl activity was due to a negative regulatory element 
which contained the downstream SpII region.
A second negative regulatory element is located directly upstream of enhancer II (Lo 
and Ting, 1994). This represses both the stimulatory effects of enhancer II and the
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stimulatory effect which sequences overlapping with enhancer II have on the core 
promoter (Yuh et al., 1992).
1B3.3 T ranscriptional regulation by the X protein
The X protein transactivates a large number of viral and cellular promoters (reviewed 
by Rossner, 1992), including all four HBV promoter elements (Colgrove et al., 1989; 
Siddiqui et al., 1989; Raney et al., 1990; Unger and Shaul, 1990). Using nuclear run-on 
transcription assays, increased gene expression was shown to be due to an increased rate 
of transcription (Colgrove et al., 1989). As these experiments also utilised recircularised 
HBV genomes to express the X protein at in vivo  levels, it seems likely that the role of 
this protein during the viral life cycle is to increase the levels of viral mRNAs required for 
viral replication. The precise mechanism for this transcriptional transactivation is 
unknown at present, but it appears that the X protein effects this by performing a dual 
role, depending on its subcellular location. The X protein has been reported to 
transactivate gene expression in two ways: (i) by directly interacting with components of 
the transcription machinery at the promoter (Haviv et al., 1996; Cheong et al., 1995; 
Qadri et al., 1995, 1996; Maguire et al., 1991; Unger and Shaul, 1990; Seto et al., 1990) 
or (ii) by acting indirectly on transcription factors, modifying their activity through 
cellular signalling pathways (Benn et al., 1996; Su and Schneider, 1996; Benn and 
Schneider, 1994; Natoli et al., 1994; Kekule et al, 1993; Cross et al., 1993; Lucito and 
Schneider, 1992). Experiments carried out by Doria et al. (1995) showed that the X 
protein could both stimulate signal transduction pathways (when located in the cytoplasm) 
and transactivate transcription elements, such as the HBV enhancer I (when located in the 
nucleus). Therefore the activation of gene expression by the X protein may be regulated 
by proteins which affect its subcellular localisation.
1B4 Viral Proteins
The four classes of HBV mRNAs act as the templates for the translation of seven viral 
proteins, the structures and functions of which are described below. Probably only one of 
these proteins, the HBe protein or e antigen, is not found in the virion; instead it is 
detected mainly in the serum of patients. The question as to whether the X protein is 
located within the virion or is synthesised only after viral entry and transcription have 
occurred remains to be resolved. Analysis of the kinetics of the X gene transcripts 
showed that they were degraded more rapidly than other viral mRNAs (Wu et al., 
1991b). Analysis of the X protein expressed in HepG2 cells from a recombinant vaccinia 
virus showed that the protein had a half-life of 3hr (Schek et al., 1991). The X protein 
may not, therefore, remain in the cell long enough to be encapsidated, a hypothesis 
disputed by Wu et al. (1990), who claimed to detect the X protein in virions.
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1B4.1 The e antigen
The 3.5kb pre-core mRNAs serve as the templates for e antigen production, as they 
are the only viral RNAs to include the pre-core ATG. The e antigen is translated as a 
25kDa precursor protein, p25e (Jean-Jean et al., 1989a; Yang et al., 1992). The p25e 
protein includes all of the core protein residues plus an additional twenty-nine N-terminal 
amino acids which are largely hydrophobic. The nineteen N-terminal residues constituted 
a signal peptide sequence, which directed p25e to the membranes of the endoplasmic 
reticulum (ER) (Ou et al., 1986). Co-translational signal peptide cleavage of the 
transmembrane protein occurred at pre-core residue A la-19, producing p22e in the ER 
lumen (Standring et al., 1988; Bruss and Gerlich, 1988). As p22e passes through the 
cellular secretory pathway it is further cleaved to remove part or all of the 37 C-terminal 
amino acids, producing p l6e , the 16kDa secreted e antigen detectable in the serum 
(Magnius and Espmark, 1972; Takahashi et al., 1983). As p22e was present in both the 
ER and the Golgi apparatus, yet p l6e  was found only in the Golgi, this C-terminal 
processing most likely occurred in the Golgi compartment. This was confirmed by 
suppression of the processing by brefeldin A, an inhibitor of protein transport between 
the ER and the Golgi (Wang et al., 1991b). Aspartyl proteases were found to be 
responsible for the processing, as it was inhibited by pepstatin, a competitive inhibitor of 
these enzymes (Jean-Jean et al., 1989a). Although the core protein contains an aspartyl 
protease-like motif, mutagenesis studies of this motif showed that the core protein was 
not responsible for the C-terminal processing of e antigen (Jean-Jean et al., 1989b; Nassal 
et al., 1989). These same experiments also showed that p22e could not process itself, 
therefore cellular enzymes are thought to be responsible. Although e antigen contains the 
core protein sequences necessary for particle assembly (see Section 1E 1), the protein is 
found only as a monomer and is antigenically different from the core protein. These 
biophysical and antigenic differences are due to the ten pre-core amino acids remaining 
after signal peptide cleavage. These include a cysteine residue and a hydrophobic triad 
motif (WLW). The cysteine residue forms a disulphide bond with Cys-61 o f the core 
protein (Nassal and Rieger, 1993) which, along with the hydrophobic triad motif, forces 
e antigen into a conformation incompatible with aggregation (Wasenauer et al., 1992). 
This results in the synthesis of the secretory form of e antigen. Although viewed primarily 
as a secreted protein, e antigen and its precursors are also found in cellular compartments, 
presumably by evading certain translocation or processing stages. These include the 
nucleus (Ou et al., 1989; Yang et al., 1992), cytoplasm (Garcia et al., 1988; Yang et al.,
1992) and the plasma membrane (Schlicht and Schaller, 1989) Despite understanding in 
detail the synthesis and biochemical properties of e antigen, ascribing a function to the 
protein has proved to be more difficult; as its amino acid similarity to core protein is high 
and it is of secretory nature, it has been proposed to act as an immune-modulatory protein 
(Milich et al., 1990; Hsu et al., 1992). However, its expression on the cell surface could
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play an opposing role by allowing antibody-mediated elimination of infected cells.
Recent results from the groups of Wands and Chisari have shown that p22e may 
regulate HBV replication. Transient or stable overexpression of p22e reduced the levels of 
HBV replicative intermediates produced (Scaglioni et al., 1997). Furthermore, expression 
of physiological levels of p22e in trans, from genomic constructs in transfected 
hepatocytes, could also reduce the levels of replicative intermediates. In transgenic 
studies, mice expressing pre-core protein were crossed with HBV genomic transgenic 
mice, which showed hepatic viral replication. Viral replication in the resulting progeny 
was inhibited in a dominant negative manner (Guidotti et al., 1996). This was not the case 
in progeny resulting from the cross of surface or X transgenic mice with the HBV 
genomic transgenic mice. These results correlated with similar observations made in 
earlier transfection assays using either a genome with an authentic pre-core gene or a pre­
core-minus genome, with a nonsense mutation at codon 28 (Lamberts et al., 1993). These 
genomes showed low and high replication levels, respectively. It is probable that the pre­
core protein interacts with core protein to form heterodimers which interfere with core 
particle assembly and pgRNA encapsidation, therefore affecting the subsequent 
replication steps.
1B4.2 The X protein
Although the transactivational properties of the X protein have been described 
previously (Section 1B3.3), other functions have also been attributed to this protein. 
However, for most of these it has not been possible to determine the relevance of such 
properties to the lifecycle of the virus. The other activities of the X protein include a novel 
serine/threonine kinase activity (Wu et al., 1990), a Kunitz-type serine protease inhibitor 
activity (Takada et al., 1994; Koike and Takada, 1995) and an AMP kinase activity 
(Dopheide and Azad, 1996). The X protein has also been shown to interact with a number 
of cellular proteins in vitro, including a probable DNA repair protein (Lee et al., 1995) 
and a novel subunit of the proteasome complex (Huang et al., 1996). However the 
importance of these interactions in the role of the X protein during HBV infection also 
remains unsolved.
The X protein may be a major determinant of the pathogenicity of HBV infection 
leading to the development of HCC, as X-transgenic mice develop carcinomas specifically 
in liver tissue (Kim et al., 1991; Koike et al., 1994a). The interaction of the X protein 
with p53, resulting in alterations in p53 function, probably contributes to its role in HCC 
development (Feitelson et al., 1993; Wang et al., 1994; Truant et al., 1995; Ueda et al., 
1995). The expression of X protein in transfection assays induced quiescent mouse 
fibroblasts to enter the cell cycle (Koike et al., 1994b) and expression of X protein in 
Chang cells, from a replication-defective adenovirus vector, deregulated the normal cell 
cycle checkpoint controls (Benn and Schneider, 1995). Both of these activities probably
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contribute to the uncontrolled cellular proliferation involved in HCC.
1B4.3 P olym erase/R everse T ranscrip tase
The viral polymerase is encoded by the 3.5kb pgRNA, but not the pre-core RNAs (Ou 
et al., 1990; see Section 1B3.1). The P gene was putatively identified as encoding the 
viral polymerase/reverse transcriptase (pol/RTase) due to the size and the amino acid 
homology of the predicted product to the reverse transcriptases of RSV and Mo-MuLV 
(Toh et al., 1983). This included conservation of the reverse transcriptase YMDD motif. 
This gene was later shown to encode the reverse transcriptase and all other activities 
required for viral replication; Laub and Bavand, 1988; Bavand et al., 1989). Mutational 
analysis of the P gene showed that it encodes a protein with three functional domains 
(Radziwill et al., 1990). These domains are termed terminal protein, pol/RTase and 
RNase H, from the N to the C terminus, respectively. There is a non-essential spacer 
region between the terminal protein and pol/RTase domains. This analysis also showed 
that the pol/RTase domain appeared to be divided by poorly conserved residues into two 
subdomains, possibly identifying the C-terminal subdomain as containing the reverse 
transcriptase activity, due to the presence of the YMDD motif.
The initiation of polymerase gene translation at the polymerase AUG appears to occur 
by a mechanism involving leaky ribosomal scanning (Lin and Lo, 1992; Fouillot et al.,
1993). However pre-core mRNA with the common pre-core mutation producing a stop 
codon at residue 28 (see Section 1D1) also has the ability to encode polymerase and core 
proteins (Fouillot and Rossignol, 1996). This occurs by translational reinitiation after 
aborted translation of the pre-core region. The importance of this phenomenon is unclear 
at present.
In addition to having a role in the major viral genome replication steps, the polymerase 
protein also plays an essential structural role during the pregenome encapsidation process 
(see Section 1B5).
1B4.4 Surface proteins
1) Sm all surface protein  (SHBs)
The SHBs protein plays an important role in HBV infection and virion formation: it is 
the main component of the 20nm subviral particles found in serum (Bayer et a l., 1968); 
the host of a possible virion attachment site to hepatocytes; and a structural component of 
the virion envelope. Translation of the S gene produces a 226 amino acid protein with a 
molecular weight of 24kDa, which can be N-glycosylated at Asn-146 to produce the gp27 
glycoprotein. This modification is common to all three surface proteins (Peterson et al.,
1982). Infected liver cells (Gerber et al., 1974) and cells stably transfected with the S 
gene (Patzer et al., 1986) accumulate 20nm spheres and filaments (characteristic of 
SHBs) within the ER but not on the cell surface. SHBs probably inserts into the ER
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membrane and particles bud into the ER lumen. Structural modelling studies have added 
to this by predicting a transmembrane conformation for SHBs, with a-helices spanning 
the membrane four times and both the N and C termini of the protein exposed on the 
virion surface (Stirk et a l ,  1992; Berting et al., 1995). This transmembrane orientation is 
due to the targeting action of two hydrophobic signal sequences located between amino 
acids 4-28 and 84-136 (with residues 80-98 being highly conserved), termed signals I 
and II respectively (Eble et a l ,  1987; Bruss and Ganem, 1991a). However, in contrast to 
conventional signal sequences, signals I and II are not cleaved in the ER. Signal I directs 
the translocation of the N-terminus of SHBs across the ER membrane and is therefore 
also important during M HBs synthesis (Eble et al., 1986, 1990). Signal II directs the 
translocation of the C-terminus of SHBs, resulting in a surface protein with two 
transmembrane spans. Whether or not the C-terminal amino acids after residue 160 form 
another two transmembrane spans, which would be in accordance with the modelling 
studies, is unclear.
After adopting this orientation, SHBs proteins first dimerise and then oligomerise 
before budding to form subviral particles (Simon et al., 1988); this last stage occurs in a 
post-ER, pre-Golgi compartment (Huovila et al., 1992) before particles are secreted via 
the cellular pathway.
The transmembrane topology of SHBs produces two major hydrophilic loops, 
consisting of amino acids 28-77 and 101-159. The first loop is exposed to the cellular 
cytoplasm during synthesis and lies along the inner surface of the envelope of the virion. 
Mutational analysis of the cysteine residues in this region showed that Cys-48, Cys-65 
and Cys-69 were all essential for secretion of SHBs particles, as was His-60 (Mangold 
and Streeck, 1993). The second hydrophilic loop, as the site of SHBs glycosylation, is 
located in the ER lumen and is therefore exposed on the external surface of the virion. 
This region contains eight highly conserved cysteine residues which participate in 
disulphide bonds. These bonds dictate the complex structure of SHBs and are important 
for its antigenicity (Ashton-Rickardt and Murray, 1989a; Bruce and Murray, 1995). The 
immunodominant B-cell epitope, the a determinant, is located within the conformational 
structure of this region, as are the d/y and w/r subtype determinants; lysine or arginine at 
residue 122 (le Bouvier, 1971; Peterson et al., 1984; Okamoto et al., 1987a) and lysine or 
arginine at residue 160 (Bancroft et al., 1972; Okamoto et al., 1987a), respectively. 
However, other residues may also affect the reactivity of this region to subtype-specific 
antibodies (Ashton-Rickardt and Murray, 1989b; Okamoto et al., 1989). Progress 
towards elucidating the conformation of this region has come from observing the 
protective efficacy of peptide vaccines covering amino acids 117-137, which had been 
cyclised by a disulphide bond between Cys-124 and Cys-137 (Dreesman et al., 1982) and 
the use of phage display libraries (Chen et al., 1996). The model for SHBs produced 
using the latter technique proposes disulphide bonds between cysteines 107-138, 137-
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149, 139-147 and 121-124. However, earlier work showed that although cysteine 
residues at 124, 147, and 149 were essential for maintenance of the conformation of this 
region, mutation of Cys-138 had little or no effect (Ashton-Rickardt and Murray, 1989a; 
Bruce and Murray, 1995). These results do not nullify the proposed model, as Cys-138 is 
not an essential residue: it is claimed that the structure of SHBs would not alter drastically 
if cysteine residues 107, 137, 138 and 149 did not form intra-chain disulphide bonds, or 
if they formed disulphide bonds with other monomers within the particle. All cysteine 
residues in this region have been shown to contribute to the efficiency of SHBs particle 
secretion (Mangold and Streeck, 1993).
2) M iddle surface protein  (MHBs)
The MHBs protein incorporates the entire SHBs amino acid sequence plus an 
additional 55 N-terminal amino acids, termed the pre-S2 region (Stibbe and Gerlich,
1983). The pre-S2 domain contains an additional site for N-linked glycosylation at Asn-4 
which, in combination with the common site at Asn-146, gives rise to the two MHBs 
glycoproteins, gp33 and gp36. MHBs is a component of both HBV virions and surface 
antigen particles (Stibbe and Gerlich, 1982; Heermann et al., 1984; M achida et al., 1983). 
The pre-S2 amino acids are thought to be exposed on the virion surface, as antibodies 
raised in chimpanzees to residues 14-32 were able to bind virions and protect the 
immunised animals from 106 infectious doses of HBV (Itoh et al., 1986). However, 
whether it is MHBs or LHBs that is responsible for these effects in vivo  is unclear, as 
both proteins contain the pre-S2 region. It has been proposed that during M protein 
production, 20nm particles are formed in the ER lumen before being transported to a post- 
ER/pre-Golgi compartment and fully glycosylated. It may be that some M HBs can evade 
this second glycosylation stage by being directed to the plasma membrane and secreted 
instead (Sheu and Lo, 1994).
3) Large surface protein  (LHBs)
The largest protein encoded by the S gene, translated from the 2.4kb mRNA, is
LHBs. This protein includes S, pre-S2 and the N-terminal pre-S 1 amino acids; the latter 
region is encoded for by a highly variable region of the HBV genome. The pre-S 1 domain 
is 108-119 amino acids long, depending on the viral subtype, and translation initiating at 
the pre-Sl start codon produces a 39kDa protein. LHBs can be present in both 20nm 
spheres and filaments (more commonly in the latter), but is more prevalent in virions, 
which contain up to twenty times more LHBs than subviral particles (Heermann et al.,
1984). LHBs is also N-glycosylated to produce gp42. The pre-Sl amino acids are 
exposed on the surface of the virion, as antibodies raised against whole virions are 
capable of binding to pre-S 1 residues. The pre-S 1 region probably masks the S region in 
LHBs, as digestion of 20nm particles with trypsin increases their reactivity with anti-
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SHBs antibodies.
As LHBs was finally present on the virion surface, it was presumed that its 
biosynthesis followed the same pathway as the S and M proteins, with the N-terminus co- 
translationally translocated into the ER lumen. However, results from in vitro and cellular 
assays showed that the N-terminal regions of virtually all LHBs proteins (possibly up to 
the signal II sequence), were initially located in the cytoplasm (Ostapchuk et al., 1994; 
Bruss et al., 1994). A post-translational translocation event then occurs to reorientate pre- 
S1 residues externally. The mechanism for retention of the pre-Sl residues in the 
cytoplasm is unclear, but does not seem to be due to membrane anchorage mediated by 
the myristylated N-terminal glycine (Persing et al., 1987; Prange and Streeck, 1995). 
Signal I residues in the S region may be unable to direct the translocation of the 163-174 
amino acid pre-S residues, which have no signal of their own (Ostapchuk et al., 1994). 
The C-terminal pre-Sl region (amino acids 70-107), however, has been shown to 
interfere with co-translational translocation of LHBs protein, possibly by interacting with 
cytoplasmic cellular proteins and inhibiting the translocation process (Prange and Streeck,
1995). These residues may, therefore, be important for regulating the later translocation 
event. The LHBs topology switch is likely to involve a reorganisation of lipid 
membranes, but insufficient studies have concentrated on these to allow determination of 
the mechanism. The initial cytoplasmic orientation of LHBs may also explain why it is not 
glycosylated in the pre-S2 region. It is possible that both SHBs and the S region of LHBs 
have a similar dual topology in the second hydrophilic loop, thus explaining the partial 
glycosylation observed at Asn-146. However reports examining this possibility are in 
conflict at present (Prange and Streeck, 1995; Wunderlich and Bruss, 1996).
1B4.5 Core protein
As this protein is the subject of this thesis (see Section IE) its role in the viral lifecycle 
will be described only briefly here.
The 21kDa core protein is the sole component of the viral nucleocapsid, or core 
particle, as was shown by the production of 27nm diameter particles when the core gene 
was expressed in E.coli (Cohen and Richmond, 1982). The icosahedral core particle is 
composed of 90 or 120 core protein dimers (Crowther et al., 1994) and assembles to 
encapsidate the polymerase/pgRNA complex (see Section 1B5). Reverse transcription of 
the pgRNA and the subsequent replication stages occur within core particles, which are 
present in the cytoplasm before entering the virion assembly pathway.
1B5 Pregenom e Encapsidation and Virion A ssem bly
As well as being the initiation site for reverse transcription of pgRNA, the 5' e signal 
is an essential element for the encapsidation of pgRNA (Junker-Niepmann et al., 1990). 
The virion assembly process is initiated by the specific interaction of £ with the viral
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polymerase (Bartenschlager et al., 1990; Roychoudhury et al., 1991; Bartenschlager and 
Schaller, 1992). This interaction may then be further stabilised by interactions with core 
protein molecules until particle assembly occurs. The pgRNA is then packaged within the 
lumen of the core particle with the polymerase-e complex intact. Mutational analysis of the 
nucleotide sequence of £ showed that the only regions not important for polymerase 
binding were the four distal bulge nucleotides (although the bulge structure itself was 
required for this interaction) and the lower region of the stem. This suggested a model in 
which the polymerase covers almost the entire upper portion of £ (Pollack and Ganem, 
1993; Fallows and Goff, 1995; Rieger and Nassal, 1995). A more complex scenario has 
arisen for the DHBV encapsidation process, which has been studied in more detail. It 
appears that the polymerase-£ interaction is insufficient for the encapsidation and priming 
of DNA synthesis and other factors, such as Hsp90 and p23 are required (Pollack and 
Ganem, 1994; Tavis and Ganem, 1996; Hu and Seeger, 1996; Hu et al., 1997). It 
remains to be seen whether similar additional factors are required for HBV.
Although pre-core mRNAs also contain e signals, pgRNA is selectively encapsidated 
because the stem-loop structure of £ on pre-core mRNA is disrupted by the 80S 
translating ribosomes (Nassal et al., 1990). Although pgRNA also acts as a translational 
template, its translation is carried out by 40S scanning ribosomes. These are probably 
blocked by the polymerase-£ interaction and core protein molecules stabilising this latter 
interaction. Therefore the concentrations of both polymerase and core proteins are able to 
regulate initiation of encapsidation.
Following encapsidation of the polymerase-pgRNA complex, the core particle is 
enveloped by a lipid bilayer containing the HBV surface proteins. As all three surface 
proteins are present in virions they must localise simultaneously in the same membrane 
region. With the exception of Ueda et al. (1991), most investigators conclude that, 
although present in virions, MHBs is dispensable for virion assembly (Bruss and Ganem, 
1991b; Fernholz et al., 1993). The amount of LHBs present, and hence the SHBs:LHBs 
ratio, determines the type of particle produced (Heermann et al., 1984). The 20nm 
spherical surface proteins contained low levels of LHBs, whereas both filaments and 
virions contained higher levels. The amounts of LHBs protein in virions were up to 
twenty-fold higher than LHBs levels in the 20nm surface particles. However, 
overexpression of LHBs resulted in the inhibition of surface particle secretion (Persing et 
al., 1986; Chisari et al., 1986). It was proposed that this LHBs-mediated retention of 
surface proteins allowed all three proteins to aggregate in the ER membrane before the 
envelopment of core particles. However, this model was disproved when virion release 
was also shown to be inhibited by LHBs overexpression (Bruss and Ganem, 1991b). 
Pre-Sl residues, therefore, are important for virion production. In particular the C- 
terminal 16 amino acids (104-119) are necessary, as N-terminal deletions which removed 
them prevented virion release (Bruss and Thomssen, 1994).
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Due to the dual topology of LHBs, cytoplasmic pre-Sl residues may be involved in 
proteiniprotein interactions required for recognition of core particles prior to envelopment. 
The use of a phage display library suggested that sequences which bound to core particles 
mimicked pre-Sl residues 19-24 and may therefore be important for coreisurface 
interactions (Dyson and Murray, 1995). However these residues are included in the N- 
terminal pre-Sl region which is dispensable for virion formation. Binding assays between 
core particles and synthetic peptides based on the amino acid sequences of pre-S 1, pre-S2 
and the cytosolic loop of S showed that the thirteen C-terminal pre-Sl residues were 
capable of efficient binding (Poisson et a l., 1997). This was more consistent with the 
results from the LHBs deletion experiments.
Virion assembly also appears to be regulated by viral DNA replication events 
occurring in the core particle interior (Gerelsaikhan et a l., 1996). A presently undefined 
signal essential for virion maturation appears to be displayed on the exterior of the core 
particle some time after the initiation of reverse transcription of the pregenome. This may 
be a conformational change induced in the particle structure, possibly due to the 
replacement of the structurally flexible pgRNA with a more rigid double-stranded DNA. 
Alternatively core protein phosphorylation by protein kinase C, which is also 
encapsidated (Kann et al., 1993), may result in a conformational change. As the core 
protein kinase C target sequence within core protein is located within the C-terminal 
nucleic acid binding region (Kann and Gerlich, 1994), dissociation of the pgRNA during 
reverse transcription would allow protein kinase C access to this sequence. This would be 
followed by phosphorylation of the core protein and the induction of a conformational 
change.
Following the interaction of the core particle and surface proteins, virions are 
generated by budding of the core particles into the ER lumen, along with the surface 
protein-containing membrane. The resulting virions are then exported from the cell via the 
constitutive secretory pathway.
IC IMMUNOPATHOGENESIS OF HBV INFECTION
Upon infection with HBV most adults develop a self-limiting acute hepatitis and are 
able to eliminate infected hepatocytes. However, approximately 5% of infected adults are 
unable to clear the virus and develop a chronic infection with or without hepatic 
inflammation: chronic active hepatitis (CAH) and chronic persistent hepatitis (CPH), 
respectively (Chu et al., 1985). Studies using various transgenic mouse lineages have 
shown that the pathologies observed are not due to a direct viral cytopathic effect (Farza et 
al., 1988; Araki et al., 1989; Guidotti et al., 1995), but rather are caused by the 
subsequent immune response directed against viral proteins (Moriyama et al., 1990). The 
outcome of infection seems to depend primarily on the strength of the response mounted
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by the host immune system against the virus. The humoral response against virion surface 
proteins neutralises viral infectivity, whilst the cellular response against these and other 
viral antigens destroys infected hepatocytes. Individuals who develop chronic infections 
are thought to be especially deficient in this latter response.
1C1 H um oral R esponse
Antibodies to all viral proteins can be detected in HBV-infected individuals. However, 
with the exception of anti-HBs antibodies, the roles played by the other antibodies 
produced during the course of virus infection are not fully understood. Anti-polymerase 
antibodies are induced in both acute and chronic hepatitis but seem to serve only as a 
marker of advanced liver disease and ongoing viral replication (Yuki et al., 1990; Weimer 
et al., 1990). Titres of anti-HBx antibodies were found to be higher and occurred more 
frequently in the sera of patients with chronic hepatitis infections compared to acute cases 
or asymptomatic carriers (Stemler et al., 1990).
Although e antigen serves as a standard serological marker for HBV replication and 
seroconversion to anti-HBe antibody is usually predictive of a remission in liver disease 
(Hoofnagle et al., 1981), the role played by anti-HBe antibodies in these processes is 
unclear. Antibodies to both e antigen and core proteins are produced in high titres in 
patients with acute and chronic infection in spite of them having no obvious virus- 
neutralising properties. The ability of core particles to act as both a T helper cell (Tty- 
independent and a Th cell-dependent antigen (Milich and McLachlan, 1986) and the high 
cross reactivity of core and e proteins at the T cell level (Milich et al., 1987a; 1988) 
probably explains the high antibody levels observed.
Early antibody binding studies on both liver-derived and bacterially-expressed core 
particles showed that a single immunodominant epitope was present, which was 
recognised by both monoclonal antibodies and human sera (Waters et al., 1986; Ferns 
and Tedder, 1986). However, further studies have mapped numerous antibody binding 
epitopes in the core protein (see Figure 1C1). This is possibly a reflection of the 
differences in the immunogens used to raise antibodies and the binding assay formats. 
The use of core particles or core protein, in the form of fusion proteins, suggested that the 
dominant epitope was located in the centre of the protein, around amino acid 74 (Bichko 
et al., 1993; Salfeld et al., 1989; Schodel et al., 1992). This epitope was shown to be 
exposed on the surface of the particle and conformational. The conformational nature of 
core antigenicity had been previously demonstrated by protease studies on core particles 
(Mackay et al., 1981). Limited proteolysis of particles under dissociating conditions 
resulted in decreased core antigenicity, with a concomitant increase in e antigenicity. This 
suggested that the particulate core antigen was being disrupted to produce e antigenicity. 
Salfeld et al. (1989) proposed that two epitopes existed on e antigen: H B el, a 
predominantly linear epitope from amino acids 76-89, which could also be detected on the
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Figure 1C1: B-cell epitopes in core protein
The positions of mapped B-cell epitopes in the core protein sequence are shown along 
with the relevant reference. Bracketed positions indicate that the epitope was recognised 
less frequently or was a minor epitope. The shaded box in the HBe2 epitope indicates 
that this region is important for antigenicity, but intra-molecular participation from the 
extended sequence shown is also required. Epitopes in the lower region of the figure 
were identified by antibodies binding synthetic peptides.
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core particle surface, and HBe2, which required most of the polypeptide and was 
probably conformational in nature. HBel overlaps with the conformational core protein 
epitope around amino acids 74-89. Results from Colluci et al. (1988) and Sallberg et al. 
(1991a) have confirmed the presence of linear epitopes within the conformational core 
protein epitope.
Other epitopes have been identified using synthetic peptides (Tordjeman et al., 1993; 
Sallberg et al., 1994), but as these may lack any conformation they may not be significant 
in vivo.
Antibodies directed against the surface proteins, and in particular the a determinant, 
have been shown to provide protection against virus challenge in chimpanzees (Iwarson et 
al., 1985; Itoh et al., 1986). As these antibodies are detectable in patients who have 
cleared the virus and are undetectable in chronic HBV infections, they are thought to play 
an essential role in virus neutralisation (Pontisso et al., 1989a). The production of anti- 
HBs antibodies is dependent on Th cells (Roberts et al., 1975) and is also linked to the 
activation of Th cells by core protein epitopes, which can elicit production of both anti- 
HBe and anti-HBs antibodies (Milich et al., 1987b).
1C2 HLA Class II-restricted T Cell Response
In acute hepatitis cases, strong human leukocyte antigen (HLA) class II-restricted 
CD4+ Th responses to core protein and e antigen are detectable in peripheral blood 
mononuclear cells (PBMCs). A number of Th epitopes have been identified in core 
protein, some of which are unrelated to HLA-type (Ferrari et al., 1990, 1991; Jung et al., 
1991, 1995; Diepolder et al., 1996; see Figure 1C2). In contrast, the surface protein- 
specific Th response is much weaker, and although this response has been detected in the 
early incubation phase of acute infections (Vento et al., 1987) the basis for the weaker 
response in the symptomatic phase is unclear. The possible depressing effect of the 
abundance of surface particles on surface-specific Th cells may provide a partial 
explanation. The lack of surface-specific Th cell stimulation for the production of anti- 
HBs antibodies is compensated for by core protein epitopes, as described above.
As yet, no substantial studies have been made on the class II-restricted T cell response 
to the polymerase and X proteins.
During chronic infection, the class II-restricted T cell response to all viral antigens is 
significantly lower compared to that in an acute hepatitis infection (Ferrari et al., 1990; 
Jung et al., 1991; Wakita et al., 1992; Lohr et al., 1995). This probably contributes to the 
antibody profiles observed during chronic infection: both sources of Th-stimulation of 
anti-HBs antibody production (surface protein epitope- and core protein epitope-specific 
Th cells) are reduced. However, core particles are still capable of eliciting anti-HBe 
antibody production independent of Th cells.
Analyses of hepatic infiltrates during chronic infections have shown the presence of
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Figure 1C2: T cell epitopes of core protein
The positions of epitopes for cytotoxic T lymphocytes (CTL) and helper T lymphocytes 
(Th) in core protein are shown above. For CTL epitopes, the HLA type of the patient is 
indicated. Th epitopes which are indicated by an asterisk (*) were identified irrespective 
of the patient's HLA type.
CD4" T cells specific for both core and surface proteins, in contrast to peripheral blood 
(Ferrari et al., 1987a, 1987b; Barnaba et al., 1989, 1994; Lohr et al., 1995). It may be 
that these cells are enriched in this compartment during chronic infections.
Core-specific Th cells are thought to play a key immunoregulatory role during 
infections, whereas surface-specific Th cells may be suppressed by the high antigen load. 
High core-specific Th cell activity is observed in the following incidences; (i) during acute 
hepatitis; (ii) in patients with chronic HBV infection compared to the asymptomatic carrier 
state (Wakita et al., 1992; Maruyama et al., 1993a); (iii) during acute exacerbations of 
chronic infections (Tsai et al., 1992; Maruyama et al., 1993b); (iv) during seroconversion
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to anti-HBe and anti-HBs (Jung e ta l ,  1995); (v) in spontaneous remission from chronic 
infection (Rehermann e t a l ,  1996); and (vi) with transaminase normalisation, anti-HBe 
seroconversion and viral DNA clearance in chronic patients who respond to interferon 
therapy (Lohr et al., 1995). The association between the class II-restricted DRB 1*1302 
allele and protection against persistent HBV infection in the Gambia also provides 
evidence for the importance of the Th response in the outcome of HBV infection (Thursz 
e t a l ,  1995).
Studies in a murine system have shown that a combination of the MHC restricting 
element, the core/e epitope recognised and the structure of the antigen can, along with 
other factors, determine whether the Th cell response is dominated by Thl or Th2 
subsets, which may also be a factor in determining the outcome of infection (Milich et a l ,  
1995a, 1997).
In summary, it is likely that the lack of a sufficient core-specific Th response is a key 
factor in the failure to eliminate virus and in the development of chronic hepatitis. The low 
levels of activity observed are probably responsible for the ongoing necroinflammatory 
disease.
1C3 HLA Class I-restricted T Cell Response
Studies on the cytotoxic T lymphocyte (CTL) response in acute hepatitis have shown 
that this is polyclonal and is directed against multiple epitopes in all viral proteins (Jin et 
a l,  1988; Nayersina et a l ,  1993; Barnaba et a l ,  1989; Ferrari e ta l ,  1992; Rehermann et 
a l ,  1995; Missale et a l ,  1993; Penna et a l ,  1991; Bertoletti et a l ,  1991, 1993; see 
Figure 1C2). The abundance of surface proteins produced during infection and the 
observation that exogenous surface protein can also enter the class I processing pathway 
(after initial endosomal processing) and induce CTL and Th cells as effectively as 
endogenously synthesised protein (Jin et a l ,  1988; Penna et a l ,  1992), may also 
contribute to the strength of the CTL response against surface proteins. However, uptake 
and presentation of exogenous surface protein also occurred in B cells and resulted in 
anti-HBs antibody-producing B cells being destroyed, leading to the decreased anti-HBs 
antibody levels which accompany the development of chronic hepatitis (Barnaba et a l ,
1990). The core protein has only one HLA-A2 epitope, whereas surface and polymerase 
proteins have four and five, respectively. Therefore, the immune response to core protein 
does not seem to predominate in the CD8+ CTL activity, as it does for the CD4+ Th cells.
Studies of the acute liver disease induced in surface protein transgenic mice upon 
transfer of surface protein-specific CTL have revealed the important events in disease 
pathogenesis (Ando et a l ,  1993). The first step is the triggering of target hepatocytes to 
undergo apoptosis. This occurs almost immediately as a direct consequence of CTL-target 
cell interaction. Within a few hours this is followed by a focal inflammatory response 
where the cytopathic effects of the CTL response are amplified in an antigen-nonspecific
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manner by lymphocytes which have been recruited by CTL. Thus the liver disease 
observed is transient and relatively mild, where no more than 5% of hepatocytes are 
destroyed and with hepatic damage being mediated mainly by CTL-activated effector cells 
and antigen-nonspecific lymphokines.
A further series of experiments using transgenic models have shown that selected 
soluble lymphokines produced by antigen-specific CTL are themselves able to non- 
cytolytically downregulate HBV gene expression at the post-transcriptional level (Guidotti 
et al., 1994b; Tsui et al., 1995). Although the precise molecular pathways responsible 
remain unsolved, it appears that both interferon-y (IFNy) and tumour necrosis factor-a are 
principally responsible, although interleukin-2, IFN a and IFNp are also involved (Gilles 
et al., 1992; Guilhot et al., 1993; Guidotti et al., 1994c). Therefore, in addition to the 
direct cytolytic action of antigen-specific CTL on infected hepatocytes, CTL-derived 
signals can activate the infected cells to an antiviral state, thus providing an additional 
means of combating HBV infection.
In contrast to the vigorous CTL response detectable in the peripheral blood of patients 
with acute hepatitis who successfully clear the virus, a weak or undetectable CTL 
response is associated with chronic disease and viral persistence (Montano et al., 1983; 
Nouri-Aria et al., 1988; Ferrari e ta l.,  1990; Jung et al., 1991, 1995; Lohr e ta l.,  1993; 
Rehermann et al., 1995). It is likely that this is linked to the low CD4+ Th cell activity 
observed in these cases as described previously (see Section 1C2). The resultant inability 
to mount a vigorous CTL response is widely acknowledged as the primary reason for the 
failure to rapidly eliminate virus and instead allow the development of a chronic infection.
The basis for the variable CTL response is poorly understood, except perhaps in the 
case of infants born to e antigen-positive mothers. In these cases, where infection is 
thought to occur at or around the time of birth (Beasley and Hwang, 1983), 
approximately 95% of neonates develop chronic infections instead of clearing the virus. 
The probable explanation for this is that e antigen, being a secreted, non-particulate 
protein, is able to cross the placenta and is present in the fetal circulation (Hsu et al.,
1992). Consequently, thymic deletion of both e- and core-specific T cells occurs due to 
the cross-reactivity of both proteins at the T cell level (Milich eta l., 1990). This results in 
a depletion of the cells responsible for directing viral clearance. Thus, if infection of the 
fetus (Alexander and Eddleston, 1986) or of the neonate (Beasley and Hwang, 1983; Li et 
al., 1986) occurs while it is tolerant to core/e protein at the T cell level, chronic infection 
will develop. Additional studies of incomplete tolerance in e antigen transgenic mice have 
shown that Th2 cells can evade tolerance induction more successfully than their Thl 
counterparts (Milich et al., 1995b). This is also likely to contribute to the abnormal T cell 
responses observed in chronically infected patients.
Suppression of cellular responses to interferons may also contribute to the inefficiency 
of the CTL response. Expression of the viral polymerase inhibited the response to IF N a
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and y, by preventing the activation of interferon-inducible genes (Foster et al., 1991 (see 
also erratum, 1995), 1993). This phenomenon was observed both in vitro and in chronic 
patients who failed to respond to IF N a therapy. Core protein is also able to inhibit 
expression of IFN(3 by acting in trans on the regulatory region of the gene (Twu et a l ,  
1988; Whitten et al., 1991). Hepatocytes from patients with e antigen-positive chronic 
hepatitis showed no increased interferon-induced membrane expression of HLA class I 
molecules compared to anti-HBe chronic cases and uninfected controls (Montano et al., 
1982; Ikeda et al., 1986). In addition, levels of 2'5'-oligoadenylate synthetase were not 
increased in patients with CAH, in contrast to those with CPH or acute hepatitis (Poitrine 
et al., 1985).
Whilst this section has primarily considered the host response to HBV infection and its 
possible defects which allow viral persistence, it is likely that variation within the 
infecting viral population is another important factor.
ID GENETIC VARIATION
With a mutation rate calculated to be comparable to the slowest evolving retroviral 
genes (Girones and Miller, 1989), a large number of HBV variants have been detected 
during HBV infection. However, both the replication competence of a particular variant 
and the resultant immune response determine to what extent it is selected for and whether 
or not it predominates in the viral population. Apart from the previous mention of surface 
gene variation in relation to subtype definition (Section 1B4.4), only pre-core and core 
gene variation will be discussed in this section as recent reviews have been published on 
both surface and X gene variation (Wallace and Carman, 1997; Carman, 1995a).
1D1 Pre-core Variants
Since the description of the original pre-core mutant, G1896A (substitution of a G 
nucleotide with an A at position 1896), in which the pre-core codon 28 was converted 
from a tryptophan to a stop codon, many other pre-core variants have been described and 
are summarised in Figure 1D1 (Carman et al., 1989; Fiordalisi et al., 1990; Okamoto et 
al., 1990; Raimondo et al., 1990; Tong et al., 1990; Blum et al., 1991; Santantonio et a l ,  
1991; Carman et al., 1992; Gunther et al., 1992; Laskus et al., 1994). Although not all 
variation leads to the formation of a stop codon, production of e antigen is precluded by 
many of the variations. Other variants have been reported which do not affect e antigen 
synthesis but these are not shown in this Figure 1D1 (Akarca et al., 1994; Laskus et al., 
1994). The reason for the 200-fold higher prevalence of G1896A compared to other 
variations is unknown and it is simply termed a mutational 'hotspot' (Yuan et al., 1995).
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Figure 1D1: Variations observed within the pre-core region
The nucleotide sequence of the pre-core region is shown, along with reported mutations 
that abolish the production of e antigen, and some additional commonly observed 
variants. The key at the bottom of the figure depicts the type of mutation; all others 
shown are nucleotide substitutions. The start codons for both e antigen (pre-core start 
codon) and core protein are boxed. References identifying these mutations are cited in 
the main text.
Examination of the secondary structure of the £ RNA sequence (see Figure 1D2) 
shows that the G1896A and G1899A mutations replace the non-Watson-Crick U:G bond 
with a U-A bond. This may stabilise the £ signal (Lok et al., 1994), especially as G1899A 
rarely occurs without G1896A. The secondary structure of the £ sequence may also 
explain the occurrence of other pre-core variations. For example, C1856T, which was 
always detected in association with the conservative variation T1858C, was found to be 
mutually exclusive with G1896A, possibly as the new combination of base pairs would 
lead to an unstable encapsidation signal (Carman et al., 1992; Lok et al., 1994). The 
C1856T variation does not seem to affect either the amount of e antigen produced, or the 
efficiency of its secretion from cells (Boner et al., 1995). C1856T can, however, be 
detected in combination with T1856C and G 1898A, as the variation at the two positions 
maintains the overall number of base pairs in the lower stem of £. The positions of other 
naturally occurring pre-core variants have been mapped and it is interesting to note that no 
variation occurs in the loop or right-hand side of the upper stem of £; these sequences are 
indispensable for encapsidation. Also, there is no variation in the UUCA sequence in the 
bulge, which is required for the initiation of minus-strand DNA synthesis (Laskus et al.,
1994). Another line of evidence for the importance of the structure of £ in permitting
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Figure 1D2: Secondary structure of the e encapsidation signal
The pregenomic RNA encapsidation signal possesses a stem-loop structure formed b y 
sequences in the pre-core region. This structure includes the six nucleotide bulge 
required for initiation of minus-strand DNA synthesis. The positions of some important 
variant nucleotides are marked and the start codon for the core gene is boxed.
variation at only certain positions is the observation that G1896A is very rarely found in 
viruses of genotype A (Li et al., 1993), which have the sequence CCC at positions 1856- 
1858. The G1896A mutation would destroy the C-G base pair which, as shown in 
transfection experiments, decreases the RNA packaging efficiency.
The G1899A mutation is also commonly described, usually in association with 
G1896A; the combination has been linked with severe disease (Carman et al., 1989; 
Ulrich et al., 1990; Hasegawa et al., 1994). However, they have no effect on the levels of 
viral RNA or replicative intermediates produced after transfection of genomic constructs
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containing both mutations (Hasegawa et a l , 1994). Virion assembly and secretion were 
also similar to wild-type (Ulrich et al., 1990), demonstrating that neither the variants nor 
the absence of e antigen affects any of these processes. Similarly, the G1896A variation 
alone did not affect the replication efficiency of transfected genomes (Hasegawa et a l ,  
1994; Tong et a l ,  1992).
Many studies have been carried out in order to determine whether or not a link exists 
between selection of G1896A and the severity of the disease. During and after 
seroconversion to anti-HBe, pre-core stop mutants were detected both in patients who 
become asymptomatic and also in patients who continued to have ongoing liver disease 
(Lai et a l ,  1994; Tur-Kaspa et a l ,  1992; Okamoto et a l ,  1990; Tong et a l ,  1990). These 
same studies also showed that a high proportion of pre-core stop mutants after 
seroconversion was, in general, associated with a higher viremia and a more active 
hepatitis whilst mixed populations of G1896A strains and e antigen-producing strains 
seemed to be associated with a less severe form of hepatitis (Carman et a l ,  1989; 
Naoumov et a l ,  1992; Lai et a l ,  1994). Predominance of pre-core stop mutants after 
seroconversion to anti-HBe was also associated with a course of hepatitis characterised by 
flare-ups of liver cell necrosis interspersed with asymptomatic periods (Brunetto et a l ,
1991). That selection of a pre-core mutant virus does not necessarily lead to a quiescent 
state indicates that other factors contribute to disease progression. One possibility is 
variation within the core gene, although variation in other genes may be as important.
The most likely mechanism of selection for pre-core stop mutants is the pressure 
imposed by the immune system. The lack of a virus protein which is normally secreted 
and accessible to the immune system may result in less scope for sensitisation of immune 
effector cells and recognition of hepatocytes containing either e or core proteins.
1D2 C ore Variation
As the core protein is thought to be a major target of the antiviral immune response, a 
number of groups have examined the variation occurring in the core gene during chronic 
infection, to determine whether or not a causal link exists. These studies attempted to 
identify whether amino acid changes were more prevalent in certain regions and whether 
these regions were functionally relevant.
1) Do core mutations cluster?
Unlike the pre-core region, only the extreme 5' end of the core gene contains elements 
which are functionally essential at the RNA level. Therefore, for the majority of the 
nucleotide sequence only missense mutations, affecting the amino acid sequence, are 
important. The high ratio of non-synonymous to synonymous mutations also implies that 
mutation at the amino acid level is of consequence.
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There have been six major studies to date that have examined mutation clustering in the 
core gene (Ehata et al., 1992, 1993; Chuang et al., 1993; Boner et al., 1995; C a rm a n ^  
al., 1995b; Akarca and Lok, 1995a). The results of all studies showed that the core gene 
mutations affecting the core protein did cluster in specific regions, but the locations and 
sizes of these regions were disputed.
Ehata et al. (1992) showed that, of 39 core gene mutations leading to amino acid 
substitutions in virus isolates from 20 chronic carriers with fluctuating ALT levels, 21 
(54%) clustered in the region encoding amino acids 84-101. In addition, 15 of these 
patients, suffering from CAH, all had at least one mutation in this region, whereas the 5 
remaining patients had no mutations in this region and had only CPH. Upon closer 
examination of the 84-101 region, 14 of the 15 patients all had mutations leading to amino 
acid substitutions within the smaller region encoding amino acids 87-97. A second 
mutation clustering region was identified in the region encoding amino acids 130-156, 
with 14 of the 39 mutations (36%) located here and, in addition, sporadic mutations were 
identified at amino acids 27, 49 and 60.
In a second paper the same group identified 29 or 34 missense mutations in the core 
genes from patients infected with adr or adw  subtype viruses respectively (Ehata et al.,
1993). These patients all had either acute exacerbations of chronic hepatitis or fulminant 
hepatitis, the most severe form of the disease. For the adr subtype viruses, mutations 
clustered mainly between amino acids 84-99 (12/29; 41%), 130-156 (6/29; 21%) or 20- 
35 (5/29; 17%) with sporadic mutations at amino acids 5, 13, 60, 74 and 105. Mutation 
in the adr subtype viruses, however, clustered between amino acids 48-60 (9/34; 26%) or 
105-113 (5/34; 15%), with 7/8 patients having an additional substitution at amino acid 77. 
Sporadic mutations were observed at ten other positions.
A third paper by this group detected 62 missense mutations in the core genes from 17 
CAH cases (Chuang et al., 1993). Similar clustering regions to those described 
previously were examined and found to contain 19/62 (31%), 14/62 (23%) and 10/62 
(16%) mutations in the regions encoding amino acids 84-101, 48-60 and 147-155, 
respectively. However, the positions of the mutational clusters did not seem to show the 
same subtype dependency as mentioned previously, as the same clusters were found in 
both adr and adw patients.
A much larger study of core gene mutations in chronically infected patients was carried 
out by Akarca and Lok (1995a), who identified regions encoding core protein amino acids 
59-66, 87-100, 125-135 and 147-155 as mutational clustering regions and regions 
encoding amino acids 14-25, 101-124, 136-146 and 156-183 as completely devoid of 
mutations. The relative absence of mutations leading to amino acid substitutions in the C- 
terminus of the core protein is probably due to the overlap of core and polymerase genes 
in this region: mutations here could possibly have a deleterious effect on the polymerase 
protein. Also, clusters of arginine residues in the C-terminus of the core protein are
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required for its nucleic acid binding properties (see Section 1E1). It was therefore of 
interest that, in this region, only Arg-151 was mutated, and in some cases an arginine 
residue was restored at position 153. All cysteine residues, important for core particle 
assembly, were also conserved. Of additional interest was the fact that the mutation 
clustering regions overlapped with known epitopes in the protein. This linkage of 
increased mutations and Th and B-cell epitope regions was also identified in a smaller 
study of serial samples from Chinese chronic carriers (Boner et al., 1995). Another 
region which did not correspond to any known epitopes, but showed higher variability 
than expected was identified between amino acids 21-40. Carman et al. (1995b) have also 
shown that mutations occur predominantly in both Th and B-cell epitopes. Both these 
papers also reported a low incidence of cysteine mutations or mutations in the C-terminal 
region with only two cases of mutated arginine residues.
2) Functional relevance o f  core mutations
An increase in core gene mutations leading to amino acid substitutions was found in 
patients with CAH when compared to asymptomatic carriers (Ehata et al., 1992; Chuang 
et al., 1993); in patients with fulminant hepatitis or with severe exacerbations, when 
compared to acute hepatitis cases (Ehata et al., 1993); and when CAH cases were 
compared to those with only CPH (Ehata et al., 1992; Akarca and Lok, 1995a). These 
associations suggest a role for core gene variation in determining the severity of an 
infection.
Selection of the pre-core stop mutant G1896A was also associated with increased core 
mutation (Akarca and Lok, 1995a; Boner et al., 1995; Carman et al., 1995b). This may 
be linked to seroconversion to anti-HBe antibody, as greater numbers of mutations have 
been reported in some patients who are anti-HBe positive, compared to those who are e 
antigen positive (Carman et al., 1995b; Akarca and Lok, 1995a). It has also been 
observed that mutations do not develop at a constant rate, but are more frequent around 
the time of seroconversion (Akarca and Lok, 1995a) or occur at the same time as, or after, 
the selection of the pre-core stop codon (Boner et al., 1995; Carman et al., 1995b).
The relevance of core gene mutations which lead to amino acid substitutions may be 
connected to the importance of the core protein as an immune target. Despite the 
importance of CTL in clearing the virus, relatively few studies have examined any 
possible associations between core gene mutations and CTL epitopes and very few 
patients have been HLA-typed in any of these studies. Much attention has been focused 
on the well-defined HLA-A2 core epitope between amino acids 18-27. Carman et al. 
(1995b) showed that some patients with ongoing active disease after seroconversion had 
mutations within this epitope (at Ser-21 and Val-27). However, mutations in the epitope 
were also found in a patient who went into remission after seroconversion; not all patients 
with active disease after seroconversion had mutations in this region; and not all patients
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studied were HLA-A2 positive. Ehata et al. (1992) identified a potential HLA-A2 epitope 
between amino acids 84-91, positioned in the mutation clustering region, although none 
of the patients were actually HLA-typed and this epitope has never been recognised 
before. Work by Bertoletti et al. (1994a, b) showed that mutations observed in the epitope 
between core protein residues 18-27 in two HLA-A2 positive chronic patients could 
inhibit the core-specific CTL response. Peptides containing the observed mutations at Ser- 
21 (S21N, S21A or S21V) or double mutations at Ser-21 and Val-27 (V27A or V27I) 
acted as T cell receptor antagonists for >80% of the CTL clones, when presented to CTL 
by the same target cell. Val-27 mutations also reduced the HLA binding affinity of the 
peptide. The CTL inhibition was observed at physiological levels of peptide and was not 
due to competition with wild-type peptides for HLA binding or to anergy induction. As 
infected cells harbouring these viral variants would presumably escape cell-mediated 
elimination, the variant would be allowed to propagate. However this scenario is 
restricted in providing an explanation for the relevance of viral variation in the 
development of chronic disease. The CTL response against this epitope in the two patients 
studied was vigorous, in contrast to the weak CTL response normally observed in chronic 
cases. It was also focused on one epitope, in contrast to the multispecific nature of the 
CTL response against HBV.
Other studies have examined core protein epitopes recognised by B- or Th cells, the 
latter being recognised seemingly irrespective of HLA class II-restriction (Lerrari et al.,
1991). Akarca and Lok (1995a) claimed that the mutation cluster regions observed 
overlapped with both Th and B- cell epitopes. However, no functional analysis of the 
effects of these mutations has been attempted. The clusters of mutations observed by 
Carman et al. (1995b) also correlated with the positions of Th and B- cell epitopes, but 
again, these mutations were not analysed functionally. As the relevance of anti-HBe 
antibody in chronic infection is not fully understood, the importance of mutations 
observed within B-cell epitopes is hard to determine, but mutations with Th epitopes 
could weaken, or even eliminate, the CD4+ T cell response against core protein, with 
chronic hepatitis ensuing.
Another problem is relating viral variation to the ongoing disease observed in some 
patients. If variation within an epitope leads to non-recognition by the immune system, 
why do such patients have continuing disease? In addition, is the variation observed a 
result of immune pressure or does it evoke the immune response? The observation of 
mutation in the clustering region suggested by Ehata et al. (1992), after the ALT level had 
risen, supports the former possibility. However, the existence of a minor viral population 
having the same mutation before the ALT increase is also possible. It may also be the case 
that variation creates new targets for the immune system, thus evoking an ongoing, cyclic 
response.
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IE CORE PROTEIN
1E1 C haracterisation of the core protein
The discovery that expression of the core gene alone was sufficient to produce 
nucleocapsids, or core particles, antigenically (Pasek et al., 1979; Burrell et al., 1979) 
and morphologically (Cohen and Richmond, 1982) identical to the virion-derived 
nucleocapsid, initiated the search for the mechanism of core particle assembly and the 
amino acid sequence requirements. The ability of the core protein to self-assemble into 
core particles has now been demonstrated in mammalian cells (Roossinck and Siddiqui, 
1987), insect cells (Lanford and Notvall, 1990), yeast (Miyanohara et al., 1986), 
Xenopus oocytes (Zhou and Standring, 1991) and in vitro via association with a cytosolic 
chaperonin (Lingappa et al., 1994).
The predicted core protein amino acid sequence, derived from cloned HBV DNA, 
gave a 183 amino acid (185 for subtype adw  (Ono et al., 1983)) protein with a highly 
basic C-terminus (see Figure 1E1). In this region (amino acids 150-183), 16 out of the 34 
residues are arginines, arranged in four clusters of three or four arginines, including three 
repeats of the motif SPR4. The obvious prediction for the function of this region was 
nucleic acid binding. In addition, the repeated SPXX sequence is known to be a DNA- 
binding m otif (Suzuki, 1989).
The C-terminal limit for core particle assembly was investigated by a number of 
groups using C-terminally truncated core proteins in a variety of systems (Birnbaum and 
Nassal, 1990; Hatton et al., 1992;Nassal, 1992a;Beames and Lanford, 1993), as earlier 
experiments had indicated that the arginine-rich region was dispensable (Gallina et al., 
1989). All showed that residues C-terminal to P ro-144 were not required but truncation 
N-terminal to L eu-140 abolished particle production. Later studies showed that truncation 
C-terminal to Leu-140 allowed assembly (Zlotnick et al., 1996).
To test the predicted nucleic acid binding function of the C-terminal arginine-rich 
region, packaging of nucleic acids into particles formed from C-terminally truncated 
proteins was also assayed. Truncation after Arg-164 allowed the same amount of RNA 
packaging as full-length protein, showing the C-terminal nineteen amino acids to be 
dispensable (Birnbaum and Nassal, 1990; Nassal, 1992a). A different set of truncations 
were made by Hatton et al. (1992) in an adw  subtype core protein which sequentially 
removed groups of arginine residues. Truncation after residues 172, 162 or 157 all 
decreased RNA packaging by only two-fold, whereas truncation after Val-149 (A149) 
resulted in a twenty-fold decrease, suggesting that the first group of three arginine 
residues (150-152) was important. This was confirmed when the addition of four arginine 
residues to the A149 truncation restored packaging levels to only two-fold less than for 
full-length protein. Examination of DNA-binding and subsequent DNA synthesis showed
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1 MDIDPYKEFG ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP
51 HHTALRQAIL CWGELMTLAT WVGNNLQDPA SRDLWNYVN TNMGLKIRQL
101 0AJFHISC0TF GRE10LEYLV £@3VWIRTPP AYRPPNAPIL STLPETTWR 
145
151 RRDRGRSPRR RTPSPRRRRS QSPRRRRSQS RESQC
Nucleic acid 
binding:
RNA - strand +strand 
DNA DNA
NLS: (Eckhardt et al., 1991)
156 172 183
(Yeh eta!., 1990)
163 178
Figure 1E1: Functionally important regions of the core protein
The amino acid sequence of the core protein (subtype adw) is shown: other subtypes 
are missing the D and R residues at positions 153 and 154. The asterisk denotes the 
position of the maximal C-terminal truncations which still allow core particle assembly. 
Cysteine residues are shown in bold and residues comprising the hydrophobic heptad 
repeat element are boxed. Groups of arginine residues involved in nucleic acid binding 
are underlined and labelled, while the nuclear localisation signals (NLS) mapped by two 
groups are also indicated.
different requirements in the core protein: core proteins truncated beyond residue 157 did 
not bind DNA in South-western blots but the A162 truncation showed a high affinity for 
DNA, thus identifying residues 157-162 as the essential region for DNA binding. 
Interestingly this contains another group of arginine residues in an SPRR motif. As the 
A 162 and A172 truncations showed decreased DNA binding compared to full-length 
protein, the remaining two groups of arginines must also contribute. A model was 
proposed whereby the groups of arginines at 150-152, 159-161 and 166-169 were 
required for binding RNA, minus-strand DNA and plus-strand DNA, respectively, with 
the final group being redundant. This model was supported in experiments where strand- 
specific probes were used to demonstrate that the A164 truncation showed a defect in 
plus-strand DNA synthesis, possibly at the oligoribonucleotide primer translocation stage 
(Nassal, 1992a). In this genomic context, amino acid sequences beyond residue 164 were 
also non-essential for the formation of enveloped virions. This has been recently 
supported by results showing that only the initiation of minus-strand DNA synthesis is 
necessary for envelopment to occur (Gerelsaikhan et a l., 1996).
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The nucleic acid-binding properties of core protein fulfil two functions: the 
protein:nucleic acid interactions act to stabilise the particle structure and to condense the 
DNA into its most compact form. The latter function has been proposed due to the 
similarities between the core protein C-terminal amino acid sequence and cellular 
protamines, found in sperm.
How is this stable interaction eliminated to allow disassembly of the core particle 
during natural infection? As a virus-associated kinase (now known to be protein kinase C 
(Kann et al., 1993)) had been discovered with specificity for serine residues (Gerlich et 
al., 1982; Roossinck and Siddiqui, 1987), modification of the protein:nucleic acid 
interaction by phosphorylation of C-terminal serines seemed the most likely mechanism. 
Use of a phosphorylation state-dependent antibody against an epitope between amino 
acids 165-175 showed that Ser-168 and/or Ser-170 were phosphorylated in vivo  
(Machida et a l ,  1991). In addition, core protein synthesised in Xenopus  oocytes showed 
no detectable DNA binding, in contrast to bacterially-expressed protein, the only 
difference being phosphorylation of the C-terminal region of the former protein (Hatton et 
al., 1992). In in vitro binding experiments, phosphorylated core protein showed a 
decreased affinity for DNA (Machida et al., 1991).
1E2 A ssem bly o f core particles
Much of the information regarding the mechanism of core particle assembly has come 
from studies in Xenopus oocytes by the group of Standring. A population of 'free' core 
protein is the direct precursor of core particles, which self-assemble once a critical 
threshold level of 'free' core protein is reached (Zhou et al., 1992). Later work showed 
that the 'free' core protein population consisted mainly of disulphide-linked core protein 
dimers, but not of higher order structures (Zhou and Standring, 1992a). Particle assembly 
is a co-operative process which initiates once the concentration of core protein reaches an 
estimated 0.8pM and proceeds without the detection of any intermediates (Seifer et al.,
1993). Once formed, the particles showed an increased protease resistance compared to 
core protein dimers. As the C-terminal 44 amino acids are thought to be the major 
protease target it suggests that this region is located inside the particle, (Zhou et al., 1992; 
Seifer and Standring, 1994).
In the Xenopus system, removal of the nucleus did not affect particle production, 
which is in keeping with the observation that the majority of free core protein is also 
located in the cytoplasmic compartment (Zhou and Standring, 1991). However opinions 
differ with regard to this subject (see Section 1E4).
Due to their conservation among all mammalian hepadnaviruses, the function of the 
four cysteine residues in the core protein was examined in site-directed mutagenesis 
experiments. Replacement of all cysteine residues with serine or alanine had no detectable 
effect on dimer formation, particle assembly or envelopment (Nassal, 1992b; Nassal et
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al., 1992; Zhou and Standring, 1992b). In addition, such particles were antigenically 
identical to wild-type particles (Nassal et al., 1992). However, dimers and particles 
formed from the Cys-minus core protein did show a decreased stability (Zhou and 
Standring, 1992b). Therefore, these residues probably act to lock dimers and particles 
into their conformations and positions during particle assembly. Detailed analyses of 
disulphide bonding patterns and free thiol groups have shown that Cys-61 participates in 
a disulphide bond to the corresponding residue in another core protein subunit, whereas 
Cys-107 does not, due to its buried position in the folded core protein (Zheng et al., 
1992; Nassal et al., 1992). Cys-48 partially forms a disulphide bond, but also exists as a 
free sulphydryl group. Cys-183 does participate in disulphide bond with other Cys-183 
residues, but it is not clear as to whether these bonds form between core protein dimers 
(Nassal et al., 1992; Zheng et al., 1992) or between core protein monomers in one dimer 
(Seifer and Standring, 1994). In the virion, the free Cys-48 may be important for binding 
to one of the cysteine residues in SHBs, acting to link the core particle to the envelope 
layer. Lack of this residue in particular may have accounted for the slightly decreased 
envelopment of Cys-minus core particles observed by Nassal (1992b).
Although experiments in HepG2 cells using a modified yeast two-hybrid system have 
shown that core proteins from WHV and HBV (which differ at 46 residues) can hetero- 
oligomerise, subsequent co-expression of full-length and C-terminally truncated HBV 
core proteins in Xenopus  oocytes showed that dimer assembly was not a non-specific 
process (Chang et al., 1994). In these co-expression experiments, homodimers formed 
preferentially, even although the smaller protein was missing only 26 residues. As core 
protein monomers were undetected, dimerisation must occur rapidly after synthesis, with 
the core protein most likely associating with the nearest monomer. This is probably 
produced from the same polysome, thus giving rise to the observed cA-preferential nature 
of dimerisation.
Relatively little attention has been paid to the sequence requirements for particle 
assembly in the N-terminal and central regions of the protein. Analysis of particle 
assembly using twelve mutants of the larger and less homologous DHBV core protein 
showed that three to four amino acid insertions in the N-terminus and deletions of C- 
terminal amino acids were still assembly-competent. However N-terminal or central 
deletions, or a four amino acid central insertion eliminated particle assembly (Yang et al.,
1994). Similar studies with two to four amino acid linker insertion mutants throughout the 
core gene showed regions which were essential for assembly (Beames and Lanford,
1995). Core proteins with insertions after positions 36, 44, 66 and 89 all formed particles 
when expressed in insect cells, as did a K96R point mutant. However, when expressed in 
Huh7 cells, core protein with an insertion after position 69 also formed particles. When 
supplied in trans to transfected core-defective genomes, only core proteins with an 
insertion after residue 44 and the K96R mutant were able to encapsidate HBV RNA and
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show DNA synthesis in the endogenous polymerase assay, albeit at lower levels than 
wild-type core protein. These results showed that even though large insertions can be 
tolerated around residue 78 (See Section 1E5), much smaller insertions in both termini 
and in the central region of the protein can disrupt particle assembly, or other stages in the 
viral life cycle.
The central region of WHV core protein contains a hydrophobic heptad repeat element: 
L I01, L I 08, V I 15 and F I 22. These residues are conserved among the mammalian and 
avian hepadnaviruses (Yu et al., 1996). Mutagenesis experiments showed that changing 
the regular spacing of these residues abolished particle assembly, as did the introduction 
of a proline residue by mutagenesis of any amino acid in this region. This indicated that 
the secondary structure of this region was important, and probably a-helical, with the 
hydrophobic residues on the outer surface of the helix. This would provide a hydrophobic 
surface accessible to the equivalent region in another monomer, allowing the two proteins 
to interact in a manner analogous to leucine zipper-containing proteins. Although four 
residues are conserved in the mammalian protein (five for the larger DHBV protein), 
mutation of any one of these residues did not affect particle assembly. The conservation 
of four residues may be due to the increased stability this would give to the protein:protein 
interaction. Unfortunately the previous insertion mutants generated by Beames and 
Lanford did not cover this region, so correlations could not be made. Interestingly, 
Akarca and Lok (1995a) concluded that the region between amino acids 101-124 was 
devoid of mutations. In other studies, mutation of the heptad repeat residues was rare and 
tended to be conservative: L 1011 (Ehata et al., 1992) and L108I (Carman et al., 1995b) 
have been observed. Mutations producing proline residues in this region are also very 
rare.
1E3 Three-dim ensional structural analyses of core particles
Until recently, very little information was available concerning both the tertiary 
structure of the core protein and the orientation of the protein, as a dimer, in the core 
particle. Most of this information had come from direct biochemical studies on core 
particles along with indirect information obtained though the use of core particles as 
carriers of foreign epitopes (see Section 1E5).
Surface-exposed regions of core protein that bound to monoclonal antibodies were 
mapped by Pushko et al. (1994) and are shown in Figure 1E2. Some antibodies 
recognised only core particles in solution, but not denatured protein or synthetic core 
peptides (in a competition ELISA). This confirmed the existence of conformational core 
epitopes. These antibodies did, however, recognise immobilised peptide corresponding to 
amino acids 74-90, which may be a linear component of a larger discontinuous epitope, 
as was previously suggested (Sallberg et al., 1991a). This region is therefore likely to be 
exposed at the surface of the particle. The region between amino acids 125-133 was also
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5 1  HHTALRQAIL CWGELMTLAT WVGNNLQDPA SR DLW NYVN TNMGLKIRQL
125 * 133 145 **
1 0 1  LW FHISCLTF GRETVLEYLV SFGVW IRTPP A Y R PPN A PIL  S T L P E T T W R
134 ’  144
**153
1 5 1  RRDRGRSPRR RTPSPRRRRS QSPRRRRSQS RESQC
surface-exposed regions - Pushko et al. (1994) 
surface-exposed regions - Seifer and Standring (1994) 
surface-inaccessible regions - Pushko et al. (1994)
Figure 1E2: Surface-exposed regions of the core protein in core particles 
The amino acid sequence of the core protein is shown above. Lines above sequences 
indicate that these regions were identified as being exposed on the particle surface b y 
the workers indicated. Hatched lines below sequences indicate that these regions were 
not exposed at the surface.
surface-exposed, but the adjacent region from 134-144 had only low-level accessibility. 
Two proline residues at positions 134 and 135 possibly mediate this turn in the 
polypeptide backbone. Residues 9-20 were also surface-inaccessible and this N-terminal 
region may be important for assembly (Khudyakov et al., 1991).
Protease studies of core particles by Seifer and Standring (1994) showed that the C- 
terminal region between amino acids 145-153 was the only accessible target (see Figure 
1E2). This sequence was proposed to act as a hinge between the C-terminal domain and 
the N-terminal region essential for assembly. The basic C-terminal region was sensitive to 
proteolysis when in the form of dimers, but not when in particles, suggesting that it was 
tethered inside the core particle. This retention was shown to be mediated by the inter­
dimer disulphide bond formed by Cys-185, as increased surface exposure of the C- 
terminal domain was observed when this residue was deleted or the protein truncated after 
amino acid 172. The latter truncated protein was also capable of packaging RNA (Hatton
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et al., 1992), suggesting that a dynamic equilibrium exists between the interior and 
exterior localisation of the C-terminal region. Despite the seemingly conflicting results 
from these two studies, the polypeptide chain may loop around between amino acids 134 
and 144 and reappear on the core particle surface again, before once again burying itself 
after residue 153. As proteases with targets between residues 134 and 144 were not used 
it was not possible to test this theory.
These biochemical studies have been dwarfed by the results generated by the use of 
electron cryomicroscopy and image reconstruction in the study of the core particle 
structure. Early electron microscopic studies of liver-derived core particles had shown that 
particles were of 28nm external diameter and 21nm internal diameter, with a 3.5nm thick 
shell (Onodera et al., 1982). The particle was predicted to be icosahedral in shape with 
approximately 180 component subunits and aT=3 morphology. Electron cryomicroscopic 
studies on bacterially-expressed core particles by Crowther et al. (1994) showed two 
distinct sizes of particles with diameters of 30 and 34nm, with the larger particles forming 
85% of the population. The two different particle sizes were also observed in particles 
assembled from core protein C-terminally truncated after amino acid 144 (A 144 
truncation). Protein spikes were also visible projecting from the surface of the shells, 
giving overall diameters of 32 and 36nm for small and large particles, respectively. 
Particles formed from the expression of full-length protein were either empty or had 
internal contents, presumably RNA molecules. The A144 truncation particles appeared 
empty and contained <1% RNA by weight, compared to approximately 10% for the full- 
length protein particles.
Image reconstructions showed that the small particles consisted of 180 subunits, 
arranged with T=3 quasiequivalence and the large particles contained 240 subunits with 
T=4 quasiequivalence. In both types of particle, the subunits were dimer clustered and 
thought to have an inverted T  shape, with the 'handle' forming the spiked projections on 
the particle surface and the 'head' forming the shell of the particle. The mechanism of 
selection of the T=3 or T=4 morphology was not due to protein:nucleic acid interactions, 
as the A144 truncation protein also formed both types of particle. The C-terminal domain 
of full-length protein did seem to contact packaged RNA, as the RNA was ordered in an 
icosahedral orientation by this interaction. This allowed it to be detected and mapped. In 
empty particles no internal structure was observed, due to the absence of RNA and the 
disordered nature of the C-terminal protein domain. In both sizes of particles the shell was 
penetrated by 1.3 and 2nm holes (110 in the T=4 particles and 80 in the T=3), 
presumably allowing the influx of nucleotides for reverse transcription and DNA 
replication and the efflux of digested RNA. The two sizes were also present in the liver, 
as detected by electron microscopy (Cohen and Richmond, 1982). Although T=4 particles 
were more prevalent in bacterially expressed samples (Crowther et al., 1994), only 
recently has it been demonstrated that the same is true for liver-derived particles, with an
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even higher prevalence of the larger particles (Kenney et a l ,  1995). These liver-derived 
particles also contained more RNA, probably due to the increased efficiency of the 
encapsidation process in infected cells.
Further studies provided evidence for the importance of the C-terminus of the core 
protein and possibly the disulphide bonds in determining the particle morphology 
(Zlotnick et al., 1996). Progressive truncation of the region between amino acids 149 and 
140 decreased the proportion of T=4 particles produced from >90% to only 15% and, in 
addition, m oreT=3 particles were formed when a Cys61Ala mutation was created in the 
A149 truncation. The relevance of these results to the in vivo situation is not immediately 
clear.
The most recent structural studies have increased the core particle image resolution 
from the original limit of approximately 30A to 9 A (Conway et al., 1997) or 7 .4A 
(Bottcher et al., 1997; see Figure 1E3). The information made available by these studies, 
not only as regarding the overall structure of the core particle, but even concerning the 
exact conformation of the polypeptide backbone in the assembled particle, is invaluable. 
Prior to these electron cryomicroscopy studies, the only model had been theoretical 
(Argos and Fuller, 1988), based on the homology of WHV core protein with the Mengo 
virus vp3 capsid protein, which has an eight-stranded anti-parallel (3-barrel conformation, 
common to capsid proteins. The resulting model showed a protein with nine (3-sheets, 
comprising 48% of the polypeptide backbone, which concurred with the accessibility of 
the H Bel epitope and the inaccessibility of the HBe2 epitope; the requirement of the N- 
terminal 140 amino acids for particle assembly; and the internal orientation of the 
phosphorylation sites within core protein. However, later studies on bacterially expressed 
particles using several biophysical methods showed that, in contrast to the Argos and 
Fuller model, core protein had a high (43-60%) a-helical content, whether in the form of 
dimers or particles (Wingfield et al., 1995). The (3-sheet content of the protein was very 
low (5-35%), suggesting that core protein may not adopt the canonical eight-stranded 
anti-parallel (3-barrel conformation which all, but one, icosahedral viral capsids exhibit.
The new structural information did show that the HBV core protein conformation is 
structurally different to the standard isocahedral capsid protein: a new four-helix bundle 
viral capsid fold existed in the core particle, with neighbouring polypeptide chains 
contributing an a-helix pair to each bundle (Bottcher et al., 1997; Conway et al., 1997; 
see Figure 1E4). Core protein itself also contains four helices: helices 2 and 3 project out 
from the shell, while the other two contribute to the shell structure. In the model of 
Bottcher et al., helix 2 was predicted to run from residue 50-78, halted by a conserved 
proline at position 79, with residues 78-82 constituting the exposed tip of the spike (see 
Figure 1E5). However, Conway et al. placed these residues at the base of helix 2. 
According to Bottcher et a l ,  helix 3 then runs from residue 82-110, with a kink 
approximately halfway down corresponding to the conserved Gly-94 residue. The
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Figure 1E3: Surface representation of the T=4 core particle
The 31 oA diameter particle is viewed down a 2-fold axis of symmetry (Scale bar = 50A). 
The structure was determined at 9A resolution by electron cryomicroscopy. (This image 
was kindly provided by Dr. J. Conway, NIH, Bethesda)

Figure 1E4: Stereo pair of density maps with 'wire' model of the core protein dimer 
The core protein dimer is viewed tangentially to the particle surface. Subunits are shown 
in red and blue. Scale bar represents 10A. (This image was kindly provided by Dr. J. 
Conway, NIH, Bethesda)
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149
128
110,
112
Figure 1E5: Polypeptide fold of the core protein
The four a-helices of core protein are shown as cylinders and the putative N and C 
termini are marked. In the text, helices are numbered 1 to 4, from the N- to the C-terminus. 
An approximate numbering scheme for amino acids is also indicated. (Reproduced from 
Bottcher et a/. (1997) by kind permission of Dr. R. Crowther)
C-terminal helix runs from 112-128 and is also terminated by a proline residue at position 
129. The proposed exposure of the region between 125-133 also concurs with the model 
as this region lies at the end of the C-terminal helix, protruding on the surface of the 
particle. The models also show Cys-48 and Cys-61 to be present on the outer surface of 
helix 2, making them available for the disulphide bonding necessary for dimerisation. 
Cys-107 was shown to be buried within the protein. As these models were determined 
using C-terminally truncated proteins, no position was determined for Cys-183. 
However, as the C-terminus appears to have no defined structure, this residue is likely to 
be available for the formation of intra-dimer or inter-dimer disulphide bonds. The 
previously described hydrophobic heptad repeat element would be partitioned between 
helix 3 and the C-terminal helix with an intervening short looped region. It may be, 
therefore, that this element does not consist of a single continuous helix, as was originally 
thought, but contributes to two separate helices. Hopefully the increase in resolution that 
should come from further electron cryomicroscopic studies, possibly even to atomic level, 
will help in answering these questions.
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1E4 Subcellu lar Localisation of Core Protein
Immunohistochemical and immunofluorescence studies of liver biopsy samples from 
patients suffering from chronic hepatitis B have shown that core protein can be detected in 
the nucleus, cytoplasm or both (Gudat and Bianchi, 1977; Gowans et al., 1985; Ulrich et 
al., 1985; Chu and Liaw, 1987; Hsu et al., 1987; Chu et al., 1995). Similar results have 
been obtained for cell lines such as NIH 3T3 (Eckhardt et al., 1991; Yeh et al., 1993), 
Vero-C3 (Yeh et al., 1993), COS 7 (Yeh et al., 1990) and in HBV genome (Farza et al.,
1988) or core gene (Guidotti et al., 1994a) transgenic mice.
Studies using both COS 7 (Yeh et al., 1990) and NIH 3T3 (Eckhardt et al., 1991) 
cells have identified nuclear localisation signals (NLSs) in the C-terminal region of the 
core protein (see Figure 1E1). The clusters of arginine residues in this region resemble the 
stretches of consecutive basic amino acids observed to function as NLSs in other proteins 
such as the influenza virus NS1 protein (Greenspan et al., 1988), adenovirus E la  protein 
(Lyons et al., 1987), yeast histone 2B (Moreland et al., 1987) and nucleoplasmin 
(Dingwall et al., 1988).
Deletion analysis of the C-terminal arginine-rich clusters demonstrated the importance 
of residues 145-156 for nuclear localisation, as removal of the region C-terminal to 
residue 144 caused this protein to accumulate in the cytoplasm (Eckhardt et al., 1991), 
The possibility that this localisation was mediated by arginine residues between 150-154 
and the particular importance of the second residue in this cluster, as has been shown for 
the corresponding residue in the NLS of SV40 large T antigen (Kalderon et al., 1984), 
were examined by mutagenesis of this Arg-151 residue to a threonine. In the context of 
the full-length protein, cellular localisation was not affected by this mutation. However, 
when between 12-39 C-terminal residues were deleted, Thr-151 core protein localised to 
the cytoplasm, whereas the Arg-151 protein was located in the nucleus. These results also 
suggested the presence of a second NLS in the C-terminal 12 residues of the core protein 
(172-183), which also included an arginine cluster (amino acids 172-175). As yet it is not 
known whether these signals can function independently, although the presence of two 
NLSs in the same protein has been reported previously (Greenspan et al., 1988).
Yeh et a l  (1990) identified a C-terminal core protein NLS by examining the cellular 
localisation of human a-globin:HBV core fusion proteins in transfected COS 7 cells. The 
location of the NLS was finely mapped by demonstrating that core protein residues from 
Pro-163 to Ser-178 were necessary and sufficient to translocate the a-globin protein to the 
nucleus. This region contains two repeats of the sequence PRRRRSQS and is completely 
conserved in both WHV and GSHV.
Most studies agree that core protein detected in both the nucleus and the cytoplasm is 
in the form of core particles, as confirmed by electron microscopic examination (Yamada 
and Nakahane, 1977; Michalak and Nowoslawski, 1982; Sakamoto et al., 1983; Guidotti 
et al., 1994a). However, the results of Chu and Liaw (1992), obtained by the use of
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monoclonal antibodies specific for either the c or e antigenic determinants on core protein 
or particles, suggested that whereas particles may predominate in the nucleus, non­
particulate core protein was more prevalent in the cytoplasm. This was contradicted by 
Bock et al. (1996). who could not detect particles within the nuclei or at the nuclear 
membrane.
The function of the core protein NLS in the viral lifecycle is unclear as yet, although 
several possibilities exist: 1) transport of the uncoated core particle to the nucleus after 
viral entry, to deliver the genome; 2) directing newly synthesised core protein dimers or 
particles to the nucleus in order to allow pgRNA encapsidation into core particles; 3) 
directing newly assembled, genome-containing core particles to the nucleus to allow 
intracellular genomic amplification. As the NLS overlaps with the core protein nucleic 
acid binding region, it may not be accessible on the particle surface and therefore not 
detected by the cytoplasmic NLS-recognising proteins. The same problem exists if the 
NLS is involved in the third possibility listed above. It may be that some core protein C- 
terminal tails are not tethered in the particle interior and are surface-accessible, either 
because they are not required for nucleic acid binding or due to the lack of a disulphide 
bond between Cys-183 residues in the reducing environment of the cell. Immunoelectron 
microscopic examination of infected hepatocytes (Yamada and Nakahane, 1977) and an 
HBV-producing cell line (Bock et al., 1996) showed core protein localised around the 
nuclear membrane and especially near nuclear pores, suggesting that the transfer of 
contents between core particles and the nucleus does occur.
An additional focus on the investigation of core protein localisation has attempted to 
relate this to the disease severity. Several studies have concluded that purely nuclear 
localisation of core protein, as detected mainly by immunostaining or 
immunofluorescence of liver biopsy samples, is more prevalent in CPH and occurs rarely 
in cases of CAH (Hsu et al., 1987; Kojima et al., 1987; Yoo et al., 1987; Chu and Liaw, 
1987, 1992; Chu et al., 1995). Conversely, the localisation of core protein to the 
cytoplasm or plasma membrane was increased in CAH cases from these studies. In situ 
hybridisation in infected hepatocytes demonstrated that intracellular levels of cytoplasmic 
HBV replicative DNA correlated with the level of cytoplasmic core protein, but not with 
the presence or absence of nuclear core protein (Gowans et al., 1985). This suggests that 
cytoplasmic core protein is indicative of active replication In addition it was thought that 
the shift in localisation of core protein, especially if it led to increased plasma membrane 
expression, could lead to an increased immune attack on these cells. Both of these 
scenarios could explain the more aggressive disease connected with the cytoplasmic
location of the protein.
However, more recent experiments in both transfected cell lines and liver biopsy 
samples have shown that, rather than the shift in localisation being responsible for the 
worsened disease state, this subcellular shift may be a secondary effect, caused by the
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regeneration of surviving hepatocytes after immune-mediated killing of infected cells.
Yeh et al. (1993) showed that the nuclear localisation of core protein was subject to 
regulation by the cell cycle in both NIH 3T3 and Vero-C3 cells. Cells were synchronised 
in either the G0 phase (by using serum-free medium) or at the G,/S phase boundary (by 
using the DNA polymerase inhibitor, aphidicolin) and core protein localisation determined 
at various time points after cells were allowed to re-enter the cycle. The results from both 
subcellular fractionation and immunofluorescence experiments showed an increase in the 
amount of core protein in the nucleus during the G| phase. Nuclear core protein decreased 
during S phase to undetectable levels, with a concomitant increase in the cytoplasmic 
levels. Levels of nuclear core increased again during G2 phase. Double immunostaining 
for proliferating cell nuclear antigen (PCNA) and core protein in biopsy samples showed 
the same pattern (Chu et al., 1995). Approximately 50% of hepatocytes containing 
cytoplasmic core protein also stained positive for PCNA, a reliable marker for 
proliferating cells, whereas this antigen was rarely detected in cells with nuclear core 
protein. Although both sets of results are consistent with disease severity being linked to 
altered core protein localisation, a mechanism for the cell cycle dependency is still 
unknown. Yeh et al. (1993) observed that cytoplasmic but not nuclear core protein was 
phosphorylated. The C-terminus contains three S/TPXK/R recognition motifs for p34cdc2 
kinase, which is activated during the G] to S transition of the cell cycle. As this kinase can 
phosphorylate core protein in vitro (unpublished observations quoted by Yeh et al., 
1993), this may be relevant.
1E5 Structural Flexibility o f Core Particle Assembly
The ability of the core particle to be correctly self-assembled when expressed in a 
variety of systems, coupled with the presence of CTL, Th and B-cell epitopes on the 
protein and particle, make it suitable as a carrier for various foreign epitopes. Many 
chimeric core proteins, containing foreign epitopes, have been assayed for antigenicity. 
These studies are detailed in a recent review by Pumpens et al. (1995). These studies 
indicate a tremendous 'structural flexibility' of the core protein, shown by the range of 
alterations that can be made without abrogating particle assembly.
Foreign sequences from a variety of sources have been inserted at three major regions 
of the protein: the N-terminus (including the pre-core region), the C-terminus of full- 
length or truncated core protein and centrally in the region around amino acid 78.
N-terminal insertions of 50 (human chorionic gonadotrophin), 41 and 27 (HBV pre- 
S l)  amino acids have been made after pre-core residues Leu-24, Trp-26 and the core start 
codon, respectively (Beesley et al., 1990; Schodel et al., 1992).
Internal insertions have been made in the central region containing the main B-cell 
epitope, as this was predicted to be exposed (Argos and Fuller, 1988). Insertions of up to 
27 amino acids of the SIV envelope protein were possible in full-length core protein,
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between Ser-81 and Arg-82 (Yon et al., 1992) and of up to 39 amino acids from HBV 
SHBs in a C-terminally truncated protein, replacing core residues 79-81, although 
replacement of residues 76-82 has also been successful (Schodel et al., 1992).
Insertion of up to 53 amino acids of HBV pre-S2 sequence was possible between Pro- 
144 and Glu-145, at the C-terminus (Borisova et al., 1989), with smaller insertions 
between Arg-179/Glu-180 (del Val et al., 1991) and after the C-terminal cysteine residue 
(Yon et al., 1992). However perhaps the most impressive successful chimeric proteins 
were produced when multiple copies of the 180 amino acid long HCV core protein were 
added to the C-terminus of core protein truncated at residue 149 (Yoshikawa et al., 1993). 
Fusion of linker sequences plus either three or four copies of the HCV core sequence, to 
produce insertions of 559 and 741 amino acids respectively, maintained the ability to 
correctly assemble into core particles. Such large C-terminal insertions are possible due to 
the probable location of the foreign sequences in the interior of the particle. They may 
even be exposed on the particle surface as they are detectable by ELISA (Yoshikawa et 
al., 1993). The same mechanism may apply to the N-terminal insertion of foreign 
sequences. However, the proven ability of core protein to tolerate deletions of 
approximately 25% of its length, or to accommodate internal insertions of approximately 
20% of its size without protein folding or particle assembly being affected is quite 
remarkable. The structural flexibility of this protein may have a bearing on the relevance 
of naturally-occurring HBV variants with deletions of core gene regions.
1E6 HBV Deletion Variants
In addition to variation in the amino acid sequence of the HBV proteins resulting from 
nucleotide substitutions caused by the pol/RTase infidelity, variation on a larger scale, in 
the form of insertion and deletion of sequences, has also been reported. This section will 
describe some of the deletion variants reported, along with any significance that has been 
attributed to them, and then focus on core gene deletion variants.
I) Deletion variants o f  the polymerase, surface and X  genes
Although naturally occurring HBV isolates with amino acid variation in the 
polymerase gene have been reported, as yet no studies have shown deletions in genomic 
regions containing only polymerase sequences. Studies of either core (Okamoto et al., 
1987b), X (Feitelson et al., 1995) or surface (Yamamoto et al., 1994; Xu and Yen, 1996) 
genes have all reported deletions which would affect the N- or C-termini or internal 
regions of the polymerase protein, respectively. These deletions will be discussed under 
the headings of the specific gene being studied at the time of their discovery. In vitro 
mutational analysis of the polymerase gene did show that the spacer region, from amino 
acids 178-336, could be largely deleted (A201-292) with little effect on function 
(Radziwill et al., 1990).
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Many of the reported deletions in the surface gene occur in the pre-S regions, which 
overlap with the polymerase spacer region and so would probably not affect the function 
of the polymerase protein (Santantonio et al., 1992; Yamamoto et a l ,  1994). However 
the viability of these mutants has not been formally evaluated. This is especially important 
for deletions in the pre-S 1 region, as the corresponding region in the LHBs protein is 
implicated in binding to hepatocyte plasma membrane receptors. This also applies to large 
variations in the surface gene sequence, such as the mutations leading to the insertion of 
three or eight amino acids between Thr-123 and Cys-124 (Yamamoto et al., 1994; Hou et 
al., 1995), as this protein is also important for hepatocyte binding.
Functional analysis has been performed on an in-frame deletion of 129bp in the 3 ' 
pre-S 1 region, which removed the CCAAT element from the SpII promoter (Xu and Yen,
1996). When Huh-7 cells were transfected with a corresponding genomic construct, only 
very small amounts of 2.1 kb surface transcripts were produced, with resulting low levels 
of M and SHBs proteins. As this deletion also included the negative regulatory region for 
the Spl promoter, increased levels of 2.4kb pre-S 1 transcripts and LHBs protein were 
observed. As LHBs is incompetent for secretion, its overexpression caused the 
accumulation of 20nm particles within dilated perinuclear vesicles, giving the transfected 
cells the appearance of ground-glass cells which are commonly observed in HBV carriers 
(Hadziyannis et al., 1973). Virion production from the transfected cells was also greater 
than that observed for a wild-type control, suggesting that not only does this type of 
deletion have a pathological relevance, but may also confer the viral variant with a growth 
advantage.
Analysis of large variations in the X gene is complicated by the fact that the precise 
role of this protein in infection is unknown, making determination of their functional 
relevance difficult. This gene also overlaps with important transcriptional regulatory 
elements, such as enhancer II, core upstream regulatory sequence and negative regulatory 
element, core promoter and DR 1/2. In renal dialysis patients, X gene deletions resulted in 
removal of the pre-core start codon, DR2, core gene regulatory elements and also either 
removed sequences at the 3' end of the polymerase gene or produced possible X-core 
fusion proteins (Feitelson et al., 1995). Analysis of the same region, but concentrating on 
the relevance of variation to the enhancer ll/core promoter, showed that major viral 
populations had deletions, insertions and/or substitutions (Gunther et al., 1996a). All but 
two variations created an HNF1 site or potential HNF3 site. All variations decreased 
steady-state pre-core mRNA levels and increased pgRNA levels, with a consequent 
decrease in e antigen production and increased intracellular core and polymerase proteins, 
replicative intermediates and virion production.
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2) Core gene deletions
Many groups have now reported the detection of deletions within the core gene, which 
are detailed in Figure 1E6. In general, the deletions cluster in the central region of the 
gene, around nucleotide 2200, but some groups have reported deletions which localise to 
the 5' end of the gene, either exclusively (Valliammai et al., 1995; Zoulim et al., 1996) or 
as one of two deletions in the gene (Fiordalisi et al., 1994; Akarca and Lok, 1995b; 
Gunther et al., 1996b; Marinos et al., 1996; Zoulim et al., 1996). Some deletions 
extended far enough in the 3' direction to remove the polymerase ATG codon and 
presumably do not allow production of a functional polymerase protein (Okamoto et al., 
1987b; Akarca and Lok, 1995b; Marinos et al., 1996; Gunther et al., 1996b). In contrast 
to these cases with mixtures of polymerase defective and non-defective genomes, Uchida 
et al. (1994) reported a single polymerase defective deletion, which presumably 
represented a non-viable virus. However viral DNA containing no evidence of core gene 
deletions was also isolated from this patient, thus providing the requisite polymerase, in a 
manner analogous to the /rans-complementation demonstrated in vitro (Okamoto et al., 
1993). This scenario is common to all but two reported cases of core gene deletions: full- 
length virus can also be detected, either by PCR or sequencing of cloned PCR products. 
The only exceptions to this are of a 33 nucleotide deletion observed in clones sequenced 
from a patient with no anti-HBc antibodies (Valliammai et al., 1995) and an unspecified 
deletion present in all six genomic clones analysed from an immunosuppressed renal 
transplant patient (Gunther et al., 1995). The former deletion removed nucleotides 2021- 
2053, corresponding to core protein amino acids 41-51. Either the HBV viruses from 
these two cases were able to produce functionally normal, but structurally altered, core 
particles, or the number of clones analysed was too small to detect what may be a 
minority viral population with full-length core genes.
Despite the large number of deletion mutants described, their mechanism of generation 
has not been elucidated. Mapping of a 2.2kb HBV RNA isolated from HCC cases 
showed two deletions: an in-frame deletion in the core gene spanning nucleotides 2068- 
2349 inclusively (core amino acids 56-150) and a 1016 nucleotide deletion from the 3 ' 
end of the core gene (nucleotide 2454) into the 5' end of the surface gene (Chen et al.,
1989). Analysis of the boundaries of these deletions showed sequences which were 
conserved in all subtypes subsequently examined and the deleted sequences showed the 
consensus 5’ GC/T and 3' AG boundary sequences for introns, suggesting that these 
deletions were the products of RNA splicing. However, as the termini of all other 
deletions reported cover a large region of the core gene (nucleotides 1950-2334), with 
differing sequences at the boundaries, it is unlikely that RNA splicing is the usual 
mechanism responsible for their generation.
The contribution of core gene deletion variants to the disease states observed in
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Figure 1E6: Summary diagram of core gene deletions (continued with figure legend on 
following page)
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Figure 1E6: Summary diagram of reported core gene deletions (continued)
All reported cases of core gene deletions are summarised diagrammatically, along with 
the positions of the deletion/s. Numbers in brackets indicate the amino acids deleted. 
Deletions marked with an asterisk (* )  resulted in a frame-shift of the core gene. Asterisks 
at additional positions in the gene show nucleotide deletions resulting in frame-shifts. 
Cases marked with a cross (x) show the presence of a novel stop codon either in 
addition to the deletion, or resulting from the frame-shift. The position of the polymerase 
start codon is also shown.
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patients is also unknown at present. The presence of deletions has been demonstrated in 
cases of CAH, but not in ASCs (Wakita et al., 1991; Takanayagi et al., 1993; Uchida et 
al., 1994); in e antigen positive CAH cases, but not those with CPH or anti-HBe positive 
CAH (Ackrill et al., 1993); in e antigen positive patients with severe liver damage but no 
evidence of anti-HBe antibody (Zoulim et al., 1996); and in patients with a similar anti- 
HBc negative serology, but for whom no clinical details were given (Fiordalisi et al., 
1994; Valliammai et al., 1995). These results all point towards a role for core deletion 
variants in severe chronic hepatitis. However, other similar studies have not supported 
this hypothesis, finding deletions in e antigen positive patients with either CAH, CPH or 
non-specific reactive hepatitis (Akarca and Lok, 1995b) and in symptom-free carriers 
(Okamoto eta l., 1987b).
Two studies of chronic HBV-infected immunosuppressed renal transplant patients 
have shown that if deletions persist or increase, cirrhosis or death from end-stage liver 
disease occurs, whereas if the deletions disappear, no further liver deterioration is 
observed (Gunther et al., 1995, 1996b). In patients with an absence of deletions, only a 
few cirrhosis cases occurred and no mortalities.
As the general positions of the deleted regions correspond well to the locations of core 
protein epitopes, the deletion variants have been proposed to represent viral escape from 
the immune response. Even though the core-specific CD4+ Th cell response is thought to 
be the most important determining factor in whether or not chronic or acute disease 
develops, epitopes related to all branches of the host immune response are affected by the 
overall range of deletions observed. In the absence of HLA-typing studies of patients with 
deletions, the relevance of the CTL epitopes cannot be determined. However as certain Th 
epitopes are HLA type-independent, disruption of these epitopes may contribute to the 
chronic disease. Additionally, although B-cell epitopes were also affected by the 
deletions, the significance of this is difficult to determine without further studies on the 
role of the anti-HBe or anti-HBe responses.
1E7 Aim s of the work presented in this thesis
The main aim of the work presented in this thesis was to determine whether or not 
core genes with naturally-occurring central deletions were competent lor core particle 
assembly. This would allow an assessment of their relevance in HBV infection. If core 
particle-like structures were able to form when these core genes were expressed, their 
ability to react with monoclonal and polyclonal antibodies would be assayed. This would 
determine whether or not this class of variant virus could iepresent escape fiom the host 
immune response.
As very little information was available on the three-dimensional structure of the HBV 
core particle when these studies were initiated, we also planned to provide samples of 
purified wild-type core particles to collaborating groups in oider to assist this work. The
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three-dimensional structures of any core particle-like structures formed from core deletion 
proteins would also be examined.
The core gene deletions examined in this thesis were all isolated by the group of Dr. 
N. Naoumov (Kings College, London). Expression of the core protein with amino acids 
84-109 deleted had been initiated by this group using a recombinant baculovirus and both 
this and a similar virus expressing full-length core protein were kindly given to us in 
order that we could initiate our studies.
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2A Materials 
2A1 Plasmids
Plasmid p R l-1 1 was a kind gift from Prof. K. Murray (University of Edinburgh). 
This pBR322-based plasmid contained a fusion of (3-gal actosidase coding sequence and 
a fragment of the HBV genome containing the core gene (Stahl eta l., 1982). The fusion 
protein expressed was under the control of the lacUV5 prom oter and the cloning 
strategy resulted in the protein expressed containing 10 N-terminal amino acids of [3- 
galactosidase with the core start codon deleted and the aspartate residue at position 2 
mutated to a histidine (Figure 2A1). For the purposes of this project, the HBV fragment 
was excised from the plasmid with an Eco RI/Bam  HI digest and replaced by PCR- 
amplified core gene sequence.
Core gene sequence:
M D I D P Y K E . . . .  
ATGGACATTGACCCTTATAAAGAA. . .
pR1 -11:
Eco RI site
M T M I T D S L E F H I D P Y K  E . . . .  
GC TATGAC CATGATTACGGATTCACTGGAATTCCACATTGACCC TTATAAAGAA. . .
lac DNA original core gene sequence
Figure 2A1: Core protein expression from plasmid pR1 -11
Plasmid pR1 -11 was used for expression of full-length and deletion core proteins in 
E.coli as described in the text. The core protein produced from this plasmid is a fusion 
protein with 10 N-terminal [3-galactosidase residues, including the start codon. The 
original core protein methionine is missing and the aspartate residue at position 2 of 
core is mutated to a histidine.
Plasmids pET3a and pET9a were obtained commercially from Novagen (see 
Figure 2A2). Core gene sequences amplified by PCR with primer pair cp3 and Bamtag 
were cloned using the NdeMBamWl sites, placing them under the control of the
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Figure 2A2: Map of plasmid pET3a
Plasmids pET3a and pET9a were used for the expression of full-length core genes and 
core gene deletions in E.coli. Core genes were amplified by PCR using primer pair 
cp3/Bamtag or cp3/cd2 (see Section 2A3) for cloning into pET3a or pET9a, 
respectively. Genes were cloned between the Nde I and Bam HI sites and were 
expressed under the control of the T7 promoter. Plasmid pET9a is identical to the 
plasmid shown, but encoded resistance to kanamycin instead of ampicillin.
bacteriophage T7 transcription and translation signals. Plasmid pET3a also encoded 
ampicillin resistance and pET9a encoded kanamycin resistance.
Plasm id pRK5 was obtained from Prof. H. Will (Heinrich Pette Institut, 
H am burg). This pUC118-based plasmid contains a CMV IE prom oter and SV40 
polyadenylation site to allow expression of cloned genes in mammalian cells, as well as 
the gene for ampicillin resistance. This plasmid is shown in Figure 2A3.
Plasmid pTZ18R was purchased commercially from Pharmacia. This plasm id 
contains a gene conferring ampicillin resistance and also the pUC18 multiple cloning 
site, which was located in the middle of the lac Z ' gene, allowing blue/white colour 
selection of recombinant plasmids on LB agar plates supplemented with IPTG and X- 
gal. This plasmid is shown in Figure 2A4.
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SV40 polyA site
SV40 ori
Figure 2A3: Map of plasmid pRK5
Plasmid pRK5 was used to express full-length core genes and core gene deletions in 
mammalian cells. Full-length core genes and core gene deletions were amplified by 
PCR using primer pair cpk/Hintag (Section 2A3) and cloned into Eco RIIH in  d lll- 
digested pRK5.
2A2 Enzymes
Restriction enzym es were obtained from Boehringer M annheim , with the 
exception of N d e l , which was obtained from New England Biolabs. RNase and 
lysozyme were purchased from Sigma. DNase I, calf intestinal phosphatase, T4 DNA 
ligase and proteinase K were all purchased from Boehringer M annheim. E. coli DNA 
polymerase I Klenow fragment and T4 polynucleotide kinase were purchased from New 
England Biolabs. PCR was carried out using Thermus aquaticus DNA polym erase 
obtained from Gibco. DNA polymerase I/DNase I was also obtained from Gibco.
2A3 Synthetic oligonucleotides
Oligonucleotides were synthesised on site using a Cruachem PS250 automated 
synthesiser by Dr. J. McLauchlan, Miss S. Fitzpatrick, Mr. J. McGeehan or Mr. R. Reid. 
Oligonucleotides used during this project are listed in Table 2A5.
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Figure 2A4: Map of plasmid pTZ18R
Core genes were amplified by PCR amplification of HBV DNA, extracted from human 
serum, using primer pair C1/C2 (see Section 2A3). Amplified core genes were made 
blunt-ended and cloned into Sma l-digested pTZ18R. The lac Z  gene allowed 
identification of recombinant plasmids by blue/white colour selection.
2A4 Bacteria (E. coli strains)
The E.coli strain D H 5a(O 80dlacZAMJ5 recAl endAl gyrA 96 thi-1 hsdR17(rk~ 
m k-) supE44 re lA l deoR A(lacZYA-argF)U  169) was used for m aintenance and 
propagation of plasmid DNA and for expression of core protein from plasmid pR 1-11.
Strain BL21(DE3)pLysS (F" ompT hsdSB(rB' m o d e r n  ga l X ( DE3) pLysS(Cm r) 
(Studier et al., 1990) was used for expression of proteins using pET vectors: the 
integrated lysogenic X bacteriophage DE3 has an IPTG inducible lacUV5 prom oter 
from which T7 RNA polymerase is expressed and the plasmid pLysS encodes T7 
lysozyme and also a gene conferring chloramphenicol resistance.
2A5 Bacterial culture media
The D H 5a strain was grown in L-broth (lOg NaCl, lOg BactoTryptone, 5g yeast 
extract in 11 water) and the BL21(DE3)pLysS strain in 2YT broth (5g NaCl, 16g 
BactoTryptone, lOg yeast extract in 11 water). Agar plates were made with 1% (w/v) 
agar in L-broth.
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W here necessary, media and LBagar plates were supplemented with antibiotics: 
lOOmg/ml am picillin for bacteria harbouring plasmids pR 1-11, pET3a and pRK5, 
30m g/m l kanam ycin for strains harbouring the pET9a plasm id and 25m g/m l 
chloram phenicol for strains harbouring the pLysS plasmid. For blue/w hite colour 
selection, bacteria transformed with plasmid pTZ18R were plated onto LB agar plates to 
which lOmg/ml X-gal (Section 2A9) and 50mM IPTG had been added.
2A6 Cell culture media
All cell culture media were obtained from Gibco.
S/21 cells, derived from the pupal ovarian tissue of the fall army worm  
(Spodoptera frugiperda), were grown in T C I00 Medium supplemented with 5% bovine 
calf serum  (A pplied Protein Products), 100 units/m l penicillin and 100gg/ml 
streptomycin (Gibco).
COS 7 cells (Gluzman, 1981) and HepG2 cells (Knowles et al., 1980) were grown 
in Dulbecco's modified Eagles Medium (DMEM) supplemented with 10% bovine calf 
serum, 2mM glutamine (Gibco) and antibiotics as before.
2A7 Antibodies
The anti-core mouse monoclonal antibodies ocHBcBFl-5 were a kind gift from Dr. 
B. Ferns (University College Hospital, London) and were used at a recom m ended 
dilution of 1:10.
Anti-core mouse monoclonal antibody 42B12 was a kind gift from Prof. W .H. 
Gerlich (Justus-Liebig Universitat, Giessen). The antibody was thought to recognise an 
epitope between residues 115-135, and was used at a dilution of 1:750.
The anti-pp65 mouse monoclonal antibody 9220 was purchased commercially 
from Capricorn Products Inc. and was used at a 1:1000 dilution on Western blots and at 
a 1 GOO dilution for immunofluorescence assays.
Anti-core rabbit polyclonal antisera were purchased com mercially from Zym ed 
Laboratories Inc., Dako Corporation and Life Sciences. These were used at dilutions of 
1:2, 1:1000 or 1:200, respectively on Western blots. The Zymed polyclonal antiserum 
was used undiluted in immunofluorescence assays.
Goat anti-mouse IgG whole molecule peroxidase conjugate, goat anti-rabbit IgG 
whole molecule peroxidase conjugate, goat anti-mouse IgG whole m olecule FITC 
conjugate and anti-rabbit IgG whole molecule FITC conjugated immunoglobulin were 
all supplied by Sigma.
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Sense primers
Primer Position Sequence (5'>3‘)
cd1
cp3
1905-1932 (core 
gene)
1901-1922
ggaattccAC ATT G ACCCGTAT AAAG AATTTGG A 
GC
ggaattccatATGG AC ATT G ACCCGTAT AAAG
s1
s4
cd4
2112-2140 (core)/458- 
479 (surface)
458-479 (surface) 
2264-2289
GGGTGGGAAGTAATTGGAAGACCCAGCAGG
TATGTTGCCCGTTTGTCCTC
GGTATGTTGCCCGTTTGTCCTC
TTT/CGGAGTGTGGATTCGCACTCCTCC
5f1 OA 
5f20A 
5f30A
2145-2170/2264-2286
2179-2200/2264-2286
2205-2230/2264-2286
CCCTTGATCATCAGTCGATACAGTTA/TTTGG
AGTGTGGATTCGCACTCC
CCCGGATTTTTAGTCCGTTGAT/TTTGGAGTG
TGGATTCGCACTCC
C C A A AGT G T AAAG G ACG G A AT G A A A A/TTT G G 
AGTGTGGATTCGCACTCC
3f 10 
3f20 
3f30
2234-2258
2204-2233
2174-2206
AG AG AG ACT GT ACTT G AAT ATTTGGTCT CTTT 
CGG
T G GTTT CAT AT AT CTT G CCTT ACTTTTGG A AG 
AGAGACTG
AACATGGGTTTAAAGATCAGGCAACTATTGTG
G
cpk
C1
1901-1914
1737-1754
ggaattcATGGACATTGACCC
GAGTTGGGGGAGGAGATT
Table 2A5: Oligonucleotide primer positions and sequences (continued on following 
page). Numbering is according to Ono et al. (1983).
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Antisense primers
Primer Position (core gene) Sequence (3'>5‘)
cd2 2441-2458 GCCCTT AG AGTT AC AAT Cgccctagggc
Bamtag 2439-2455 GAGCCCTTAGAGTTACActcgcgttctgcggggcgc
agtggccgccgatccctagggc
Thrtag 2267-2284 GGAGTGTGGATTCGCACTctcgcgttctgcggggc
gcagtggccgccgatccctagggc
s2 557-580
(surface)/2264-2291
(core)
GGGAGAACAACGACATGTTTTGGA-
AAACCTCACACCTAAGCGTGAGGAGGGC
s3 557-580 (surface) GGGAGAACAACGACATGTTTTGGA
cd3 2112-2140 CCCACCCACCATTAAACCTTCTGGGTCGT
5f10 2145-2170 CCCTTGATCATCAGTCGATACAGTTA
5f20 2179-2200 CCCGGATTTTTAGTCCGTTGAT
5f30 2205-2230 CCAAAGTGTAAAGGACGGAATGAAAA
3f10A 210-238/332-356 CCCACCCATTATTAAACGTTCTAGGTCGT-
TCTCTCTGACATGAACTTATAAACC
3f20A 210-238/302-331 CCC ACCC ATT ATT AAACGTT CT AGGTCGT - 
ACC AAAGTAT AT AG AACGG AATG AAAACC
3f30A 210-238/272-293 CCCACCCATTATTAAACGTTCTAGGTCGT- 
TTTGTACCC AAATTT CT AGTCCG
Hintag 2439-2455 GAGCCCTTAGAGTTACActcgcgttctgcggggcgc
agtggccgccgatcttcgaagggg
C2 2475-2495 TTCC ACCCTTTG AAAT G ACCC
Primer sequences for amplification of surface gene regions are shown in bold 
Restriction enzyme sites and non-coding sequences are shown in lower case 
pp65 epitope tag sequences are shown in bold lower case
Table 2A5: Oligonucleotide primer positions and sequences (continued). Numbering is 
according to Ono et al. (1983).
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2A8 Radiochemicals
All radiochemicals were purchased from Amersham at the following specific activities: 
a 32P-dATP 3000Ci/mmol (10pCi/pl)
a 32P-dTTP 3000Ci/mmol (lOpCi/pl)
35S-L-Methionine ~800Ci/mmol (15pCi/pl)
a 35S-dATP lOOOCi/mmol (lOpCi/pl)
2A9 Solutions
6xagarose gel loading buffer:
Blocking buffer (Western blots): 
Coomassie stain:
40xdNTPs 
Denaturation buffer: 
50xDenhardt's solution:
2xHBS:
Hybridisation buffer:
5xkinase buffer:
5xligase buffer:
Lysozyme extraction buffer:
Miniprep solution I:
Miniprep solution II:
Miniprep solution III: 
Neutralisation buffer: 
Oligonucleotide elution buffer:
Oligonucleotide sample buffer: 
PBS(A):
PBS:
lxTE, 40% sucrose, 1 mg/ml bromophenol 
blue
3% gelatin in TBS
0.2% Coomassie brilliant blue, 50% methanol, 
5% acetic acid in water 
lOmM of each of dATP, dCTP, dGTP, dTTP 
0.6M NaCl, 0.2M NaOH 
1% polyvinylpyrrolidine, 1% ficoll, 1% BSA 
280mM NaCl, 50mM HEPES, 1.5mM 
Na2HP0 4 , pH to 7.05 with NaOH 
5xSSC, lOxDenhardt's solution, 0.5% SDS, 
20pg/pl denatured salmon sperm DNA 
350mM Tris.HCl, 50 mM MgCl2, 25mM DTT, 
5mM ATP, pH7.6
250mM Tris.HCl, 50mM MgCl2, 5mM ATP, 
5mM DTT, 25% PEG 8000, pH7.6 
50mM Tris.HCl, lOOmM NaCl, 0.2mM EDTA, 
ImM lysozyme, 1.5mM MgCl2, 0 .5m M  
PMSF, pH8.0
25mM Tris.HCl, 50mM glucose, lOmM EDTA,
0.2N NaOH, 1% SDS
3M potassium acetate, 11.5% acetic acid
1M Tris.HCl, 0.6M NaCl, pH8.0
0.5M ammonium acetate, lOmM M gCl2 , 0.1%
SDS, ImM EDTA
90% deionised formamide in lxTBE
170mM NaCl, 3.4mM KC1, lOmM Na2H P 0 4,
1.8mM KH2P 0 4, pH 7.2
PBS(A) plus CaCl2.2H20  and MgCl2.6H20  at
lg/1
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Pre-hybridisation buffer:
Protein gel destain: 
lOxSDE:
SDS PAGE buffers:
(i) 3xSDS PAGE sample buffer:
(ii) 3xSDS PAGE sample buffer: 
(non-reducing)
(iii) RGB (resolving gel buffer):
(iv) SGB (stacking gel buffer):
(v) Tank buffer:
Serum extraction buffer:
Sonication buffer:
20xSSC:
50xTAE
lOxTBE:
TBS:
TE:
TE/RNase:
TN buffer:
TNE I:
TNE II:
Towbin blotting buffer:
TTBS:
Versene:
X-gal
5xSSC, 5xDenhardt's solution, 0.1% SDS,
20ptg/pil denatured salmon sperm DNA 
50% methanol, 5% acetic acid in water 
250mM sodium acetate, 25mM EDTA
10% SGB, 2% SDS, 5% p-ME, 10% 
glycerol, 1 mg/ml bromophenol blue 
10% SGB, 2% SDS, 10% glycerol, lmg/ml 
bromophenol blue 
1.5M Tris.HCl, pH8.8 
0.5M Tris.HCl, 0.4% SDS, pH6.9 
40mM Tris, 185mM glycine, 0.1% SDS 
lxSDE, lmg/ml proteinase K, 0.45% SDS, 
lOpg/ml tRNA
50mM Tris.HCl, 1% Triton X-100, pH8.0 
3M NaCl, 0.3M trisodium citrate 
2M Tris, 50mM EDTA, pH to 8.0 with acetic 
acid
liM Tris, 1M boric acid, 20mM EDTA 
20mM Tris.HCl, 500mM NaCl, pH7.5 
lOmM Tris.HCl, ImM EDTA, pH8.0 
lxTE, 20fig/ml RNase 
50mM Tris.HCl, lOOmM NaCl, pH8.0 
lOmM Tris.HCl, 50mM NaCl, 0 . ImM EDTA, 
pH7.4
50mM Tris.HCl, lOOmM NaCl, 0.2mM EDTA, 
0.1% Triton X-100, 1.5mM MgCl2 , 0.5mM 
PMSF, pH8.0
25mM Tris.HCl, 192mM glycine, 20% methanol, 
pH8.3
TBS plus 0.05% Tween-20
0.6mM EDTA in PBS(A), 0.002% phenol red
20mg/ml X-gal in dimethylformamide
2A10 Chemicals and reagents
All chemicals and reagents were purchased from BDH Chemicals UK or fiom Sigma 
Chemical Co. unless otherwise stated in this section or in the Methods section.
Aldrich: 4-Chloro-l-naphthol
Beecham Research: Ampicillin
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Bio-Rad:
Boehringer Mannheim 
Camlab:
DuPont:
Gibco:
Melford Laboratories: 
Pharmacia:
Prolabo:
TEMED, ammonium persulphate, Coomassie brilliant 
blue, gelatin 
Tris, agarose
Phenol:chloroform (25:24:1 with isoamyl alcohol)
En3Hance
IPTG, tRNA
CsCl
ATP
Boric acid, butanol, chloroform, ethanol, glycerol, 
hydrochloric acid, isopropanol, methanol
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2B Methods
2B1 Nucleic acid manipulation and cloning procedures 
2B1.1 Large scale plasmid DNA preparations
(i) Continuous CsCl:EtBr gradients
An aliquot of E .co li harbouring the plasmid was spread on an agar plate 
containing the appropriate antibiotics (see Section 2A5) and incubated overnight at 
37°C. Colonies were inoculated into 300ml L-broth containing the appropriate 
antibiotics and incubated overnight at 37°C with shaking.
Plasmid DNA was prepared by a modification of the alkaline lysis method of 
Birnboim and Doly (1979) and supercoiled plasmid DNA was purified on CsCl 
gradients. Bacterial cultures were centrifuged at 6k rpm for 15min at 4°C (Sorvall GS3 
rotor) and the pellets resuspended thoroughly in 5ml miniprep solution I. Fresh 
miniprep solution II was prepared and 10ml was added to the resuspended cell pellet, 
which was then mixed by several inversions and incubated on ice for 5min. Ice-cold 
miniprep solution III (7.5ml) was added and the mixture shaken vigorously to mix, 
followed by a lOmin incubation on ice. Cell debris was then pelleted by centrifugation 
at 3k rpm for 15min at 4°C (Sorvall SS34 rotor). The supernatant was carefully 
removed and mixed with an equal volume of phenol:chloroform solution before being 
centrifuged again at 3k rpm (Sorvall RT6000B benchtop centrifuge) for lOmin at 4°C 
and the aqueous phase retained. DNA was precipitated by the addition of 0.6vol 
isopropanol and collected by centrifugation at 3k rpm (Sorvall RT6000B) for 20min at 
4°C. The pellet was air dried, resuspended in CsCl solution (10ml water plus lOg CsCl) 
and 0.4ml lOmg/ml EtBr solution added. ProteimEtBr complexes were removed by 
centrifugation at 3k rpm (Sorvall RT6000B) for 15min at 18°C and the supernatant 
transferred to a Beckman Quick-Seal centrifuge tube. Tubes were balanced with CsCl 
solution and heat sealed using metal former caps. Supercoiled plasmid DNA was 
purified by centrifugation at 45k rpm (Sorvall T1270 angled rotor) for 64hr at 18°C. 
The plasmid DNA band was removed using a syringe, taking care to avoid 
contamination from the upper chromosomal DNA band. The EtBr was removed from 
the plasmid solution by 2-3 extractions with TE-saturated butanol and diluted by the 
addition of 3vol of water. DNA was precipitated by the addition of 3.5vol of ethanol 
and incubation at -20°C. The DNA was pelleted by centrifugation at 3k rpm (Sorvall 
RT6000B) for lOmin at 4°C, resuspended in 2ml water and reprecipitated by the 
addition of 0.5vol 7.5M ammonium acetate and 2vol ethanol. After centrifugation at 3k 
rpm (Sorvall RT6000B) for 30min at 4°C the DNA pellet was air dried and resuspended 
on 200pl TE.
70
Chapter 2 Materials and M ethods
(ii) Plasmid purification using Qiagen columns
Qiagen columns were occasionally used to purify smaller quantities of plasmid 
DNA for use in sequencing reactions. Bacterial lysates are applied, under defined salt 
conditions, to the column resin and the DNA is selectively bound and purified from 
RNA, proteins and other cellular contaminants.
Sm aller 50ml cultures were grown as above and the cells pelleted by 
centrifugation at 6k rpm for 15min at 4°C (Sorvall GSA rotor). The cell pellet was 
resuspended thoroughly in 4ml of buffer PI, 4ml of buffer P2 was added and mixed by 
inversion 5-6 times. After a 3min incubation at room temperature 4ml of buffer P3 was 
added, the solution mixed immediately by several inversions and incubated on ice for 
15min. After centrifugation at 16k rpm (Sorvall SS34 rotor) for 30min at 4°C, the 
supernatant was removed and added to a Qiagen 100 column, equilibrated with 4ml 
equilibration buffer QBT. After the supernatant had dripped through, the resin was 
washed twice with 10ml wash buffer QC before elution of the DNA by the addition of 
6ml elution buffer QF. Plasmid DNA was precipitated by the addition of 0.7vol 
isopropanol and centrifugation at 10k rpm (Sorvall SM24 rotor) for 30min at 4°C. The 
pellet was washed with 70% ethanol, air dried and resuspended in 1 OOjul TE.
Plasmid concentrations were determined by measuring the absorbance at 260nm, 
assuming 1 A26o=50|ig/ml.
2B1.2 Miniprep plasmid DNA preparation
Single colonies of transformed bacteria were inoculated into 3ml of L-broth 
containing the appropriate antibiotics and incubated overnight at 37°C with shaking. 
Aliquots (1.5ml) of the cultures were centrifuged at 13k rpm for 30sec in a microfuge 
and the pellet resuspended in lOOpl of miniprep solution I. A 250pl aliquot of fresh 
miniprep solution II was added and mixed by several inversions before addition of 
1 50 j l l 1 of ice-cold miniprep solution III, which was mixed by vortexing. A lOOpl aliquot 
of phenol:chloroform was then added to the mixture, which was vortexed once more 
before centrifugation for lOmin in a microfuge. Plasmid DNA was precipitated from the 
aqueous phase by the addition of 400pl ethanol and pelleted by centrifugation for 20min 
in a microfuge. The pellet was washed with 70% ethanol and air-dried before 
resuspension in 30pl TE/RNase and incubation at 37°C lor 30min.
2B1.3 Restriction enzyme digestion of DNA
Restriction enzyme digestion of DNA was carried out at 37°C (or the temperature 
specified by the supplier) in 20|il volumes using 1 unit of enzyme per 0.5pg DNA per 
hour in the buffer supplied with the enzyme. The buffer system used most often was the 
Boehringer Mannheim A, B, M, L, H system and less frequently the New England
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Biolabs NEBuffer 1, 2, 3, 4 system. Typically 0.5pg DNA was digested to identify 
recombinant plasmids and l-5pg for isolation of specific restriction fragments.
2B1.4 Electrophoretic separation and purification of DNA fragments
(i) Non-denaturing agarose gels
DNA fragments produced by restriction enzyme digestion or PCR were resolved 
by non-denaturing agarose gel electrophoresis. Horizontal slab gels approximately 
0.5cm thick were used and samples loaded following the addition of agarose gel loading 
buffer. For separation of fragments over 200bp, 1% agarose gels in lxTBE were made 
up to a final concentration of lpg/ml EtBr before casting and run at 7V/cm in lxTBE 
buffer, containing EtBr. For separation of small PCR products, 2% agarose gels were 
used. Gibco lOObp ladder or lkb ladder standard size markers were used where 
appropriate. Following electrophoresis, DNA was visualised under short-wave UV light 
(long-wave for preparative gels). Photography was carried out using The Imager 
(Appligene).
(ii) Purification of DNA from agarose gels
Agarose blocks containing appropriate DNA fragments were excised from gels 
under long-wave UV transillumination and the DNA recovered using a commercial kit, 
Geneclean II (Bio 101 Inc., La Jolla, CA). The kit contains a silica matrix which binds 
DNA in the presence of high concentrations of sodium iodide. Agarose blocks were 
mixed with 4.5 volumes of Nal solution and 0.5 volumes TBE modifier and incubated 
at 55°C until the gel slice had melted. The silica matrix was then added (5pl for up to 
5gg DNA) and the mixture vortexed and incubated on ice for 5min, with further 
occasional mixing. Following a 30sec centrifugation, the silica matrix was washed 3 
times in 500ml ’NEW ’ wash and the DNA eluted into an appropriate volume of water by 
mixing the washed pellet with the water and incubating at 55°C for 5min. The matrix 
was again pelleted and the supernatant containing the DNA removed for subsequent 
use. The Geneclean II kit was also used in situations where electrophoresis was not 
required, particularly for separating DNA from nucleotides and PCR primers. In these 
cases, 3 volumes Nal were used and the TBE modifier omitted.
(iii) Non-denaturing polyacrylamide gels
Vertical non-denaturing polyacrylamide (Protogel (acrylamide:bisacrylamide 
37.5:1), National Diagnostics) gels, containing lxTBE, were used to purify synthetic 
oligonucleotides. Polymerisation was instigated by adding lOOpl TEMED and 100 pi 
25% APS. Prior to loading, oligonucleotides were boiled with sample buffer for 2min. 
Electrophoresis was carried out using 15% polyacrylamide gels (0.3cm thick x 25cm 
long) in lxTBE running buffer at 200V for 3-5hr.
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(iv) Denaturing polyacrylamide gels
Vertical denaturing polyacrylamide gels, containing 8M urea and lxT B E  
(Sequagel 6 (5.7% acrylamide:0.3% bisacrylamide) National Diagnostics) were used to 
resolve the products of DNA sequencing reactions. Polymerisation was instigated by 
adding 600pl 10% APS. Sequencing gels were 0.4mm thick x 39cm long. The samples 
were heated to 72°C for 2min prior to loading. Electrophoresis was in lxTBE running 
buffer at 70W for 1.5-5hr.
2B1.5 End repair and DNA ligation
Modifications to the ends of purified DNA fragments were carried out prior to 
ligation, as detailed below, and the modified DNA purified by extraction with 
phenol:chloroform, followed by extraction by chloroform and an ethanol precipitation. 
The DNA pellets were washed with 70% ethanol and resuspended in water for use in 
ligation reactions.
(i) Removal of 3' overhangs
It was necessary to remove adenosine nucleotides added to the 3' termini of DNA 
fragments amplified by PCR using Taq DNA polymerase (Clark, 1988), to enable 
efficient ligation. DNA fragments were made blunt-ended in Klenow buffer by 
incubation with 3 units of Klenow fragment. The reaction was carried out for 40min at 
37°C.
(ii) Phosphate removal from 5' ends
Removal of the 5' phosphates from vector fragments with blunt ends was done by 
incubation with 1 unit of calf intestinal phosphatase in the appropriate buffer for 30min 
at 37°C. A further 1 unit of enzyme was added and the incubation repeated before 
purification of the vector fragment.
(iii) Phosphate addition to 5' ends
It was necessary to add phosphate to the 5' ends of blunt-ended PCR products to 
facilitate blunt-end ligation reactions with a plasmid vector. The reactions were carried 
out in 30pl of lxkinase buffer with 5 units T4 polynucleotide kinase for 45mins at 37°C.
(iv) Ligation reactions
Purified vector and insert fragments prepared by restriction enzyme digestion and 
with ends suitably repaired, were ligated in a L3 or 2:1 ratio for sticky- or blunt-ended 
ligations, respectively. Reactions were carried out in a lOgl volume ol lxligase buffer 
with 1 or 3 units of T4 DNA ligase for sticky- or blunt-ended ligations respectively.
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Reactions were carried out at 16°C for 4-15hr. Ligated DNA was stored at -20°C prior 
to transformation of competent E.coli.
2B1.6 Preparation and transform ation of com petent E.coli cells for plasm id  
growth and maintenance
Plasmids were grown and maintained in E.coli strain DH5a. A 0.5ml aliquot of 
overnight culture grown in L-broth from a single colony was inoculated into 50ml L- 
broth and grown for 2.5-3hr at 37°C in a shaking incubator, until the OD630 was 
approximately 0.3. The culture was cooled on ice and the cells pelleted by 
centrifugation at 3k rpm for 15min at 4°C. The cell pellet was resuspended in 15ml cold 
50mM CaCl2- After a lhr incubation on ice, the cells were pelleted as before and 
resuspended in 2.5ml cold 50mM CaCl2. For storage, 500pl aliquots of resuspended 
cells were added to an equal volume of 30% glycerol, flash frozen and stored at -70°C. 
For more immediate use resuspended cells were stored at 4°C overnight to enhance their 
competency.
For transformation of E. coli, lOOng plasmid DNA (or half of a ligation reaction) 
was added to a lOOpl aliquot of competent DH5a bacteria, which had been thawed on 
ice if frozen. The mixture was incubated on ice for 20-45min prior to heat shock in a 
42°C water bath for lmin, followed by a 2min incubation on ice. A pre-warmed 1ml 
aliquot of 2YT broth was added to the cells which were then shaken for lh r  at 37°C 
before plating onto LB agar plates containing the appropriate antibiotics. The plates 
were incubated overnight at 37°C.
2B1.7 Preparation and transform ation of com petent E.coli cells for protein  
expression
E .coli strain BL21(DE3)pLysS was transformed with plasmids from the pET 
expression system immediately before use. Bacteria were streaked onto LBagar plates 
containing chloramphenicol and fresh colonies inoculated into 10ml 2YT containing 
chloramphenicol and grown in a shaking incubator for 2-3hr at 37°C, until the OD630 
reached approximately 0.3. The cells were pelleted by centrifugation at 3k rpm for 5min 
at 4°C, resuspended in 0.5ml cold 0. ImM MgCl2 and repelleted by centrifugation under 
the same conditions for 2min. The pellet was resuspended in 0.5ml cold 0.1M CaCl2 
and incubated on ice for 2hr prior to use. Approximately 0.5|ig ot the relevant plasmid 
was used to transform a 100gl aliquot of the competent cells as described in Section 
2B1.6.
2B1.8 Purification of synthetic oligonucleotides
Synthetic oligonucleotides were produced by the phosphoramidite method using 
200pl synthesis columns. To remove the oligonucleotide from the column, 5ml
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disposable syringes were attached to both ends of the column with one containing 1.5ml 
ammonium hydroxide (0.88 specific gravity (Fisher Scientific)). The solution was 
pushed through the column in 200pl aliquots with a 20min incubation between each 
fresh addition. After incubation with the final aliquot, the 1.5ml solution was pushed 
backwards and forwards through the column 4-5 times to mix the aliquot thoroughly. 
The oligonucleotide solution was incubated in a tightly sealed tube for 5hr at 55°C to 
remove protecting groups. Following lyophilisation, the oligonucleotide was dissolved 
in 200pl water and boiled in an equal amount of oligonucleotide sample buffer prior to 
electrophoresis on a 15% non-denaturing polyacrylamide gel (Section 2B1.4(iii)). 
Oligonucleotides were purified by passive elution from gel slices excised from the gel 
following visualisation of the DNA by long wave UV transillumination: bands were 
visible as dark shadows against a fluorescing TLC plate. Gel slices were diced, added to 
lml oligonucleotide elution buffer and the DNA eluted overnight at 37°C in a shaking 
incubator. The liquid phase, containing the DNA, was separated from the gel fragments 
and any residual acrylamide removed by centrifugation for 5min (microfuge). The DNA 
solution was extracted with phenokchloroform, followed by chloroform extraction and 
DNA purified by ethanol precipitation followed by centrifugation for lOmin 
(microfuge). The pellet was lyophilised and resuspended in TE. The DNA concentration 
was determined by measuring the absorbance at 260nm, assuming that for short 
oligonucleotides 1 A 26o=2 0 pg/ml.
2B1.9 Extraction of HBV DNA from serum
All manipulations involving serum samples were carried out in a Microflow class 
2 biological safety cabinet.
Viral DNA was extracted from a 25pl aliquot of serum by overnight incubation at 
37°C in serum extraction buffer. The mixture was then phenokchloroform extracted, 
followed by an extraction with chloroform, and the DNA precipitated by the addition of 
0.1 vol 3M sodium acetate and 2.5vol ethanol. Following incubation at -70°C for at least 
30min, the DNA was pelleted by centrifugation for 15min (microfuge) and washed 
twice with 70% ethanol before lyophilisation and resuspension in 15pl water. Extracted 
viral DNA was stored at -20°C and 5pl used in subsequent PCR reactions.
2B1.10 Preparation of baculovirus DNA
Baculovirus DNA was extracted from infected 5/21 cells (see Section 2B2.2 for 
infection of 5/21 cells) for subsequent analysis by Southern blotting.
Infected 5/21 cells in 35mm plates were scraped into 0.5ml PBS and pelleted by 
centrifugation at 6k rpm (microfuge) for 2min. The pellet was resuspended in 250pl TE 
and 250pl buffer containing 50mM Tris.HCl, 5% p-ME, 0.4% SDS, lOmM EDTA, 
lOmg/ml proteinase K and lOmg/ml RNase and incubated at 37°C overnight. The mix
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was extracted twice with phenokchloroform and DNA precipitated from the aqueous 
phase by the addition of 0.1 vol 3M sodium acetate, 2vol ethanol and incubation at 
-70°C. The DNA was pelleted by centrifugation for lOmin at room temperature 
(microfuge), washed with 70% ethanol and air dried before the addition of lOOpl TE. 
DNA was allowed to resuspend slowly by incubation for lhr at 37°C and overnight 
incubation at 4°C and was stored at 4°C.
2B1.11 Polymerase chain reaction (PCR) amplification of DNA
PCR amplification was carried out to amplify core gene sequences from extracted 
DNA for sequence analysis or, using primers including restriction enzyme sites, to 
amplify core gene sequences for subsequent cloning steps. PCR reactions were set up in 
a Microflow class 2 biological safety cabinet, to avoid contamination, and carried out 
using a Biometra TRIO-Thermoblock machine.
Reactions were carried out in 50pl volumes containing lx  reaction buffer 
(supplied with the enzyme), 250pM dNTPs, 25pmol of each primer, 1.5mM MgCl2, 1.2 
units Taq DNA polymerase and template DNA (purified DNA fragments or extracted 
viral DNA). The mixtures were overlaid with mineral oil to prevent evaporation during 
cycling. Cycling conditions were typically: 5 cycles at 95°C for 4min (denaturing), 55°C 
for lmin (annealing), 72°C for lmin (elongation), followed by 35 cycles at 90°C for 
lmin, 55°C for lmin 15sec, 72°C for lmin 30sec. A final elongation step was then 
performed at 72°C for 5min. Cycling conditions were varied in attempts to allow 
efficient priming to occur or to minimise non-specific priming events, by lowering the 
annealing temperature to 42°C or raising it to 60°C, respectively. PCR products were 
purified (Section 2 B 1.4(i)) before restriction enzyme digestion, end repair or use in 
further PCR reactions.
Core deletion protein A81-121 was modified by exact replacement of deleted core 
gene sequence with surface gene sequence, to create the Acore-surface hybrid gene 
(Section 3C4) and also by gradually replacing the deleted core gene sequence from 
either the 5' or 3' end of the deletion, creating a series of 'fill-in' core genes (Section 
3E3). Details of the PCR-based protocols used are shown in Figure 2B 1.1 la  and Figure 
2B 1.11b, respectively and Table 2B 1.11c shows all proteins produced using this 
method.
2B1.12 Dideoxy sequencing of DNA
Plasm id D NA  or DNA amplified by PCR was sequenced  by the 
dideoxy nucleotide chain termination method based on that of Sanger et al. (1977). 
Sequencing was carried out using the Amersham Sequenase version 2.0 kit, which 
utilises a modified bacteriophage T7 DNA polymerase.
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Figure 2B1.11a: Construction of the Acore-surface hybrid gene by PCR
Primers used are detailed in Table 2A5 and are indicated by arrows (i— ). A 123bp 
fragment of the HBV surface gene (nucleotides 458-580) was amplified twice by PCR 
(r1 and r2) using two separate pairs of primers (s4/s2 and s1/s3) to give products p1 
and p2. From the core gene with nucleotides 2141-2263 deleted (Acore) two fragments 
adjacent to the deleted region were amplified separately (r3 and r4) using primer pairs 
cd4/Bamtag and cd1/cd3, resulting in products p3 and p4, respectively. Primers s2 and 
s1 include sequences complementary to core gene sequence adjacent to the 3'Coooo1) 
and 5'Cxxxx1) limits, respectively, of the deleted region. Products p2 and p4 were 
annealed and amplified (r5) with primers cd1 and s3 to give product p5 and products
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p1 and p3 were amplified similarly (r6) with primers s4 and Bamtag to give product p6. 
Finally, products p5 and p6 were annealed and amplified (r7) with primers cd1 and 
Bamtag to give final product p7, which has the deleted core sequence 2141-2263 
exactly replaced with foreign sequence.
Purified plasmid DNA (2-5pg) was denatured at room temperature for lOmin in a 
20pl reaction volume containing NaOH at a final concentration of 0.4M. The denatured 
DNA was precipitated by addition of 6gl 3M sodium acetate, 14gl water and 120pl 
ethanol and incubated in a dry-ice:ethanol bath for lOmin. Denatured DNA was then 
pelleted by centrifugation for lOmin (microfuge), washed with 70% ethanol, air-dried 
and dissolved in 7pl water.
The appropriate primer (2-5pmol in lpl volume) was added to the DNA with 2pl 
lOxreaction buffer (supplied with the kit) and annealing carried out for 20min at 37°C. 
Annealed DNA was added to 3pi labelling mix (7.5pM each of dGTP, dCTP and dTTP) 
containing 5mCi a 35S-dATP. The four chain termination mixes were aliquotted in 2.5pi 
volumes into four wells of a round bottomed 96-well microtitre plate (Costar). The 
chain termination mix for each nucleotide contained the appropriate dideoxynucleotide 
at a concentration of 8pM, 80pM of the three remaining deoxynucleotides and 50mM 
NaCl. Sequenase T7 DNA polymerase was diluted 1:8 in enzyme dilution buffer 
(supplied with the kit) and 2pl (approximately 3units) added to the labelling mix, 
followed by incubation for 2min at 20°C. For the chain termination reactions, 3.5pl 
aliquots of the labelling reaction were transferred to each termination mix and the 
reactions incubated for 15min before being stopped by the addition of 4pl of stop 
solution, supplied with the kit.
For sequencing PCR products, the initial alkaline denaturation step was omitted 
and the primer annealed to the template using the following protocol: 95°C for 2min 
(followed by a brief centrifugation (microfuge)), 70°C for 3min, 95°C for 45sec and 
37°C for lOmin. Labelling and termination reactions were carried out as above.
Prior to electrophoresis, the reaction mixes were denatured at 72 C for 2min using 
a Biometra UNO-Thermoblock. Electrophoresis was carried out on a denaturing 
polyacrylamide gel (Section 2B1.4(iv)) and gels vacuum dried and exposed to Kodak 
X-OMAT film. Sequences were analysed using the Wisconsin Genetics Computer 
Group Package, Version 8.
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Figure 2B1.11b: Construction of the A81-121 5'fill-in genes
Primers used are detailed in Table 2A5 and are indicated by arrows (« -) .  Fragments of 
the 5' region of a full-length core gene were amplified by PCR (r1) using primer pair 
cp3 and 5f10, 5f20 or 5f30. The products of these reactions (p1) consisted of the 
original core gene sequence 5' to the region deleted in A81-121 with increasing sizes of 
additional core gene sequence, deleted in the A81-121 gene. Sequences 3 to the 
deleted region were amplified by PCR (r2) using primer pair Bamtag and 5f10A, 5f20A
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or 5f30A. Primers 5f10A, 5f20A and 5f30A included sequences complementary to the 
3' terminii of the corresponding product from r1 (oooo, xxxx and * * * * ) .  Corresponding 5 ' 
and 3' fragments were annealed and amplified by PCR (r3) using primer pair 
cp3/Bamtag to give the final products (p3). These products consist of the A81-121 
deletion filled in, from the 5' terminus of the deleted region, with increasing sized 
fragments of original core gene sequence.
2B1.13 Southern blotting (transfer of DNA to nylon) and DNA-DNA hybridisation
Restriction enzyme digestions of miniprep DNA and baculovirus DNA were 
probed with core gene fragments to determine the presence and size of the cloned core 
genes.
(i) Transfer of DNA to nylon
Restriction enzyme digestion reactions were electrophoresed on an agarose gel in 
lxTBE. The gel was incubated in denaturation buffer for 45min, followed by 
neutralisation buffer for 45min, both with shaking at room temperature. The DNA was 
transferred overnight onto Hybond-N membranes (pre-soaked in water before use) by 
placing the gel on a wick of Whatman 3MM paper (soaked in 20xSSC and descending 
into a 20xSSC reservoir), then adding sequentially to the top of the gel, Hybond-N 
membrane, three pre-soaked sheets of Whatman 3MM paper and a stack of absorbent 
paper towels. Care was taken to eliminate air bubbles between layers and a light weight 
was added to the top of the stack to aid buffer transfer. After transfer, the filter was air 
dried and DNA cross-linked to the filter by exposing the filter, DNA side down, to 
short-wave UV light for 4min.
(ii) DNA-DNA hybridisation
Hybond-N membranes were pre-hybridised for 4hr at 65°C in pre-hybridisation 
buffer, followed by overnight incubation at 65°C in hybridisation buffer containing 
probe DNA (see below). The filter was washed once in 2xSSC, 0.1% SDS for 15min 
and twice in O.lxSSC, 0.1% SDS for lOmin, at room temperature. The filter was air 
dried and exposed to Kodak X-OMAT film at -70°C.
(iii) Probe preparation
PCR amplified DNA fragment probes were prepared by nick translation. Purified
core gene PCR product was added to a reaction mix containing 20gM dGTP and dCTP, 
25pCi oc32P-dATP, 25pCi a 32P-dTTP and 2units of DNA pol I/DNase I in buffer 
containing 50mM Tris.HCl pH7.8, 5mM MgCl2, lOmM (3-ME, lOpg/ml BSA and
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incubated at 16°C for lhr. The reaction was stopped by the addition of lOpl of lOOmM 
EDTA, 50% sucrose. Bromophenol blue was added to colour the mix which was then 
loaded on a Sephadex G-50 (Pharmacia) column that had been equilibrated with TE. 
Fractions (approximately 0.25ml) were collected from the column and those containing 
the highest counts in the initial peak were pooled and stored as probe. Before use, the 
probe was denatured by boiling for 5min, followed by flash cooling on ice.
Protein Residues deleted Predicted molecular weight (kDa)
Full-length _ 24.3
A84-109 84-109 20.9
A81-121 81-121 18.8
A79-125 79-125 18.2
A60-117 60-117 16.7
T-128 129-183 16.9
Acore-surface hybrid 81-121 replaced 23.6
5'F10 91-121 20.2
5'F20 101-121 21.5
5'F30 111-121 22.9
3'F10 81-111 20.2
3'F20 81-101 21.6
3'F30 81-91 22.7
Table 2B1.11c: Summary table of core deletion proteins and core deletion protein 
modifications
The names of all core deletion proteins are shown, along with a description of the 
deletion or other modification in the protein. The predicted molecular weights of all 
proteins are also shown. All molecular weights were calculated without the inclusion of 
the pp65 epitope tag (predicted molecular weight=1,3kDa).
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2B2 Cell culture
2B2.1 Growth of cells
Mammalian-derived cells were passaged in sterile, disposable 175cm2 plastic 
flasks (Nunclon) in the appropriate media (Section 2A6) and were grown at 37°C in a 
humidified incubator under 5% C 0 2. Confluent monolayers were harvested by washing 
the monolayer with 20ml versene, followed by washing in 25ml trypsin:versene (1:4) 
(supplied by the Institute of Virology Media Services) and resuspending the cells in 
10ml medium.
S f2 \ cells were grown at 28°C in the absence of CCk and trypsinisation was 
unnecessary, as cells could be removed from flasks by tapping.
For continual passage, all cells were split in a 1:10 ratio every 3-4 days.
2B2.2 Infection of 5/21 cells with recombinant baculovirus and plaque assays
For preparation of viral DNA, and 35S-methionine labelling experiments, S f2 \ 
cells were seeded in 35mm plates at lxlO6 cells per plate and infected at a moi of 10. 
For the production of high titre viral stocks, 2 x l07 cells were seeded in 175cm2 flasks 
and infected at a moi of 0.1. For protein purification experiments, cells were grown in 
roller flasks and infected at a moi of 10 when the cell density was l-2 x l0 6 cells/ml.
Medium was removed from cell monolayers and the virus suspension added and 
allowed to adsorb to the cells for lhr at room temperature. The virus suspension was 
then removed from the monolayer, an appropriate volume of T C I00 Medium added and 
the cells incubated as normal. For infection of 5/21 cells in roller flasks, virus was 
added to the cell suspension and incubation continued as normal.
Plaque assays to determine titres of virus stocks were carried out on 5/21 cells 
seeded in 35mm diameter plates, as above. Seaplaque low gelling temperature agarose 
(3% in water (Flowgen)) was melted, cooled and added to an equal volume of pre­
warmed T C I00 Medium. After infection of the cells with a range of dilutions of virus 
suspension, and removal of the medium, 2ml of the agarose mix was added to the plates 
and allowed to set. T C I00 Medium (2ml) was added and the plates incubated for 5 
days. Plaques were visualised by adding 1ml 0.4% neutral red solution (Institute of 
Virology Media Services) diluted 1:50 with TC100, to the plates, followed by 
incubation in the dark for 2hrs. The stain was removed and the plates inverted and 
allowed to dry before plaques were counted.
2B2.3 35S-methionine labelling of infected 5/21 cells
5/21 cells were seeded in 35mm diameter plates, as above, and infected at a moi 
of 10 with recombinant baculovirus. At the required time post-infection, medium was 
removed and replaced with 1ml TCI00-methionine (Gibco) and the cells incubated for
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30min at 28°C. A further 1ml of TCIOO-methionine containing 30pCi 35S-methionine 
was added to the plate and the incubation continued for up to 18hr. Cells were scraped 
into the medium, pelleted by centrifugation at 6k rpm (microfuge) for 3min at room 
temperature and the cell pellet washed once with cold PBS. The pellet was resuspended 
in 0.5ml TE, mixed with SDS PAGE sample buffer and heat denatured by boiling for 
lOmin. Duplicate infections were carried out without radiolabelling and the extracts 
analysed by Western blotting. Cellular extracts were stored at -70°C.
2B2.4 Calcium phosphate-mediated transfection
Cells were seeded on 13mm glass coverslips in 35mm (HepG2 cells) or 60mm 
(COS 7 cells) diameter plates at 2 x l0 5 cells per plate for HepG2 cells and lx lO 6 cells 
per plate for COS 7 cells, in 2ml of the appropriate medium and incubated overnight at 
37°C prior to transfection. Plasmid DNA (5pg) was made up to a volume of 125pl in a 
solution of 250mM CaCl2 and to this 125pl of 2xHBS was added dropwise, before 
vortexing for 5sec. The solution was incubated for at least 20min at room temperature 
before addition to the cells. After mixing by gently swirling the plates, the cells were 
incubated for 16-20hr at 37°C. The medium was removed and replaced by a 2ml aliquot 
of fresh medium and the incubation continued for a further 24hr.
HepG2 cells were blocked at the G,/S boundary of the cell cycle prior to 
transfection and immunofluorescence assays. Approximately 8hr before transfection, 
cells were incubated in fresh medium containing 2pg/ml aphidicolin. Cells were then 
maintained in aphidicolin-containing medium until assayed by immunofluorescence.
Transfected COS7 cells were assayed for expression of core proteins by Western 
blot analysis (Section 2B3.4). Cells were scraped into the medium and pelleted by 
centrifugation at 6k rpm for 3min (microfuge) at room temperature. The pellet was 
washed once with cold PBS, resuspended in 0.5ml PBS and mixed with SDS PAGE 
sample buffer, before heat denaturation for 5min in a boiling water bath.
2B2.5 Immunofluorescence
Transfected cell monolayers were washed twice with PBS for 5min and fixed at 
room temperature for lOmin with cold methanol. Cells were washed three times for 
5min with PBS and permeabilised for 15min at room temperature with 0.5% Triton X- 
100 in PBS. The cells were again washed three times for 5min at room temperature in 
PBS and then washed briefly in PBS containing 0.05% Tween 20. Aliquots (20pl) of the 
relevant primary antibody diluted in PBS were then added to each coverslip for 60min. 
The anti-pp65 mouse monoclonal antibody was used at a 1:300 dilution and the Zymed 
anti-core rabbit polyclonal antiserum was used undiluted. The cells were washed three 
times for 5min at room temperature with PBS containing 0.05% Tween 20 and then 
incubated with secondary antibody (20pl) diluted in PBS. The goat anti-mouse FITC
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was used at a 1:100 dilution and the goat anti-rabbit FITC conjugate was used at a 1:60 
dilution. Incubations with secondary antibodies were carried out for 30min, after which 
the cells were washed three times for 5min at room temperature in PBS containing 
0.05% Tween 20. The cells were air dried and mounted on glass slides with 10ml 
Citifluor, a glycerol/PBS solution (UKC Chemical Laboratories). Cells were examined 
using a Nikon Microphot-SA fluorescence microscope and photographed using Kodak 
ASA400 black and white film.
2B3 Detection and purification of core particles
2B3.1 Core protein expression and purification using recombinant baculovirus
The procedure for core protein expression and purification was based on that of 
Takehara et al. (1988). High titre stocks of recombinant baculoviruses were produced 
by continual rounds of low multiplicity infection of 5/21 cells, until the titre was at least
o
1x10 pfu/ml, as determined by plaque assay. Typically, 5/21 cells were grown in 
300ml volumes in roller bottles until the cell density had reached l -2 x l0 6 cells/ml, 
when cells were infected with the relevant virus at a moi of 10 and the incubation 
continued for a further 4 days. Cells were collected by centrifugation at 3k rpm (Sorvall 
RT6000B centrifuge), the pellet resuspended in 3ml TNE I buffer and disrupted by 
sonication for 15sec with a Branson 450 soni-probe. Soluble protein was removed after 
centrifugation at 10k rpm (Sorvall SS34 rotor) for lOmin at 4°C to remove cell debris, 
and stored at 4°C until required.
Attempts were made to purify core particles using two approaches, isopycnic 
CsCl centrifugation and sucrose density gradient centrifugation, as described below:
(i) Isopycnic CsCl centrifugation
Centrifugation was performed according to the method of Takehara et al. (1988). 
Soluble extract from infected 5/21 cells was centrifuged through a 30% sucrose cushion 
(30% sucrose in TNE I) at 24k rpm (Sorvall TST41 rotor) for 14hr at 4°C. The resulting 
pellet was resuspended in 200pl TNE I and layered onto CsCl solution (1.25g/ml in 
TNE I buffer). The gradient was centrifuged at 35k rpm (Sorvall TST41 rotor) for 35hr 
at 18°C and 1ml fractions removed from the top of the gradient. Any pelleted material 
was resuspended in 1ml TNE I and all fractions analysed on Coomassie stained 
polyacrylamide gels (Section 2B3.3)
(ii) Sucrose density gradient centrifugation
The protocol for purification of core particles using sucrose gradients was adapted 
from that supplied by the group of Prof. K. Murray (University of Edinburgh). Linear 
10-50% sucrose gradients (10ml volume) were prepared in TNE I buffer, soluble
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extracts from infected 5/21 cells layered onto the gradient and centrifuged at 35k rpm 
(Sorvall TST41 rotor) for 5hr at 4°C. Fractions were removed from the top of the 
gradient and analysed by Western blotting.
2B3.2 Core protein expression and purification from E.coli
Core proteins were expressed in E.coli using two plasmid systems, p R l - 1 1 and 
pET plasmids, as described below:
(i) Core protein purification using plasmid pR 1-11
Plasmid pR 1-11 was kindly supplied by the group of Prof. K. Murray (University 
of Edinburgh). A single fresh bacterial colony transformed with the relevant pR 1-11 
plasmid was inoculated into 10ml L-broth containing ampicillin and grown up overnight 
at 37°C with shaking. An aliquot (6ml) of this culture was added to 300ml pre-warmed 
(37°C) L-broth containing ampicillin and the constitutive protein expression carried out 
at 37°C with shaking for 4hr. Bacteria were harvested by centrifugation at 6k rpm 
(Sorvall GS3 rotor) for 15min at 4°C and the cell pellet resuspended in 10ml sonication 
buffer prior to sonication in 20sec bursts with a soni-probe. Cell debris was removed by 
centrifugation at 10k rpm (Sorvall SS34 rotor) for lOmin at 4°C. Ammonium sulphate 
was added to the supernatant to 30% volume and the mixture stirred on ice for lhr. 
Precipitated proteins were pelleted by centrifugation at 10k rpm (Sorvall SS34 rotor) for 
lOmin at 4°C and the pellet resuspended in 3ml TN buffer before overnight dialysis 
against TN buffer at 4°C. Precipitated protein was removed by centrifugation at 10k 
rpm (Sorvall SS34 rotor) for lOmin at 4°C and the supernatant layered on 10-50% 
sucrose gradients.
Modifications to this protocol included omission of the overnight dialysis step, 
with the resuspended ammonium sulphate pellet layered onto the gradient, or 
precipitation of nucleic acids by the addition of PEI, prior to ammonium sulphate 
precipitation of protein. The cellular extract was made up to 0.5M NaCl to disrupt any 
protein:DNA interactions and nucleic acid precipitated by the addition of PEI to 0.2%. 
After incubation for 5min on ice, precipitated nucleic acid was removed by 
centrifugation at 15k rpm (Sorvall SS34 rotor) for 15min at 4°C. Protein was then 
precipitated from the supernatant, as above.
(ii) Core protein purification using pET plasmids
A single fresh E.coli colony (strain BL21(DE3)pLysS), transformed with either 
pET3a or pET9a plasmids containing core gene sequences, was inoculated into 10ml 
2YT broth containing appropriate antibiotics and grown shaking overnight at 37°C. A 
sample (200gl) was added to 50ml pre-warmed (37°C) 2YT broth with antibiotics and 
the culture grown at 37°C with shaking until the OD630 reached 0.5. Protein expression
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was induced by adding IPTG to 300pM and incubating for a further 4hr. The bacteria 
were harvested by centrifugation at 3k rpm (Sorvall RT6000B centrifuge) for 20min at 
4°C and the pellet stored frozen overnight at -20°C. After thawing, 3ml of TNE II, 8pl 
of lOmg/ml DNase I and 30pl of lOmg/ml RNase were added and the mixture incubated 
on ice for 30min to allow cell lysis. Complete lysis of the cells was ensured by 
sonication in 20sec bursts with a soni-probe. Cell debris was pelleted by centrifugation 
either at 13k rpm (microfuge) or at 35k rpm (Beckman TLA 100.3 rotor) for 20min at 
4°C and soluble protein removed. Aliquots of protein removed before sonication, as 
total protein samples, were stored at 4°C, as was soluble protein prior to purification on 
sucrose gradients.
Centrifugation and fraction analysis were as described in Section 2B3.1(ii).
2B3.3 SDS polyacrylamide gel electrophoresis (SDS PAGE) of proteins
Proteins were resolved by electrophoresis through SDS polyacrylamide minigels 
(Laemmli, 1970) using the Bio-Rad Miniprotean II apparatus. Gel mixes were made up 
as follows:
Solution_____________ 12% resolving gel 17.5% resolving gel Stacking gel
30% acrylamide 8ml 11.7ml 1.3ml
(2.7% cross-linker)
RGB 5ml 5ml
SGB - - 2.5ml
10% SDS 0.2ml 0.2ml
water 6.7ml 3ml 6.2ml
A lOpl aliquot of TEMED and lOOpl of 10% APS were added to each resolving gel mix 
and lOpl TEMED and 50pl 10% APS to stacking gel mix.
Resolving gel mixes were poured into glass plate sandwiches in the gel-former 
apparatus, overlaid with 80% isopropanol and allowed to set. The isopropanol was 
washed away with water, the stacking gel mixture overlaid and a comb inserted. Protein 
samples were mixed with SDS PAGE sample buffer and boiled for lOmin prior to 
loading. Gels were run at 200V until the bromophenol blue dye reached the bottom. The 
gels were stained with Coomassie blue for 15min and destained in protein gel destain. 
Gels with radiolabelled protein samples were fixed in protein gel destain for 15min, 
incubated in En'Hance for 30min, washed with water for lOmin and vacuum dried prior 
to exposure to Kodak X-OMAT S film.
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2B3.4 Western blot analysis of proteins
(i) Electroblotting to nitrocellulose
Proteins resolved on SDS PAGE minigels were transferred to nitrocellulose by the 
method of Towbin et al. (1979) in a Bio-Rad mini transblot cell. A blotting sandwich 
was set up with the gel in contact with the nitrocellulose (Schleicher and Schuell Inc.) 
and both were sandwiched between Whatman 3MM paper. This was in turn sandwiched 
between sponges provided by Bio-Rad. All materials were equilibrated in blotting 
buffer for at least 20min prior to assembly of the blotting sandwich. Blotting was 
carried out at 250mA for 3hr.
(ii) Immunodetection
Nitrocellulose membranes were blocked by incubation at 37°C with gentle 
shaking for a minimum of 60min in blocking buffer, with one change of buffer. 
Membranes were then washed twice in TTBS for 5min at room temperature before 
incubation with the primary antibody, diluted appropriately in 1% gelatin in TTBS, at 
room temperature with shaking. Incubation with primary antibody was for a minimum 
of 4hr. Membranes were washed twice for lOmin in TTBS and anti-mouse IgG whole 
molecule or anti-rabbit IgG whole molecule peroxidase conjugate, diluted in 1% gelatin 
in TTBS, added. After a 2hr incubation at room temperature, again with shaking, 
membranes were washed four times for 15min in TTBS and proteins detected using the 
Amersham enhanced chemiluminescence (ECL) system. The two reagents were mixed 
in equal volumes and a total of 3ml poured onto the membrane, which was then agitated 
for lmin. The membranes were wrapped in cling film and exposed to Kodak X-OMAT 
film for 5-45sec.
On blots from the initial experiments, a colour development reaction was used as 
to detect proteins on the membrane. The substrate for the peroxidase conjugate was 
prepared by mixing 20ml cold methanol, containing 60mg 4-chloro-l-naphthol, with 
100ml TBS, containing 60pl of 30% hydrogen peroxide. After incubation with 
secondary antibody, blots were washed twice for 5min in TTBS and twice for 5min in 
TBS, both at room temperature and the freshly prepared substrate added immediately.
Blots were stripped before being probed with different primary antibody by 
incubation at 55°C for 45min in 60mM Tris, 0.7% fTME, 2% SDS, with one change of 
solution after 20min. Membranes were then washed four times for 5min in TTBS at 
room temperature with shaking, before being blocked as befoie and incubated with the 
second primary antibody.
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2B3.5 Detection of core particles by electron microscopy
Core protein containing fractions from sucrose gradients were pooled and dialysed 
overnight against the appropriate buffer at 4°C to remove the sucrose, followed by 
concentration by centrifugation at 6k rpm (Sorvall SS34 rotor) in Centricon 50 
centrifugation units (Amicon) at 4°C.
Samples were examined by negative stain electron microscopy, performed by Mr. 
J. Aitken or Dr. F. Rixon. The concentrated sample was mixed with an equal volume of 
either 1% (w/v) phosphotungstic acid, pH 7.0, or sodium silicotungstate, before being 
placed onto a 200 mesh copper grid coated with parlodion and allowed to stand for 2- 
3min at room temperature. Excess liquid was removed using Whatman filter paper and 
the sample examined at a magnification of 40 000 on a Jeol 1200EX2 electron 
microscope, operating at 80kV.
2B3.6 Agarose gel assay for core particles
Core particles can be detected on agarose gels by Coomassie staining of the 
protein and detection of the encapsidated nucleic acid under UV transillumination, in 
the presence of EtBr (Birnbaum and Nassal, 1990). Concentrated core protein 
containing samples were mixed with agarose gel loading buffer and loaded onto a 1% 
agarose gel in TAE, containing 0.5mg/ml EtBr. Electrophoresis was carried out at 70V 
and the nucleic acid visualised under UV transillumination. The gel was then stained 
with Coomassie blue and destained for protein visualisation. Gels were photographed 
using The Imager (Appligene).
CHAPTER 3 RESULTS
3A E xpression and purification o f fu ll-length core protein and core  
deletion protein A84-109 using recom binant baculoviruses 
3A1 Introduction
The purpose of this project was to characterise possible functions of naturally 
occurring core proteins from which central regions were deleted. The initial aim was to 
determine whether or not these core deletion proteins retained the ability to spontaneously 
assemble into core particles, or more properly, core particle-like structures. The method 
chosen and initiated by the group of Dr. N. Naoumov (Kings College, London) was 
expression of these proteins in A/21 cells using recombinant baculoviruses. The 
baculovirus Autographica califomica multiple nuclear polyhedrosis virus (AcMNPV) has 
been widely used as an expression vector (see review by Bishop, 1992) and has been 
used previously by the group of Bishop to produce and analyse wild-type core particles 
(Takehara et al., 1988 and Hilditch et al., 1990). Before the work presented in this thesis 
was started, the group at Kings College had constructed two recombinant baculoviruses: 
one containing the full-length core gene and the other containing the gene for the core 
deletion protein A84-109. These viruses were constructed using the Invitrogen transfer 
vector pVL 1393, placing the cloned genes under the control of the polyhedrin promoter. 
Initial experiments by this group had shown expression of the full-length core protein on 
Coomassie stained polyacrylamide gels, but were unable to detect the core deletion protein 
using this method.
This section describes the experiments carried out to authenticate these recombinant 
baculoviruses and to detect expression of both proteins. Initial attempts at purification of 
core particles or core particle-like structures from infected A/21 cells are also described 
and finally, details of problems encountered using this particular system for the 
expression and purification of core particles.
3A2 A uthentication of recom binant baculoviruses by Southern blotting
Before any further expression experiments were carried out it was necessary to 
characterise the recombinant baculoviruses to ensure that the material received from the 
group at Kings College had not been damaged or degraded in any way. It was decided to 
extract viral DNA from infected A/21 cells and confirm the presence of the core genes by 
Southern blotting (Figure 3A2). The transfer vector pVL1393, containing either the core 
gene or the core deletion gene, used to construct these viruses had also been supplied and 
were included as size controls for the genes digested from the baculovirus DNA. The blot
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Figure 3A2: Southern blot of recombinant baculovirus DNA
DNA was extracted from S/21 cells infected, at a moi of 10, with recombinant baculovirus 
containing the full-length core gene (C), core gene with nucleotides 2152-2229 deleted 
(A), AcPAK6 baculovirus (P) or mock-infected cells (M). Xba I/Pst I digests of 
baculovirus transfer vector pVL1393 mini-prep DNA containing the full-length core gene 
(pC) or core gene with nucleotides 2150-2227 deleted (pA) were used as controls. 
Nucleic acid was transferred to nylon membrane by Southern blotting, and the 
membrane probed with a 32P-labelled core gene PCR product, amplified using primer pair 
C1/C2.
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showed single bands, indicating fragments which had hybridised to the labelled core 
gene probe, in the lanes containing digested baculovirus DNA. The sizes of these bands 
were equal to those of their corresponding controls, indicating that the construction of the 
recombinant viruses was correct. No fragments hybridised in the lanes containing 
digested DNA from cells infected with AcPAK6 virus, which contains the gene for (3- 
galactosidase under the control of the polyhedrin promoter, or from mock infected cells, 
indicating that the hybridisation observed was specific for the core gene. The recombinant 
viruses were further characterised by fully sequencing the inserts in their transfer vectors 
(results not shown), which confirmed the size and position of the deletion in the core gene 
as identical to that published (Ackrill et al, 1993).
3A3 D etection o f expression  of fu ll-length and A84-109 core proteins b y  
3:,S -m eth ion ine labelling
As stated previously, initial results from the Kings college group showed that 
expression of the full-length core protein by the recombinant baculovirus could be 
detected on a Coomassie stained gel, but the core deletion protein was not visible by this 
method. This may have been due to the fact that its predicted size would result in co­
migration with other Coomassie stained bands or that expression levels for this protein 
were not as high, when compared to those of the full-length protein. The possibility of the 
core deletion protein being toxic to the cells was only briefly considered, as expression 
from the late polyhedrin promoter occurs in insect cells after the production of mature, 
infectious virus particles. This prevents synthesis of cytotoxic proteins from adversely 
affecting virus replication and spread to other cells. It was decided to investigate 
expression of both proteins by radiolabelling virus-infected cell proteins with 35S- 
methionine. High titre stocks of recombinant viruses containing full-length core and core 
deletion genes and AcPAK6 virus had been produced with titres of 2 x l0 8, lx lO 8 and 
2 x l0 8 pfu/ml respectively, on A/21 cells. These stocks were used to synchronously infect 
cells at a high moi and at 24hr and 48hr pi cells were incubated in labelling medium for an 
18hr period, before total cellular extracts were prepared.
As was seen from the gel (Figure 3A3), at 24hr pi proteins of the approximate 
predicted size were being synthesised (see Table 2B1.1 lc), but the core deletion protein 
was present at lower levels compared to the full-length protein. This may have reflected 
the differences in efficiency of expression for different proteins, as can occur with any 
expression system. By 48hr pi the full-length core protein represented one of the major 
proteins present in the cells, confirming the initial results from Coomassie stained gels. 
The core deletion protein seemed to be present at moderate levels, however this was 
difficult to determine precisely, due to the presence of several co-migrating proteins which 
had also been labelled. For both time-points examined the levels of (3-galactosidase
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Figure 3A3: 35S-methionine labelling of infected S/21 cells
S/21 cells in 35mm dishes were infected, at a moi of 10, with recombinant baculoviruses 
expressing full-length core protein (C), core protein with amino acids 84-109 deleted (A),  
AcPAK6 baculovirus (P) or mock-infected (M). Cells were labelled with 35S-methionine for 
18h at 24h and 48h pi. Cellular extracts were separated on a 12% polyacrylamide gel, 
which was dried down and exposed to film. The sizes of the radiolabelled molecular 
weight markers used are shown (kDa).
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protein produced by the AcPAK6 virus were higher than the levels of core proteins 
produced by the two other viruses. This was probably because the expression of (3- 
galactosidase by this virus has been thoroughly optimised for commercial purposes. 
Although it was not possible to obtain the original wild-type AcMNPY DNA from which 
the recombinant viruses were constructed, detection of novel proteins of the correct 
molecular weight in cells infected by these viruses was good evidence that these were the 
core proteins, and not cellular or other viral proteins.
3A4 D etection o f expression  of fu ll-length  and A84-109 core proteins by  
W estern blotting
In order to confirm that the proteins of the correct predicted molecular weights 
detected in the previous section were full-length and core deletion proteins it was decided 
to use Western blotting and detection with antibodies raised to core protein. A number of 
monoclonal antibodies raised against either core protein or e antigen which had been given 
as gifts from other groups were available, however the precise backgrounds as to which 
protein these antibodies had been raised against, or which epitopes they identified, was 
unknown. In an initial Western blot experiment (results not shown), using cellular 
extracts from infected S/21 cells at different times pi, one of these monoclonal antibodies 
reacted with a protein of 21 kDa present in the extract from cells infected by the full-length 
core gene-containing baculovirus, and not in extracts from cells infected by baculovirus 
containing the core deletion gene or AcPAK6 or in mock-infected cells. This confirmed 
the identity of the labelled band from Section 3A3 as core protein, and showed that the 
protein was synthesised at least up to 120hr pi. However, none of the extracts from cells 
infected with core deletion-containing baculovirus showed any reactive bands. As core 
protein has one immunodominant B-cell epitope which has been mapped between amino 
acids 74-89 (Salfeld et a l ,  1989), the likely cause of non-reactivity in these extracts was 
that this epitope was partially within the deletion. In view of this result it was decided that 
a variety of different monoclonal and, more importantly, a polyclonal antibody raised 
against core protein should be assayed for the ability to detect the core deletion protein on 
Western blots. At 48hr pi, extracts were prepared from cells infected with core and core 
deletion baculoviruses and Western blotted (Figure 3A4). The membranes were cut into 
strips, with each strip containing a lane each of extract from cells infected with full-length 
core and core deletion baculovirus. Antibodies aHBe 141/152 and 87-141-03 were used 
at an experimental dilution of 1:1000 and all other antibodies used at the recommended 
dilution, as indicated. All of the monoclonal antibodies raised against core protein also 
detected the core deletion protein, which was unexpected, although mAb BFaHBc2 and 
BFaH Bcl were less effective. It may have been that these antibodies, despite the 
immunodominancy of the 74-89 epitope, had been raised against other epitopes of the 
protein, which were unaffected by the A84-109 deletion. Monoclonal antibodies
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Figure 3A4: Western blots of St21 infected cell extracts
S/21 cells were infected, at a moi of 10, with recombinant baculoviruses expressing full- 
length core protein (CoreWT) or core protein with amino acids 84-109 deleted (A84-109). 
Cellular extracts were separated on 12% polyacrylamide gels and transferred to 
nitrocellulose membranes by Western blotting. After blocking, the membranes were 
incubated with the primary antibodies listed below and specific binding detected with 
HRP-conjugated secondary antibody. Full-length core protein is on the left and Gore 
deletion protein A84-109 on the right of each nitrocellulose strip.
Antibodies used:
1 mAb BFaHBc2 - 1:10 5 mAb BFaHBcl - 1:10
2 mAb BFaHBc3- 1:10 6 mAb 42B12 - 1:750
3 Zymed pAb - undiluted 7 mAb aHBe 141/152 - 1:1000
4 mAb BFaHBc4 - 1:10 8 mAb aHBe 87-141-03 - 1:1000
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BFaHBc3 and BFaH Bcl also showed reactivity with proteins of approximately 34kDa 
and 50kDa, respectively. The core deletion protein seemed to be detected less efficiently 
than the full-length protein by all monoclonal antibodies used, but this may have simply 
been a consequence of the lower levels of expression of this protein already observed in 
the infected cells. The monoclonal antibody 42B 12 was chosen for further use, due to the 
fact it was capable of detecting both proteins and the epitope it recognised had been 
identified as being approximately amino acids 115-135 (W.H.Gerlich - personal 
communication). In addition, we had been kindly supplied with a reasonable quantity to 
use with this project.
As hypothesised, the Zymed polyclonal antibody detected both the full-length 
protein and the core deletion protein. This was probably due to detection of a number of 
different epitopes throughout the protein, so increasing the chance of core deletion protein 
detection. A number of other commercial polyclonal antibodies were also tested in this 
manner and were shown to have the ability to detect both proteins (results not shown). 
The polyclonal antibody used, however, reacted with many other proteins on the blot. It 
may have been of value to repeat the experiment with an increased period of blocking the 
membrane to try and reduce the non-specific nature of this binding, but as the other bands 
were larger in size than the core proteins and did not interfere with their detection, this 
was not thought to be essential.
Only one of the antibodies raised against e antigen (aHBe 141/152) detected both 
the proteins. As core protein and e antigen are known to have epitopes in common, 
antibodies raised against one have been known to react with the other, as the result here 
has shown. The 87-141-03 antibody, again raised against e antigen, did not react with 
either protein. It may be that the experimental dilution used for this antibody was too 
high, compromising its detection ability. As all monoclonal antibodies gave a fainter band 
for the core deletion protein, nothing can be stated conclusively about the ability of this 
antibody to detect this protein, at the dilution used.
3A5 Purification of core particles using recom binant baculoviruses
The production of hepatitis B virus core particles has been achieved previously by 
expression of the core gene in recombinant baculoviruses, under the control of the 
polyhedrin promoter (Takehara et al., 1988 and Hilditch et al., 1990). The method of 
Takehara et al. consisted of infection of S/21 cells with recombinant baculovirus, 
containing the full-length core gene, at a high moi for 4 days. Cellular extracts were 
prepared by sonication and clarified by centrifugation before being subjected to 
centrifugation through a 30% sucrose solution. After the resulting pellet was 
resuspended, core particles were purified to homogeneity by CsCl isopycnic 
centrifugation. The method of Hilditch et al. consisted of the same CsCl centrifugation 
step followed by a shallow glycerol gradient to remove two contaminating proteins. It
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Figure 3A5a: Purification of core protein expressed by recombinant baculovirus 
S/21 cells in roller flasks were infected, at a moi of 10, with recombinant baculovirus 
expressing full-length core gene. Infected cells were collected by centrifugation 4 days pi 
and extracts subjected to sucrose gradient centrifugation on a 10-70% gradient. Fractions 
were collected from the top (fraction 1) to the bottom (fraction 13) of the gradient and any 
pelleted material was resuspended (P).Core protein was detected by Western blot 
analysis using mAb 42B12. Molecular weights of the markers (M) used are shown.
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Figure 3A5b: Purification of core deletion protein expressed by recombinant baculovirus 
S/21 cells in roller flasks were infected, at a moi of 10, with recombinant baculovirus 
expressing full-length core gene. Infected cells were collected by centrifugation 4 days pi 
and extracts subjected to sucrose gradient centrifugation on a 10-70% gradient. Fractions 
were collected from the top (fraction 1) to the bottom of the gradient (fraction 13) and any 
pelleted material was resuspended (P). Fractions were electrophoresed through 12% 
polyacrylamide gels alongside extracts from cells infected with recombinant 
baculoviruses expressing full-length core protein (C) or core deletion protein A84-109 
(A). Proteins were detected by Western blot analysis using a Zymed polyclonal 
antibody. Molecular weights of the markers (M) used are shown.
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was decided to follow the former method initially, using S f l \  cells grown in roller flasks. 
Cells were infected at a moi of 10 with recombinant baculovirus containing the full-length 
core gene and collected by centrifugation 4 days pi. However, after CsCl centrifugation, 
no visible band of core particles was observed, as was recorded in the original paper. 
Analysis of the fractions resulting from this step on Coomassie stained gels showed no 
evidence for core protein at any point in the gradient (results not shown). Gradient 
conditions, such as the initial density of CsCl and the rotor used for centrifugation, were 
altered but no core particle purification was achieved. After these attempts, contact was 
made with the group of Prof. K. Murray (University of Edinburgh). This group purified 
core particles from a bacterial expression system, using 30% ammonium sulphate 
precipitation of bacterial extracts, followed by centrifugation of the resuspended pellet 
through an 8-45% sucrose gradient. However, when this method was applied to infected 
S f l \  cell extracts prepared as before, core protein was found to precipitate out of solution 
during an overnight dialysis step used to remove ammonium sulphate from the 
resuspended pellet. The method was consequently altered to remove the ammonium 
sulphate precipitation step and instead the infected Sj2 \ extract was centrifuged through 
the sucrose gradient. Upon analysis of the fractions from this gradient on Coomassie 
stained gels, the only position in the gradient where core protein was observed was in the 
pellet which formed at the bottom of the centrifugation tube. Only when the concentration 
of sucrose was increased and the extracts centrifuged through a 10-70% gradient, was 
core protein actually detected in the lower gradient fractions (fractions 9-13, Figure 
3A5a). However, when the protein-containing fractions were dialysed against TNE1 
buffer and concentrated approximately five-fold for examination by electron microscopy, 
no 28nm particles were detected. The only particulate objects present were approximately 
four times as large, and few in number. When an identical purification procedure was 
carried out on extracts of cells infected by recombinant virus containing the core deletion 
gene, no protein was detected in any of the gradient fractions (Figure 3A5b). These 
results are very inconclusive as, although core particles appeared to have been purified 
using the sucrose gradient, particles of the correct size were not observed by electron 
microscopy. The observation of the larger particulate structures does correlate with the 
fact that a higher concentration of sucrose was required (70% compared to 45% used by 
the group at the University of Edinburgh) in the purification. From these results, no valid 
conclusions could be drawn regarding the purification of the core deletion protein. 
Although protein was detected in the extract loaded onto the gradient, none was detected 
in the fractions after centrifugation had taken place. This may have been because the 
protein would have been diluted in the larger fraction volume and, consequently, the 
smaller absolute amount of protein loaded onto the gel may have fallen below the 
sensitivity limit for the antibody used. The larger particulate structures observed from the 
full-length core protein purification seemed to suggest that the spontaneous assembly of
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core particles had been incorrect or that at some stage during the procedure, perhaps by 
the sonication stage, the core particles had been damaged or aggregated together. It was 
decided that in view of these results and the difficulties that still existed in setting up a 
satisfactory purification procedure for wild-type core particles from infected S f l \  cell 
extracts, that changing to a bacterial expression system may aid in solving these 
problems.
3A 6 D iscussion
The results in this section have shown the expression and detection of both full- 
length core protein and core deletion protein A84-109 from S f l \  cells infected by 
recombinant baculoviruses. Detection of both proteins was initially by 3sS-methionine 
labelling of infected cell proteins but was further enabled by a variety of monoclonal and 
polyclonal antibodies, raised against either core protein or e antigen, which were used on 
Western blots of infected cell extracts. Attempts at purification of wild-type core particles 
by either CsCl or sucrose gradient centrifugation were unsuccessful for undetermined 
reasons.
Takehara et al. (1988) showed that recombinant baculovirus-expressed core protein 
constituted 40% of the Coomassie-stained cellular proteins, corresponding to a yield of 
5mg/l cell culture. Hilditch et al. (1990) achieved a yield of 35mg/l of cell culture. 
Although no quantitation was performed, visual comparisons of i:,S-methionine labelled 
infected cell extracts showed that these expression levels were much higher than the levels 
achieved by the recombinant baculoviruses used in this section. This may be due, in part, 
to the different transfer vectors used to produce the recombinant viruses and also due to a 
decreased efficiency of core particle expression or recovery from larger volume cultures. 
Growth and infection of 5/21 cells in multiple smaller cell culture flasks, as opposed to 
roller flasks, may have increased the efficiency of infection as the virus suspension would 
be in closer contact with the cell monolayer. Consequently, the levels of core protein 
produced would be higher.
Particles of approximately 30nm were also observed by Takehara et al. (1988) and 
Hilditch eta l. (1990) in electron microscopic examination of peak core protein-containing 
gradient fractions. Although it appeared that core particles had been purified in the results 
presented here (Figure 3A5a), upon examination of peak core protein-containing fractions 
the only particulate structures observed were too large to represent wild-type core 
particles. It seems unlikely that these structures arose from aggregation of incorrectly 
folded core protein as 5/21 cells possess a normal eukaryotic translational pathway, 
allowing correct folding and disulphide bond assembly in proteins. Insect cells have also 
been used to produce other complex structures, such as polyoma and parvovirus capsids 
(Montross e t a l , 1991 and Brown e t a l , 1991), as well as the previous mentions of core 
particle production by the group of Bishop. Electron microscopic examination of sections
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of infected S/21 cells would have shown whether particles of the expected size and 
morphology were initially assembled. These may then have been damaged or become 
insoluble during the subsequent purification steps. Similar examination of S f l \  cells 
infected with the recombinant virus expressing the core deletion protein A84-109 would 
also have revealed whether particles were formed by this protein. These particles may 
have been less stable than wild-type particles and not remained intact during purification. 
This may explain the presence of the A84-109 protein in infected cell extracts, but not in 
the sucrose gradient (Figure 3A5b).
Expression of protein in E.coli has many advantages over the baculovirus system. 
Bacterial plasmids are simpler to produce and manipulate, in contrast to the production of 
recombinant baculovirus genomes. The production of high titre virus stocks is not 
required and both cell growth and the induction of protein expression are simpler for 
bacterial systems. Although the prokaryotic expression pathway differs from that of 
eukaryotes, the previous expression and characterisation of core particles expressed in 
bacteria have shown that this system is able to reproduce the core particle assembly 
process.
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3B E xpression  and purification o f fu ll-length  core protein and core  
deletion proteins in a bacterial system  
3B1 Introduction
In view of the problems encountered with purifying wild-type core particles from 
infected insect cells in our hands, it was decided to change to a bacterial expression 
system. Since it was first used by Cohen and Richmond (1982) and Stahl et al.{ 1982) to 
produce core particles from cloned HBV DNA that were morphologically and 
immunologically identical to those isolated from patients serum, E.coli has been 
successfully used by a large number of groups for the production of wild-type core 
particles. We had received a gift of plasmid pR 1-11 from the group of Prof. K. M urray, 
which was the original plasmid used to produce core particles. Details of this plasmid are 
described in Section 2A1. The group of Dr. N. Naoumov had sent a further three core 
genes containing in-frame central deletions, A81-121, A79-125 and A60-117, and it was 
decided initially to attempt to purify these using this system, along with a full-length core 
protein control. In order to achieve this, both full-length and core deletion genes were 
amplified by PCR using primer pair cdl/cd2, which contained Eco RI and Bam  HI sites 
respectively and would allow reconstruction of the correct 5' coding sequences in p R l-1 1 
after removal of the excised Eco RI/Bam HI fragment. Throughout this section the full- 
length core protein with the additional sequence from pR 1-11 is simply referred to as 
'full-length protein' to distinguish it from the core deletion proteins, and particles 
produced from this protein are referred to as 'wild-type' core particles.
3B2 E xpression  o f fu ll-length  core protein and core deletion  p ro te in s  
using p R l-1 1  and detection by W estern blotting
The initial experiments carried out with pR 1-11 were to determine whether the core 
proteins produced could be detected on Western blots, which would be necessary for 
monitoring of any purification procedure. Proteins were expressed routinely at 37°C for 
4hr before cellular extracts were prepared by sonication and samples of soluble protein 
prepared by centrifugation of these extracts. Western blots of samples were performed 
using both anti-core mAb 42B12 and a number of commercial anti-core polyclonal 
antibodies (see Figures 3B2a and 3B2b).
On Western blots with anti-core mAb 42B12, although the full-length protein was 
expressed and detected, neither of the two core deletion proteins examined could be 
detected. This may confirm the approximate epitope position for this antibody (residues 
115-135) as both of the deletions encroach upon this region. As the sizes of these 
deletions were larger than that of the core deletion protein expressed in baculovirus it was 
decided that use of a polyclonal antibody would maximise the probability of their
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Figure 3B2a: Expression of full-length core protein and deletion variants 
Full-length core protein (WT) and two core deletion proteins (A81-121 and A79-125) 
were expressed using plasmid pFM-11. Expression was carried out for 4 hrs at 37°C. 
Aliquots of total cellular extracts (ex) and soluble protein (s) were subjected to 
electrophoresis through 12% polyacrylamide gels and analysed by Western blotting. 
The blot was incubated with anti-core mAb 42B12. An aliquot of purified HBcAg (c) was 
included as a control and molecular weights of the markers used (M) are shown.
detection. Three anti-core polyclonal antibodies were obtained and all tested on three core 
deletion proteins (Figure 3B2b). All three antibodies were able to detect the full-length 
core protein expressed in this system. This appeared as a number of bands slightly 
differing in size from 14-22kDa. The lower molecular weight bands probably represent 
degradation products of the full-length protein. Proteins of approximately 44 and 64kDa 
were also observed. These are the correct sizes for higher order multimers of full-length 
core protein (see Section 3D3). Analysis of the extracts from cells expressing core 
deletion proteins A81-121 and A79-125 (predicted molecular weights of 18.8 and 
18.2kDa, respectively) did show a protein of approximately the correct molecular weight. 
This protein was detected by all three polyclonal antibodies used. However, it was also 
present, albeit at lower levels, in the extracts from cells expressing full-length core 
protein. It is therefore possible that this protein was non-specifically detected by the 
polyclonal antibodies. Another protein of lower molecular weight (approximately 14kDa) 
was also detectable by all three antibodies. However, both the Life Sciences and Zymed
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Figure 3B2b: Western blots of expressed core protein deletion variants (continued with 
figure legend on the following page)
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Figure 3B2b: Western blots of expressed core protein deletion variants (continued) 
Full-length core protein (wt) and deletion variants A81-121, A79-125 and A60-117 were 
expressed using plasmid pR1 -11. Soluble protein produced from cellular extracts was 
analysed by Western blot using (A) Dako anti-core polyclonal antibody (B) Life 
Sciences anti-core polyclonal antibody and (C) Zymed anti-core polyclonal antibody. 
Aliquots of purified HBcAg (c) and baculovirus-expressed deletion protein A84-109 were 
included as controls and the molecular weights of markers used are shown.
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Figure 3B2c: Purification of wild-type core particles
Full-length core protein was expressed using plasmid pR1 -11 and, after an ammonium 
sulphate precipitation step, was purified using a 10-50% sucrose gradient. Fractions 
were collected from the top (1) to the bottom (13) of the gradient. Any pelleted material 
was resuspended and collected (P) and an aliquot of soluble cellular extract (s) was also 
analysed. Panel A shows a Coomassie stained 12% polyacrylamide gel of the fractions 
and panel B shows specific detection of core protein-containing fractions on Western 
blots, using mAb 42B12. Molecular weights of the markers (M) used are shown and the 
position of the core protein is indicated by an arrow («—).
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Figure 3B2d: Electron micrograph of pR1-11 core particles
Core particles were purified from extracts of pR1-11 -transformed E. coli using a 10-50% 
sucrose gradient. Fractions 11 and 12, containing the highest levels of core protein as 
identified by Western blot analysis, were pooled and concentrated approximately five ­
fold using an Amicon 50 microconcentrator. An aliquot of the concentrated sample was 
negatively stained and examined by electron microscopy. Scale bar represents 50nm.
antibodies (Figure 3B2b, Panels B and C, respectively) also detected this protein in the 
extract from cells expressing full-length core protein. This protein showed greater 
reactivity in the extract from cells expressing core deletion protein A60-117 when the 
Dako polyclonal antibody was used (Panel A, Figure 2B2b). This protein may represent 
the core deletion protein, but as the concentration of acrylamide used was too low, 
complete resolution of these proteins may not have occurred. If these proteins are due to 
non-specific reactivity with the polyclonal antibodies used they could conceal detection of 
the core deletion proteins. Increasing the time taken for blocking the membrane gave no 
reduction in the number of proteins detected by these antibodies. It may have been that the 
detection method used on the blots was not sufficiently sensitive for detection of the core 
deletion proteins and a more sensitive method would have given better results.
Despite these difficulties in detecting the core deletion proteins, it was decided that 
for the p R l- l l plasmid containing the PCR amplified core gene, instead of the larger 
original HBV DNA fragment, validation of its ability to produce wild-type core particles 
would be worthwhile. Protein was expressed as before and clarified cellular extract was 
made up to 30% ammonium sulphate. After a centrifugation step, the precipitate was 
resuspended in TN buffer and centrifuged through a 10-50% sucrose gradient. The 
fractions removed from this gradient were analysed on Coomassie stained gels and by 
Western blot, using anti-core mAb 42B12 (see Figure 3B2c). A protein of approximately
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23kDa was very faintly detectable on the Coomassie stained gel, in the lower region of the 
gradient (fractions 10-12). From the Western blot of the same fractions this band was 
conclusively identified as core protein and was found to be spread over a larger region of 
the gradient than was evident from the Coomassie stained gel. Core protein was present in 
fractions 6 to 13 and also in the pelleted material. The protein seemed to peak in fractions 
11 and 12, corresponding to the core protein-containing fractions visible in the Coomassie 
stained gel. In order to determine whether the protein at this position in the gradient was 
in the form of core particles, these two peak fractions were pooled, dialysed and 
concentrated approximately five-fold before examination by negative staining electron 
microscopy (see Figure 3B2d). The particles shown here were approximately 30nm 
diameter, which was in agreement with the observed 28nm diameter of core particles and 
all the particles observed appeared to be uniform in size.
3B3 D iscussion
After the problems encountered with purification of core particles using recombinant 
baculoviruses, expression of core protein and recovery of core particles using plasmid 
pR 1-11 in a bacterial expression system has been successful. The purification protocol, 
comprising ammonium sulphate precipitation of bacterial extracts, followed by sucrose 
gradient centrifugation of the resuspended pellet, yielded particles of a similar diameter 
and morphology to core particles of HBV. The nature of the bands identified by Western 
blot above the region of the sucrose gradient where core particles were observed was only 
investigated at a later stage (see Section 3D2). Core protein was also observed in an 
equivalent region when particles were purified from Xenopus lysates (Zhou and 
Standring, 1991; Seifer et al., 1993), but no comment was made on the possible nature of 
these proteins. However, a direct comparison between the results presented here and 
those of Zhou and Standring (1991) and Seifer et al. (1993) may not be relevant, as the 
overall gradient profiles for core protein differed from those presented here. Zhou and 
Standring showed a population of free core protein in the uppermost four fractions of the 
gradient, distinct from the core particle-containing fractions (fractions 7 to 11). The same 
gradient profile was shown by Seifer et al. (1993). Core protein was not detected in the 
uppermost fractions of the gradient in the results shown in this section, but was only 
present from fraction 6 down to the bottom of the gradient.
The problem of detection of core deletion proteins remained when they were 
expressed in this bacterial system. As full-length core protein was not evident as a major 
novel band on a Coomassie stained gel showing bacterial extract (see Figure 3B2c, panel 
A), it was necessary to use Western blotting to detect proteins expressed from pR 1-11. 
Polyclonal antibodies were used in order to increase the probability of detection for these 
proteins on Western blots of cellular extracts, but this did not seem to be successful as 
numerous proteins were detected by all three antibodies. Proteins larger in size than the
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predicted molecular weights of the core deletion proteins were probably detected due to a 
non-specific reactivity with the polyclonal antibodies used.
A more fundamental problem with the methods used in this section, observed by 
Dr. H. Marsden (Institute of Virology), was that the type of polyacrylamide gel used to 
analyse these proteins should have been altered. The core deletion proteins had predicted 
molecular weights in the range of 16-21kDa (see Table 2B 1.11 c). On 12% 
polyacrylamide gels, this meant that these proteins migrated almost at the dye front and 
were not resolved to any great extent, which made their analysis difficult. It was 
suggested that an increase in the acrylamide concentration would resolve this problem, 
therefore in the following sections all gels used were 17% polyacrylamide gels. Due to the 
number of additional proteins detected by all three polyclonal antibodies on Western blots, 
it was also decided to change to a different means of protein detection. Other methods of 
detection, such as immunoprecipitation of the proteins from cellular extracts, would 
probably suffer from the same problems as encountered previously: lack of binding by 
antibodies due to the size of the deletions or consequent changes in epitope conformations 
or non-specific binding by polyclonal antibodies to cellular proteins. Although a number 
of different monoclonal antibodies were available for testing which had detected the A84- 
109 core deletion protein (Section 3A4), these were not guaranteed to recognise the 
additional deletion proteins and, even if this was the case, any alterations we had planned 
to make to these proteins may have impaired this recognition. Preliminary results obtained 
by epitope-tagging core proteins (Section 3C) had shown that this might be a more useful 
means of detection for a wide range of core deletion proteins. It was also decided to use 
the more sensitive Amersham ECL system for detection of proteins on Western blots, to 
aid in detecting any proteins expressed at low levels.
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3C E xpression  and purification of ep itope-tagged  core protein and core  
deletion  proteins  
3C1 Introduction
The use of small, discrete peptide sequences that are known to be epitopes 
recognised by specific monoclonal antibodies, has been invaluable in the analysis of a 
variety of biological processes. These epitope tags have been used to determine 
subcellular locations for proteins, such as the human ubiquitin-activating enzyme El 
(Handley-Gearhart et al., 1994) and in the purification of biologically active proteins by 
immunoaffinity chromatography, as was achieved for human interleukin-5 receptor alpha 
chain (Brown et al., 1995). It was decided that the use of an epitope tag attached to the 
core deletion proteins would greatly assist with the detection of these proteins and any 
modified proteins derived from them. The pp65 epitope tag was chosen as this sequence 
was short enough to be incorporated into an oligonucleotide primer for use in PCR 
amplification of these proteins and could be detected by a commercially available 
monoclonal antibody, mAb 9220. The ten amino acid pp65 epitope tag was derived from 
the HCMV UL83 gene product, the late nuclear protein pp65 (McLauchlan et al., 1994). 
It was decided to fuse the pp65 epitope tag to the C-terminus of the core proteins by 
amplification of the genes using primer pair cdl/Bamtag. The resulting C-terminus of the 
proteins is shown in Figure 3C1. Addition of foreign sequences at this position has been 
previously shown to have no effect on core particle assembly (see Section 1E5). The core 
genes with C-terminal pp65 epitope tags were inserted into pR 1-11 for subsequent 
expression studies.
Core protein sequence:
1 5 1  RRGRSPRRRT PSPRRRRSQS PRRRRSQSRE SQC*
1 5 1  RRGRSPRRRT PSPRRRRSQS PRRRRSQSRE SOCERKTPRV TGG*
Figure 3C1: The C-terminal end of core protein showing pp65 epitope tag sequence 
The upper sequence shows the original core protein C-terminus and the lower sequence 
shows the addition of the ten amino acid pp65 tag sequence (underlined).
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3C2 E xpression  and purification o f pp65 ep itope-tagged  fu ll-length  core  
protein
As stated previously, addition of foreign sequences to the C-terminus of full-length 
core protein has no effect on the production of core particles. However, it was decided to 
purify the particles produced by the tagged full-length core protein to verify this and, 
more importantly, to ensure that detection was specific to the epitope tag sequences, with 
minimal non-specific binding. Full-length tagged core protein was expressed from pR l- 
11 and the resuspended ammonium sulphate pellet was centrifuged through a 10-50% 
sucrose gradient. Gradient fractions were analysed on Coomassie stained gels and 
Western blots, using both anti-core mAb 42B12 and anti-pp65 mAb 9220 (see Figure 
3C2a). Controls for detection of the epitope tag were kindly supplied by Dr. J. 
McLauchlan: epitope-tagged CAT protein (20kDa) and tagged VP22 (40kDa), a tegument 
protein of HSV.
The results from the Coomassie gels of these fractions (Figure 3C2a, Panel C) 
showed that large amounts of protein were detected in the lower region of the gradient 
(fractions 14-17) and in the pelleted material. This protein corresponded well in size to 
that of the core protein expressed from pR 1-11 with the additional tag sequences 
(predicted molecular weight 25kDa). The expression levels for this protein were greater 
than those of the similar protein expressed and purified in Section 3B2. This may be due, 
in some way, to the presence of the epitope tag, or may simply be due to a more efficient 
extraction procedure for this particular experiment. The protein-containing fractions in the 
lower region of the gradient were also relatively free of other contaminating proteins, with 
only two additional major staining bands of approximately 28 and 29kDa molecular 
weight present. Western blots of these fractions confirmed that the pp65 epitope tag was 
specifically detected by mAb 9220 (Figure 3C2a, Panel A). This detection was not due to 
cross-reaction with any core protein epitopes, as no reactivity was observed for the lanes 
containing an aliquot of untagged core particles, which were included as an additional 
molecular weight marker (the band observed in the final lane was thought to be due to 
overspill of sample from the adjacent lane after size comparison with the band present on 
the Panel B blot). The VP22tag control was also detected effectively by the 9220 mAb, 
but this was not the case for the CATtag control, the reasons for which were unclear. A 
major reactive tagged core protein band was detectable, with a mass of approximately 
25kDa, which corresponded well with the band from the Coomassie gels. The peak 
fractions for this protein were 13-17, which also concurred with the Coomassie gels. As 
was observed for purification of untagged core particles (Section 3B2), this protein was 
also detectable towards the top of the gradient, from fraction 5. The nature of this protein 
was only investigated at a later stage (see Section 3D2). Several other higher molecular 
weight proteins were also detected by mAb 9220, including proteins of 28 and 29kDa. 
These particular proteins may be identical to those observed on the Coomassie stained
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Figure 3C2a: Purification of pp65 epitope-tagged core particles
Full-length core protein with a C-terminal pp65 epitope tag was expressed using 
plasmid pR1 -11 and purified on a 10-50% sucrose gradient, after an ammonium sulphate 
precipitation step. Fractions were collected from the top (1) to the bottom (17) of the 
gradient. Any pelleted material was resuspended (P) and analysed, along with aliquots 
of soluble cellular extract (ex), supernatant (sn) and pellet (p) from the ammonium 
sulphate precipitation step. Fractions were electrophoresed through 17.5% 
polyacrylamide gels which were Coomassie stained (Panel C) or Western blotted and 
incubated with anti-pp65 mAb 9220 (Panel A). This blot was stripped and reincubated 
with anti-HBc mAb 42B12 (Panel B). The position of the epitope-tagged core protein is 
indicated by an arrow (-*). Molecular weights of the markers used (M) are shown.
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Figure 3C 2b: Electron micrograph of pp65 epitope-tagged core particles 
Core particles were purified from extracts of bacteria transformed with plasmid pR1 -11 
containing full-length core gene with a C-terminal pp65 epitope tag, using a 10-50% 
sucrose gradient. Fractions 14-16, containing the highest levels of core protein as 
identified by Western blot analysis, were pooled and concentrated using an Amicon 50 
microconcentrator. An aliquot of the concentrated sample was negatively stained and 
examined by electron microscopy. Scale bar represents 50nm.
gels. Their reactivity with mAb 9220 suggests that, despite their larger size, they are 
related to the full-length core protein. These bands may, therefore, represent proteins 
produced by read-through of the stop codon encoded by the core gene. Proteins of 
approximately 44-50kDa were also detected and these may represent dimers of the core 
protein and other proteins with a slightly higher molecular weight, also detected by mAb 
9220 (see Section 3D3). The blot incubated with anti-core mAb 42B12 (Figure 3C2a, 
Panel B) again showed that there was no antibody cross-reactivity with epitope tag 
sequences. This antibody was not as sensitive, at the dilution used, as the 9220 mAb, as 
protein towards the top of the gradient was less obvious. Fractions 14-16 were pooled, 
dialysed and concentrated as before for examination by negative staining electron 
microscopy (see Figure 3C2b). Large numbers of apparently normal particles were 
observed, confirming that the epitope tag made no obvious difference to particle 
assembly.
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3C3 E xpression  and purification o f pp65 ep itope-tagged  core d e le tio n  
p rotein s
All four core deletion genes had been amplified by PCR to include the C-terminal 
epitope tag and inserted into pR 1-11. Proteins were expressed as normal and samples of 
the ammonium sulphate precipitate were analysed by Western blot with anti-pp65 mAb 
9220 (Figure 3C3a), where all four proteins were shown to be expressed and detected. 
Although all proteins were expressed for the same time and using equal culture volumes, 
differences in expression levels, as judged by the intensity of the bands on the blot, were 
observed. The number of other bands present on the blot was also variable for each 
protein. Bands of a lower molecular weight, observed for full-length core protein and 
core deletion A81-121, may have been due to degradation of the expressed protein. As 
was observed in a later section (see Section 3D3) a band of approximately double the size 
of the expressed protein represented protein dimers, however other bands were present of 
both smaller and larger molecular weights. Although the sample containing the core 
deletion A60-117 did not run well, subsequent gels for the purification of this protein 
showed that its size was the predicted 16kDa.
Purification of these expressed proteins on 10-50% sucrose gradients was 
undertaken, using the standard protocol (see Figure 3C3b). These results show that the 
four proteins differed in their movement through the gradients. Core deletion protein A84- 
109 (Figure 3C3b, Panel i) was only very faintly detectable in fractions 6-8 of the 
gradient, with none of this protein observed in fractions toward the bottom of the gradient 
in the region where core particles were detected. The lower level of expression of this 
protein, compared to the full-length protein and dilution of the protein in the larger volume 
of the gradient fractions probably both contributed to the poor levels of detection. When 
these fractions were pooled, concentrated approximately ten-fold and examined by 
electron microscopy, no particle-like structures were observed. Core deletion protein A81- 
121 (Figure 3C3b, Panel ii) was present in fractions 3-12, and also faintly in the pelleted 
material. It was likely that the protein present in the pellet represented high molecular 
weight aggregates formed during the extraction process. Again this protein is present in 
fractions nearer the top of the gradient than was observed for core particles. The intensity 
of the bands decreased in fractions 8 and 9 and then increased again in fraction 10. 
Fractions were pooled into two sets of fractions 5-7 and 10-12, in case the second peak of 
protein represented a distinct population, and concentrated for electron microscopy. For 
both sets of fractions, no evidence of particle-like structures was found. Core deletion 
protein A79-125 (Figure 3C3b, Panel iii) was only faintly detectable in fractions 6-9, 
which was, again, above the region where particles were detected. The lower levels of 
expression of this protein, when compared to the full-length protein, would have 
contributed to the difficulty in its detection. Electron microscopic examination of these 
concentrated fractions showed no particle-like structures. Core protein with the largest
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Figure 3C3a: Expression of pp65 epitope-tagged core deletion proteins 
Core protein deletions with a C-terminal pp65 epitope tag were expressed using 
plasmid pR 1 -11 and precipitated with ammonium sulphate. An aliquot of the 
resuspended pellet was electrophoresed through a 17.5% polyacrylamide gel along with 
full-length tagged core protein (WTtag) and Western blotted. The blot was incubated 
with anti-pp65 mAb 9220. Molecular weights of the markers used (M) are shown.
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Figure 3C 3b: Purification of pp65 epitope-tagged core deletion proteins (continued with 
figure legend on the following page)
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Figure 3C 3b: Purification of pp65 epitope-tagged core deletion proteins (continued)
Core deletion proteins with C-terminal pp65 epitope tags were expressed using plasmid 
pR 1 -11 and purified on 10-50% sucrose gradients, after an ammonium sulphate 
precipitation step. Fractions were collected as before and analysed on Western blots 
using anti-pp65 mAb 9220. Lanes labelled 'c' in panels i and iii show extracts from 
untransformed bacteria. Molecular weights of the markers used are shown and the 
position of the protein in each blot is indicated by an arrow (**).
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deletion, A60-117 (Figure 3C3b, Panel iv), was present in the lower region of the 
gradient, in fractions 15-19 and in the pelleted material. This corresponded well to the 
position of the core particles, but when pooled, concentrated fractions were examined by 
electron microscopy, despite thorough efforts, no particle-like structures were observed.
These results have shown that all four core deletion proteins were incapable of 
assembling into a core particle-like structure that was visible by electron microscopic 
examination. It may have been that any particulate structures formed were unstable, 
explaining their absence in samples for examination. However, precautionary measures 
were taken to prevent this: samples were kept on ice at all times and concentrated and 
examined with minimum intervening periods and samples were not frozen at any stage 
after purification. The rationale for this last precaution came from studies with C- 
terminally truncated core protein, lacking the final 32 residues (Seifer and Standring, 
1993). Mutant particles formed from this protein were originally thought to display 
'particulate' HBe epitopes, but the results from this paper showed that this was probably 
due to the instability of these particles. These results also showed that one or two 
freeze/thaw cycles increased the level of HBe antigenicity, again by disrupting the 
particles. Sonication of bacterial cell suspensions could also have disrupted any core 
particle-like structures that had assembled. The possible effects of these procedures were 
analysed in a later section (see Section 3G).
3C4 E xpression and purification o f pp65 ep itope-tagged  A core-surface  
hybrid protein
From the results in the previous section it was concluded that core proteins with 
central deletions were unable to assemble into core particle-like structures. This raised the 
question of whether this was due to deletion of specific amino acid sequences required to 
direct folding of the protein into the correct conformation, and thus correct assembly of 
the particles, or purely due to the size of the deletion being too large, with the actual 
sequence deleted being irrelevant. In order to address this question it was decided to 
produce a modified core deletion protein, where the deleted region had been replaced by 
foreign sequence of exactly the same size. Core deletion A81-121 was chosen and the 
deleted region was replaced by a 123bp fragment of the HBV surface gene, using a PCR- 
based method (see Figure 2 B 1.11 a), with the product being a Acore-surface hybrid gene. 
The amino acid sequence of this protein is shown in Figure 3C4a. However, when this 
was expressed and purified on a sucrose gradient, it became apparent that there were 
problems with this experiment (Figure 3C4b, Panel A). Although protein of the correct 
size was produced it was expressed at very low levels and was only detectable after 
concentration of proteins by ammonium sulphate precipitation. Upon Western blot 
analysis of fractions from the sucrose gradient purification of this hybrid protein, no
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1 MDIDPYKEFG A TV ELLSFLP SDFFPSVRDL LDTAAALYRD A L E SPE H C SP
81
SR E L W SY V N  VNMGLKIRQL 
5 1  HHTALRQAIL CWGDLMTLAT WVGDNLQDPA GM LPVCPLIP G SST T ST G PP
121
LW FHISCLTF GRETVLEYLV S 
1 0 1  RTCTTPAQGI SMYPSCCCTK P FGVW IRTPP A Y R PPN A PIL  S T L P E T T W R
1 5 1  RRGRSPRRRT PSPRRRRSQ S PRRRRSQSRE SQC*
Figure 3C4a: Amino acid sequence of the Acore-surface hybrid protein
The sequence of the region of surface protein inserted into the A81-121 deletion is
underlined. Above it is shown the sequence present in full-length wild-type core protein.
protein could be detected at any position on the gradient. The failure to detect protein in 
the gradient fractions may have been due to the low level of protein present, which may 
have been below the sensitivity of the monoclonal antibody used. Another possibility, 
which seemed more likely, was that during this particular purification procedure the 
protein had become insoluble. Examination of protein which had precipitated during the 
overnight dialysis step showed this to be the case, as the Acore-surface hybrid protein 
was present in this material. In order to attempt to overcome this problem, the purification 
procedure was modified in two ways. The first modification was to attempt to remove 
nucleic acids from the bacterial extract so they would not interfere with subsequent steps. 
This was achieved by the use of PEI, a positively charged polymer. PEI precipitation of 
nucleic acids is commonly used as the first step of a protein purification protocol. The PEI 
interacts with nucleic acids to form an insoluble complex which can then be removed by 
centrifugation. The bacterial extract was first made up to 0.5M NaCl before precipitation 
of nucleic acid by the addition of PEI. After removal of the PEEnucleic acid complex, 
ammonium sulphate precipitation of proteins in the supernatant was carried out as before. 
The second modification was to load the resuspended pellet from the ammonium sulphate 
precipitation step onto the sucrose gradient, without the intervening dialysis step. When 
extracts from all stages of this protocol and fractions from the sucrose gradient were 
analysed, the protein was only detected in the crude bacterial extract (the apparent band in 
lane 10 was caused by forceps, used to handle membranes). The protein appeared to have 
been removed from solution during the nucleic acid precipitation step, possibly due to the 
increased salt concentration required (0.5M, compared to 0.1M in TN buffer).
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Figure 3C 4b: Purification of epitope-tagged Acore-surface hybrid protein 
The Acore-surface hybrid protein with a C-terminal pp65 epitope tag was expressed 
using plasmid pR1-11 and purified on a 10-50% sucrose gradient, after an ammonium 
sulphate precipitation step (Panel A) or with an initial additional precipitation of nucleic 
acid using PEI (Panel B). Fractions were collected from the top (1) to the bottom (19) of 
the gradient and analysed by Western blotting using anti-pp65 mAb 9220. Any pelleted 
material was resuspended (P) and analysed, along with aliquots of soluble cellular 
extract (ex) and pellet (p) from the ammonium sulphate precipitation step. Panel A 
shows the original purification method, where the lane labelled ‘dp’ contains material 
which precipitated during dialysis of the ammonium sulphate pellet and the lane labelled 
‘c’ contains cellular extract from untransformed E.coli. Panel B shows a modification of the 
original method, as described above, where the lane labelled ‘pi’ contains an aliquot of 
the supernatant after the PEI precipitation and ‘sn’ contains an aliquot of the supernatant 
after the ammonium sulphate precipitation step. The position of the epitope-tagged 
protein is indicated by an arrow (<*). Molecular weights of the markers used (M) are 
shown. An aliquot of epitope-tagged full-length core protein (wt) was included as a control
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3C5 Discussion
The results from this section have shown the successful use of the pp65 epitope tag 
for detection of the full-length core protein, four core deletion proteins and a Acore- 
surface hybrid protein. Full-length core protein formed large numbers of core particles 
when expressed showing that the presence of the epitope tag did not alter its ability to 
assemble into morphologically normal core particles. The core deletion proteins were 
expressed and purified, however none of them were able to assemble into any form of 
core particle-like structure. This was determined by a number of criteria, the simplest of 
which was the gradient profiles of these proteins. From the results with the full-length 
protein, a marked increase in protein content was observed in fractions 13-17. Electron 
microscopic examination of these fractions, when pooled, showed that core particles were 
present in this lower region of the gradient. This increase in protein content was not 
observed for core deletion proteins A84-109, A79-125 or A60-117, where all positive 
fractions on Western blots had approximately the same, albeit very faint, intensity. Core 
deletion protein A81-121 did show two distinct peaks of protein-containing fractions (3-9 
and 10-12). However, no particles were detected in either region when they were examine 
separately by electron microscopy.
Examination of the relative positions of the core deletion proteins A84-109 and A79- 
125 in the gradient also led to the conclusion that they were unable to form particles. 
These proteins were present in the upper region of the gradient (fractions 6-8 and 6-9, 
respectively), above the fractions where core particles were detected. However, Western 
blots of fractions from the purification of full-length core protein (Figure 3C2a) showed 
that epitope-tagged core protein could also be detected in this upper region of the gradient, 
from fraction 5 down. Although this raised the possibility that protein in this region was 
in the form of particles, a more thorough investigation of core protein-containing fractions 
in this region by electron microscopy (see Section 3D2) failed to show evidence for this. 
In addition, purification of a C-terminally truncated core protein which was known to be 
unable to assemble into core particles showed that this protein was present in this upper 
gradient region (see Figure 3D2a). In contrast to the A84-109 and A79-125 proteins, core 
deletion proteins A81-121 and A60-117 were present in the lower region of the gradients 
(fractions 10-12 and 15-19, respectively). However, electron microscopic examination 
could not detect any particles. It may have been that any particulate structures formed 
were unstable, despite the precautions taken, and were unable to be detected. Aggregation 
of the particles could also have taken place, either during the purification or concentration 
stages, so hampering their detection by electron microscopy, despite thorough efforts. 
Despite these possibilities, it appeared that all four core proteins with central deletions 
were unable to assemble into core particles.
The construction of the Acore-surface hybrid protein was designed with a view to 
determining the importance of the deleted core protein sequence in directing particle
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assembly. However successful expression and purification of this protein was not 
achieved. The HBV surface protein region used to construct this protein may have 
affected its stability. Other modifications to the purification protocol for this protein could 
have been attempted, such as using DNase and RNase to remove nucleic acids instead of 
PEI or the use of larger volume bacterial cultures to provide increased amounts of protein. 
However, upon advice from other group leaders, it was decided to once more alter the 
expression system used. It was thought that achieving higher levels of protein expression 
would allow the ammonium sulphate precipitation step to be omitted, so removing its 
associated insolubility problems.
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3D Expression and purification of epitope-tagged core proteins in the pET  
sy stem  
3D1 Introduction
The pET vectors were initially constructed by Studier and colleagues as pBR322 
derivatives containing a bacteriophage T7 promoter (Studier et a l , 1990). Genes are 
cloned under the control of the strong T7 transcription and translation signals before the 
recombinant plasmid is transferred to the E.coli strain BL21(DE3)pLysS. Upon addition 
of IPTG to this strain, T7 RNA polymerase is induced and transcribes the cloned gene in 
the recombinant pET vector. These host cells also contain a plasmid encoding T7 
lysozyme, which cleaves a specific bond in the peptidoglycan layer of the bacterial cell 
wall, and allows rapid and efficient lysis of cells by either freeze/thaw or mild detergent 
treatment. It was thought that the higher levels of expression recorded using this system 
would eliminate the requirement for an ammonium sulphate precipitation step, and the cell 
lysis method would allow higher levels of protein recovery. All core gene derivatives, 
along with full-length core gene, were amplified by PCR using primer pair cp3/Bamtag 
(see Section 2A3), which include Nde I and Bam HI sites respectively. In contrast to 
plasmid pRl -11, the 5' terminus of the products of these reactions contained the authentic 
core protein start codon, with the 3' terminus including the pp65 epitope tag.
3D2 pET expression  and purification of ep itope-tagged  core d e le tio n  
p rotein s
Initial expression experiments showed that the IPTG concentration used to induce 
expression had very little effect on the levels of soluble protein recovered, therefore 
cultures were induced with a final concentration of 300pM. Production of core deletion 
proteins A81-121, A79-125 and A60-117 was found to be more efficient when induced 
expression was carried out at 26°C, instead of 30°C or 37°C. Timecourse experiments 
showed that expression periods of 3hr for A81-121 and A79-125 or 2.5hr for A60-117 
gave greater protein recovery. All other proteins were also induced at 26°C, after the 
temperature of induction was shown to have no effect on protein production, and 
expressed for a 4 hour period. The four tagged core deletion proteins, along with full- 
length core protein were shown to be expressed efficiently and detectable in Western blots 
of clarified cellular extracts (Figure 3D2a), although A79-125 consistently gave lower 
levels of expression. Additional bands were detected on these blots, the major one of 
which was approximately double the predicted size of the expressed protein. This was 
further investigated at a later stage (see Section 3D3).
After expression and overnight storage at -20°C, the cell pellet was resuspended in 
TNE II, to which was added DNase and RNase to remove the nucleic acids present. The
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Figure 3D2a: Expression of pp65 epitope-tagged core deletions using the pET system 
Core deletions with a C-terminal pp65 epitope tag were expressed in E.coli 
BL21 (DE3)pLysS for 4 hours at 26°C, after induction with 300pM IPTG. Cellular extracts 
were prepared and aliquots electrophoresed through a 17.5% polyacrylamide gel 
alongside full-length tagged core protein (WTtag). The gel was Western blotted and 
incubated with anti-pp65 mAb 9220. Molecular weights of the markers used (M) are 
shown.
cellular extract was then clarified by centrifugation and soluble protein centrifuged 
through 10-50% sucrose gradients, after which, fractions were analysed by Western blot 
(see Figures 3D2b and 3D2d).
The full-length tagged protein was detectable from fraction 7 down to the bottom of 
the gradient, again with a marked increase in protein content occurring in fractions in the 
lower region of the gradient (fractions 14-19). When the peak fractions (14-17) were 
pooled, concentrated and examined by electron microscopy, large numbers of 
morphologically normal, 28nm diameter core particles were observed (Figure 3D2c). 
Core protein had been detected in gradient fractions above this region using both the p R l- 
11 vector (see Figures 3B2c and 3C2a) and in this section, with the pET3a vector. It was 
therefore decided to examine the fractions in this region to determine the state of this 
population of core protein. Fractions 9-12 were pooled, concentrated and examined by 
electron microscopy. However, no core particles could be detected.
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Figure 3D2b: Purification of pp65 epitope-tagged core particles expressed in the pET 
system
Full length core gene with a C-terminal pp65 epitope tag was expressed in E.coli 
BL21 (DE3)pLysS for 4 hours at 26°C, after induction with 300pM IPTG. Total cellular 
extract (ex) was prepared and after centrifugation at 35k rpm for 20 min, soluble protein 
(s) was centrifuged through a 10-50% sucrose gradient. Fractions were removed from 
the top (1) to the bottom (19) of the gradient and any pelleted material was resuspended 
(P). Fractions were electrophoresed through 17.5% polyacrylamide gels along with an 
aliquot of tagged full-length core protein (c) expressed using plasmid pR1 -11 (Section 
3C2). These gels were then Coomassie stained (Panel A) or Western blotted with anti- 
pp65 mAb 9220 (Panel B). Molecular weights of the markers used (M) are shown and 
the position of the tagged core protein is indicated by an arrow («—).
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Figure 3D2c: Electron micrograph of pp65 epitope-tagged core particles expressed using 
the pET system
Core particles were purified from extracts of bacteria transformed with a pET3a plasmid 
containing full-length core gene with a C-terminal pp65 epitope tag, using a 10-50% 
sucrose gradient. Fractions 14-17, containing the highest levels of core protein as 
identified by Western blot analysis, were pooled and concentrated using an Amicon 50 
microconcentrator. An aliquot of the concentrated sample was negatively stained and 
examined by electron microscopy. Scale bar represents 50nm.
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Figure 3D2d: Purification of pp65 epitope-tagged core deletion proteins expressed in the 
pET system (continued with figure legend on the following page)
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Figure 3D2d: Purification of pp65 epitope-tagged core deletion proteins expressed in the 
pET system
Core deletion proteins with a C-terminal epitope tag were expressed in E.coli 
BL21 (DE3)pLysS at 26°C after induction with 300pM IPTG. Cellular extracts were 
prepared (ex) and after centrifugation at 35k rpm for 20 min, soluble protein (s) was 
centrifuged through a 10-50% sucrose gradient. Fractions were removed from the top (1) 
to the bottom (19) of the gradient and any pelleted material was resuspended (P). 
Fractions were electrophoresed through 17.5% polyacrylamide gels along with an aliquot 
of tagged full-length core protein (c). After Western blotting of the gels, membranes were 
incubated with anti-pp65 mAb 9220. Molecular weights of the markers used (M) are 
shown and the position of each core deletion protein is indicated by an arrow («— ).
Core deletion protein A84-109 was detected only in the central region of the gradient 
(fractions 8-13), with all fractions having approximately equal intensities (see Figure 
3D2d, Panel i). Concentration of these pooled fractions, approximately 20-fold, and 
examination by electron microscopy failed to detect core particle-like structures. A faintly 
reacting lower molecular weight protein (approximately 17kDa) was present in fractions 
9-13. This may represent a protease degradation product of the core deletion protein, as it 
was present in the same fractions. An N-terminal region of the protein must have been 
removed in order to still allow detection of the C-terminal epitope tag by mAb 9220. 
Purification of A81-121 showed that protein was again present in fractions 8-13, in the 
central region of the gradient (see Figure 3D2d, Panel ii). However, in addition this 
protein was also faintly detectable in decreasing intensity towards the bottom of the 
gradient (fractions 14-19). When the peak fractions (fractions 8-13) were examined by 
electron microscopy after 20-fold concentration, no core particle-like structures were
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observed. Core deletion protein A79-125 was detected to the same low intensity from 
fraction 8 down to the bottom of the gradient (see Figure 3D2d, Panel iii). As there were 
no fractions containing obviously higher levels of protein, fractions 9-11 and 12-14 were 
chosen for separate further examination as core particle-like structures formed from this 
protein would be expected to present in this region of the gradient, due to their smaller 
molecular mass. Upon examination, no such structures were observed. Smaller proteins 
of approximately 14kDa and 17kDa were also detectable in fractions 4-5 and 6-8, 
respectively. As no A79-125 deletion protein was present in fractions 4-6, the smaller 
proteins are unlikely to be core protein-related. Core deletion A60-117 was detected, 
again, in fraction 8 down to the bottom of the gradient, but at higher levels than A79-125 
(see Figure 3D2d, Panel iv). A smaller protein of approximately 13kDa was also present 
in these fractions. This may have been due to proteolytic degradation of the N-terminus of 
the core deletion protein. The same fractions were chosen for electron microscopic 
examination as for the previous protein, with the same results.
The conclusion drawn from these expression studies was that all four core deletion 
proteins have again been shown to lack the ability to assemble spontaneously into any 
core particle-like structures. Although the A81-121, A79-125 and A60-117 deletion 
proteins were detected in the lower regions of the sucrose gradients (corresponding to 
fractions where core particles were detected), a marked increase in protein content was not 
observed in any of these fractions, contrasting with the result for the full-length protein.
Due to the continuing difficulties in determining the state of the protein present in 
gradient fractions above those where core particles were present and the state of the non- 
particulate protein from the core deletion purifications, it was decided that an additional 
control was necessary. It was shown by Birnbaum and Nassal (1990) that if core protein 
was C-terminally truncated beyond the leucine residue at position 140, this protein lost the 
ability to self-assemble into core particles. It was decided to reproduce this truncated core 
protein and purify it on the sucrose gradient. This result should define fractions where 
core particles would definitely not be present, thus excluding them from further analyses. 
It was decided to create the C-terminally truncated core protein by a single round of PCR 
using primer pair cp3/Thrtag. When expressed this would produce core protein truncated 
at Thr-128, with the additional ten amino acid epitope tag sequence. The extra truncation 
was intended to compensate for the ten amino acid epitope tag sequence, as it was not 
known whether this could function as an equivalent to missing core protein sequence and 
so, in fact, allow core particle assembly. The results for the purification of this core T128 
protein are shown in Figure 3D2e. Protein of approximately the predicted size (16kDa) 
was produced and, as expected, was detected only in the upper region of the gradient, 
mainly in fractions 1-4. Flowever, detectable amounts of protein were also present, down 
to fraction 10. Protein in these fractions must also have been in a non-particulate form.
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Figure 3D2e: Purification of C-terminally truncated core protein, T128 
CoreT128 protein with a C-terminal pp65 epitope tag was expressed in E.coli 
BL21 (DE3)pLysS as before. A cellular extract was prepared (ex) and after 
centrifugation at 35k rpm for 20 min, soluble protein (s) was centrifuged through a 10- 
50% sucrose gradient. Fractions were removed from the top (1) to the bottom (19) of the 
gradient and any pelleted material was resuspended (P). Fractions were 
electrophoresed through a 17.5% polyacrylamide gel along with an aliquot of tagged full- 
length core protein (c). After Western blotting of the gel, the blot was incubated with anti- 
pp65 mAb 9220. Molecular weights of the markers used (M) are shown and the position 
of the tagged coreT128 protein is indicated by an arrow (*—■).
3D3 D im erisation o f core deletion proteins
Studies of core particle assembly in Xenopus oocytes showed that dimerisation of 
core protein monomers, via disulphide bonds, was the initial step in the core particle 
assembly pathway (Zhou and Standring, 1992). As the core deletion proteins in this study 
did not appear to assemble into core particle-like structures, it was decided to determine at 
which stage the assembly pathway arrested: were the core proteins able to dimerise, but 
these dimers unable to assemble into particles, or did dimerisation not occur? In order to 
address this question, core deletion proteins were analysed on Western blots under non­
reducing conditions for evidence of bands of approximately double the size of the 
monomeric protein (see Figure 3D3).
The results showed that, under non-reducing conditions, proteins of approximately 
the correct size for dimers of all four core deletion proteins were specifically detected by 
mAb 9220. Full-length core protein was included as a control for this experiment and 
under non-reducing conditions a major-staining band of approximately 48kDa was
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Figure 3D3: Dimerisation of core deletion proteins
Core deletion proteins with a C-terminal pp65 epitope tag were expressed using E.coli 
BL21 (DE3)pLysS as before. Cellular extracts were prepared and mixed with non­
reducing or reducing SDS PAGE sample buffer. Samples were heat-denatured at 100°C 
for 5 min, before being electrophoresed through a 17.5% polyacrylamide gel. After 
Western blotting of the gel, the blot was incubated with anti-pp65 mAb 9220. Tagged 
full-length core protein was also run (WTtag) as a control and the molecular weights of 
the markers used (M) are shown.
visible. This corresponded well to the predicted size of core protein dimer. This band 
decreased in intensity upon reduction, with a concomitant increase in the amounts of core 
protein monomer detected. In addition to the protein dimer, prominent lower molecular 
weight bands were observed under non-reducing conditions in all bacterial extracts 
expressing the core deletion proteins, with the exception of A79-125. These lower 
molecular weight proteins corresponded to the sizes of the respective protein monomers. 
It was not known if all the disulphide-linked dimers had remained intact, thus explaining 
the presence of the protein monomers. This may have been affected by the method of 
sample preparation, prior to electrophoresis: Gallina et al. (1989) heated samples for non­
reducing electrophoresis at 60°C for 30min, whereas Zhou and Standring (1992) used 
60°C for 5min, followed by 100°C for 5min. However, no reasons were given for these 
modifications and it seems unlikely that these differences in temperature could influence 
the stability of covalent bonds. The monomeric proteins may represent core proteins or 
core deletion proteins which had been denatured during the extraction process. This
131
Chapter 3 Results
denatured protein may have been present in a conformation where all four cysteine 
residues were buried and thus was unable to form disulphide bonds.
Under reducing conditions, the majority of the core protein and core deletion protein 
dimers were resolved into monomers. However, for all proteins, dimeric forms were still 
detectable. The use of an increased amount of (3-ME in the sample buffer used for SDS 
PAGE gels may have eliminated protein dimers completely. Kann and Gerlich (1994) also 
detected faint full-length core protein dimers on Coomassie-stained gels when core 
particles treated with 5% (3-ME were examined. Also visible under non-reducing 
conditions, in the results presented in this section, were bands of higher molecular weight 
than the core protein or core deletion protein dimers. These were particularly evident for 
the full-length and A84-109 core proteins and it may have been that these bands 
corresponded to higher order oligomers of core protein, formed by disulphide bonds 
between protein dimers.
3D4 D eterm ination o f the sensitivity o f anti-pp65 mAb
Studies of the formation of core particles in the Xenopus system have shown that 
this process is highly co-operative and also dependent upon the concentration of 
accumulated core protein dimers ( Seifer et al., 1993). Core protein was required to 
accumulate to an estimated concentration of 0.7-0.8pM  (14-16pg/ml) before particle 
assembly would initiate. As results from the purification of the core deletion A79-125 
showed only small amounts of protein detectable in the gradient fractions, it was decided 
to quantify the detection sensitivity of the anti-pp65 mAb 9220, to ensure that the smaller 
quantity produced for this protein was not a limiting factor in its assembly into particles. 
The concentration of protein in a sample of purified epitope-tagged wild-type core 
particles was determined by Bradford assay to be lpg/pl. This sample was serially diluted 
two-fold and aliquots separated by SDS PAGE and Western blotted, using the standard 
1:1000 dilution of mAb 9220 (see Figure 3D4). Under these conditions the antibody was 
capable of detecting a minimum concentration of 3.9pg/ml of tagged protein. Although 
this was lower than the minimal value required for particle assembly, the protein from the 
purification of A79-125 was distributed over twelve 0.65ml fractions. Therefore the 
original concentration of protein in the bacterial extract was greater than that required.
3D5 D iscussion
The results from this section have shown that all four core deletion proteins studied 
were unable to self-assemble into stable core particle-like structures. The same 
probabilities existed for these results as those discussed in Section 3C5.
Core deletion protein A84-109 was detected only in the central region of the 
gradient, above the fractions where core particles were observed when full-length protein 
was purified. However, it was possible that this deletion protein was capable of
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Figure 3D4: Detection sensitivity of mAb 9220 on a Western blot 
Decreasing concentrations of pp65 epitope tagged core particles were electrophoresed 
on a 17.5% polyacrylamide gel, which was then Western blotted. After blocking, the blot 
was incubated with a 1:1000 dilution of anti-pp65 mAb 9220.
assembling into particles but that the particles were extremely unstable and rapidly 
dissociated into dimers, before the purification step. A similar possibility existed for core 
deletion proteins A81-121, A79-125 and A60-117, which were detected in the lower 
region of the gradient, where wild-type core particles were observed. Core particle-like 
structures could have been formed from these proteins, but were unstable and therefore 
undetectable during electron microscopic examination. This possibility was catered for to 
some extent by rapid and careful examination of samples after purification, with no 
freezing steps in the intervening periods, which may have decreased the stability of 
particle-like structures. However, the gradient profiles for these deletion proteins also 
differed from that of the full-length protein. For all four deletion proteins, none of the 
fractions in the lower region showed as substantial an increase in protein content as was 
observed for the full-length protein. This showed that 'banding' of particles at a specific 
sucrose density was not occurring and that no distinct particulate population of protein 
was present. Instead, only a protein population with densities which increased in a 
gradual manner was observed.
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A broad gradient profile, similar to that obtained from purification of the core 
deletion proteins A81-121, A79-125 and A60-117, was also observed by another group 
who were investigating the properties of core protein insertion mutants (Beames and 
Lanford, 1995). Insertions of two to four amino acids were made throughout the first 140 
residues of the protein and these proteins were expressed in insect cells using recombinant 
baculoviruses. Expressed proteins were then purified on 5ml 10-50% sucrose gradients to 
assay for core particle formation. Under the conditions used, full-length core protein (in 
the form of core particles) was detected in two 500pl fractions in the centre of the 
gradient. Full-length proteins with two or three amino acid insertions after Ala-36 or Ser- 
44, respectively, were detected in fractions from the top of the gradient down to the 
central fractions. Insertion of three, two or four amino acids after residues Thr-67, Ala-69 
and Val-89, respectively, produced proteins which were detected in fractions below those 
to which full-length core protein migrated. The proteins with insertions after Thr-67 and 
Ala-69 were unable to assemble into core particles. These results were verified by 
expression of these two core protein insertion mutants in Huh7 cells transfected with 
core-defective HBV genomes. This experiment assayed for rrarzs'-complementation of 
HBV replication and, again, showed that no core particles were produced by these two 
proteins. This group concluded that the broader distributions of core proteins observed in 
the gradients suggested the formation of large aggregates of core protein insertion mutants 
or the formation of unstable core particles by these insertion mutants.
Two separate investigations were carried out in order to attempt to further interpret 
the results of the purification of the core deletion proteins. Electron microscopic 
examination of fractions 9-12 from the purification of the full-length core protein was 
performed in order to determine whether particles were present in this region of the 
gradient, in addition to the lower region (fractions 14-17). The results showed that core 
protein in these fractions was in a non-particulate state. The second investigation involved 
purification of the C-terminally truncated core protein, T128. After purification, this 
protein was present in fractions at the top of the gradient, but also in fractions as low as 
fraction 10. These results implied that for the core deletion proteins, protein which was 
observed in fractions from the top of the gradient down to fraction 12 were unlikely to 
represent core particle structures. Zhou and Standring (1992b) demonstrated that free core 
protein (fractions 1-4 of the fourteen fractions from a 10-60% sucrose gradient) existed as 
dimers. Therefore, the equivalent fractions on the 10-50% sucrose gradients used in the 
work presented in this thesis (fractions 1-7) are also likely to contain protein dimers. 
Unfortunately the information derived from all these results does not conclusively clarify 
the nature of proteins found to be present below fraction 12. Therefore, the conclusion of 
Beames and Lanford (1995) who stated that protein present in this region represented 
large protein aggregates, appears to be the only alternative explanation. In order to answer 
this question more satisfactorily, it would be useful to analyse the core deletion proteins
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on 3-25%  sucrose sizing gradients, similar to those used by Zhou and Standring (1992a). 
Comparison with the migration of proteins of known molecular weight, such as carbonic 
anhydrase (29kDa) and BSA (66kDa), on these gradients would have allowed 
determination of the molecular weights of the core deletion protein species. This could 
then be used to determine whether these proteins were present as dimers or higher order 
structures.
The correlation between the results obtained from expression of core deletion 
proteins using plasmid pR 1-11 (Section 3C3) and the results presented in this section is 
variable. Core deletion protein A84-109 was present in fractions 6-8 for p R l-1 1 and 8-13 
for pET purifications. Deletion protein A81-121 did show some degree of overlap with 
the two results (fractions 3-12 for pR 1-11 and 8-19 for pET). A79-125 was present in 
fractions 6-9 for pR 1-11 and 8-19 for pET purifications. Although core deletion A60-117 
was detected in fractions 15-19 for both purifications, this protein was also present in 
fractions 8-14 when expressed using the pET system and purified. These differences 
between results from the two systems are difficult to explain. The promoters used to 
express protein from each plasmid were different: p R l-1 1 utilises the lacUV5 promoter, 
whereas the stronger T7 polymerase promoter is used in pET vectors. Expression from 
plasmid pR 1-11 resulted in the production of a core:(3-galactosidase protein, with ten N- 
terminal (3-galactosidase residues replacing the two authentic N-terminal core protein 
residues. In contrast, the core protein produced from the pET3a plasmid initiates with its 
authentic methionine residue. Another factor which differed between the two sets of 
results was the strain of E.coli used for protein expression: BL21(DE3)pLysS was used 
for the pET3a plasmid compared to DH5a for pR 1 -11. The protein purification protocol 
for pR 1-11 also included 'variable' steps, such as the efficiency of sonication and 
ammonium sulphate precipitation whereas results from the pET system were consistently 
reproducible. All these factors could possibly have contributed to the differences in results 
observed with the two plasmids used.
In an investigation of protein dimerisation, full-length core protein and all four core 
deletion proteins were shown to be able to form disulphide-linked dimers, under non­
reducing conditions. The position of the deletions with respect to the four cysteine 
residues present in core protein also provides confirmatory information on the importance 
of individual residues for disulphide bond formation. As all four deletions removed Cys- 
107, this residue cannot be the only residue to participate in the formation of 
intermolecular disulphide bonds (see Section 1E2). The removal of Cys-61 by deletion 
A60-117 also shows that one of the two remaining eligible cysteine residues must be 
involved. At this stage the question as to which type of disulphide bond the Cys-183 
residue in full-length core protein participates in becomes pertinent: is it involved in a 
disulphide bond within a core protein dimer or a bond between dimers? If the latter 
situation is true, why should dimers be the predominant species detected under non­
135
Chapter 3 Results
reducing conditions? It would seem more likely that the existence of both intra-dimer 
(involving Cys-61 and possibly Cys-48) and inter-dimer (involving Cys-183) disulphide 
bonds would enable the core particle to retain its conformation under non-reducing 
conditions. This would make it unlikely to enter a resolving polyacrylamide gel, as was 
observed by Gallina et al. (1989) and Kann and Gerlich (1994). However, the model 
resulting from the analysis of core protein expressed in Xenopus oocytes shows that Cys- 
183 participates in a disulphide bond within the dimer (Seifer and Standring, 1994). This 
allowed core particles to be broken down into dimer subunits under non-reducing 
conditions. Other investigators have observed a partial effect with bacterially-expressed 
core protein: dimers can enter resolving polyacrylamide gels under non-reducing 
conditions, but intact particles are still observed at the interface of the stacking gel and the 
resolving gel (Nassal et al., 1992; Zheng et al., 1992). In these cases, the dimeric protein 
which entered the resolving gel may simply represent the population of free core protein 
dimers present within the cells. In view of these possibilities, core deletion protein A60- 
117 could be held together by intra-dimer disulphide bonds involving Cys-48 and/or Cys- 
183. However, examination of this protein under non-denaturing conditions does not 
show convincing evidence for the existence of a higher molecular weight species that 
would result from the presence of Cys-183 inter-dimer disulphide bonds.
The fact that all four core deletion proteins were capable of forming dimers indicates 
that their inability to assemble particles may be due to the failure of subsequent stages in 
the particle assembly process to occur normally. Although dimers did form, this may 
require only the region of the polypeptide chain surrounding amino acids 48-61 to be 
surface exposed. The remainder of the protein may have been in a conformation that 
would not allow the further interactions required for particle assembly.
The inability of the core deletion proteins to assemble into particles was not thought 
to be due to the concentration of protein being below that estimated to be necessary for 
core particle assembly (Seifer et al., 1993). The anti-pp65 mAb, under standard 
conditions of use, was able to detect protein at concentrations below this minimum.
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3E M odifications of the core deletion protein A 81-121  
3E1 Introduction
From the results in the previous section, it was concluded that core deletion proteins 
were unable to assemble into any type of core particle-like structure. It was decided to 
investigate further what were the determining factors in this inability to form core 
particles. As was discussed in Section 3C4, the initial question was which core protein 
sequences are essential for directing particle assembly, either through correctly folding the 
protein, or through participating in protein:protein interactions, and whether these are 
missing in core deletions. This question was to be investigated in two ways: firstly, by 
replacing the deleted core protein sequence A81-121 with foreign sequence of exactly the 
same length (as described in Section 3C4) and secondly, by sequentially replacing core 
sequence, that had been deleted in the A81-121 protein, in blocks of ten amino acids from 
either the 5' or 3' termini of the deletion. The latter approach would hopefully allow 
determination of the minimum deletion, in this central region of the protein, that would 
still allow particle assembly and would also identify core protein sequences that played an 
important role in directing particle assembly. The first experimental approach is described 
in Section 3E2 and the second approach in Section 3E3.
3E2 pET expression and purification o f pp65 epitope-tagged A core-surface  
hybrid protein
The Acore-surface hybrid gene constructed in Section 3C4 was amplified by a 
single round of PCR using primer pair cp3/Bamtag and cloned into the pET3a vector. In 
contrast to the pR 1-11 purification, this protein was efficiently expressed from the pET 
vector and was more stable under the conditions used for purification. The results of the 
sucrose gradient centrifugation are shown in Figure 3E2. The protein expressed was 
equal in size to full-length core protein and was detected from fraction 7 down to the 
bottom of the gradient. Although fractions 14-17 did seem to have an increased amount of 
protein present, this increase was far less than was observed for the purification of wild- 
type core particles. In addition, upon repetition of this experiment, this observation was 
not consistent: although the Acore-surface hybrid protein was present in the same 
fractions, the same apparent increase in protein content in fractions 14-17 was not 
evident. Examination of these pooled fractions, again, gave no evidence for the assembly 
of particles from this protein. Although on the blots, some bands of lower molecular 
weight were observed in the lanes containing cellular extract and soluble protein, these 
represented a minority proportion of the protein detected, and were not thought to 
contribute to the lack of particle detection, for example, due to protein degradation. The 
conclusion drawn from this experiment was that this Acore-surface hybrid protein was
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Figure 3E2: Purification of Acore-surface hybrid protein expressed in the pET system 
Acore-surface hybrid protein with a C-terminal epitope tag was expressed in E.coli 
BL21(DE3)pLysS for 4 hr at 26°C after induction with 300|liM IPTG. A cellular extract 
was prepared (ex) and after centrifugation at 35k rpm for 20 min, soluble protein (s) was 
centrifuged through a 10-50% sucrose gradient. Fractions were removed from the top (1) 
to the bottom (19) of the gradient and any pelleted material resuspended (P). Fractions 
were electrophoresed through a 17.5% polyacrylamide gel along with an aliquot of 
tagged full-length core protein (c) and tagged core deletion protein A81-121 (A). After 
Western blotting of the gels, membranes were incubated with anti-pp65 mAb 9220. 
Molecular weights of the markers used (M) are shown and the position of the tagged 
Acore-surface hybrid protein is indicated by an arrow («—).
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unable to assemble into core particles. This result indicated that, for the naturally- 
occurring core deletions, the physical size of the deletion was not the sole reason for the 
inability to form particles. Rather, specific core sequences, as yet undetermined, must 
play an important role in the particle assembly pathway.
3E3 Expression and purification of A81-121 fill-in  proteins
The results from previous sections had shown that deletions in the central region of 
the core protein disabled the ability of the protein to correctly form core particles, and that 
this was due to the removal of specific protein sequence essential to this process. It was 
decided to attempt to determine the location and the identity of these sequences, by 
gradually replacing increasing amounts of original sequence in the A81-121 core deletion, 
from either end of the deleted region. This was achieved using a PCR-based method to 
construct these 'fill-in' proteins and is detailed in Figure 2B1.1 lb. This method generated 
three core deletion genes, 5'F10, 5'F20 and 5'F30, with 31, 21 and 11 amino acids, N- 
terminal to amino acid 121, deleted respectively and with the pp65 epitope tag sequence at 
the C-terminus (see Table 2 B 1.1 lc). An analogous method was used to construct the 3 ' 
fill-in proteins.
After expression, proteins were detected by anti-pp65 mAb 9220 (Figure 3E3a). All 
proteins expressed corresponded well to their predicted sizes. Proteins were then 
expressed and purified on 10-50% sucrose gradients. These results are shown in Figure 
3E3b.
The results from purifications of both the 5'F10 and 5'F20 proteins showed 
gradient profiles for these proteins that were similar to that observed for the full-length 
core protein (see Figure 3D2b). Both showed protein predominantly in the lower region 
of the gradient: 5'F10 protein was detectable from fraction 8 with increased levels in 
fractions 14-19 and 5'F20 was also present from fraction 8, but peaked in fractions 15- 
lb. However, the next protein in this series, 5'F30, did not conform to this profile, as 
protein was predominantly detectable in the central region of the gradient, in fractions 6-9. 
The peak fractions for all three proteins were pooled and concentrated before examination 
by electron microscopy. However, despite thorough efforts, no particles were detected 
for any of these samples.
The 3' fill-in proteins were also constructed and proteins of the correct size were 
produced and detected by mAb 9220 (Figure 3E3c). All three proteins were expressed 
and purified on 10-50% sucrose gradients, as before, and the results shown in Figure 
3E3d.
Comparison of the results from this 3' fill-in series was treated with caution, as the 
3'F20 protein was found to be expressed poorly initially and, after further timecourse 
experiments this was found to be due to poor stability. Consequently, expression took
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Figure 3E3a: Expression of A81-121 5' fill-in proteins
A81-121 5' fill-in proteins with a C-terminal pp65 epitope tag were expressed in Ecoli 
BL21(DE3)pLysS for 4 hours at 26°C after induction with 300pM IPTG. Cellular extracts 
were prepared and aliquots electrophoresed through a 17.5% polyacrylamide gel 
alongside tagged full-length core protein (WTtag), tagged A81-121 core deletion protein 
(A81-121tag) and tagged Acore-surface hybrid protein (CSCtag). After Western blotting 
of the gel, the blot was incubated with anti-pp65 mAb 9220. Molecular weights of the 
markers used (M) are shown.
place for only 2hr, which may also have accounted for the lower levels of protein 
produced. 3'F10 protein was detected from fraction 4, but was present predominantly in 
fractions 9 - 14. As it was probable that any core particle-like structure formed from these 
deletion proteins would have a smaller size in comparison to wild-type core particles, it 
was decided to examine these pooled fractions by electron microscopy. However, again 
despite thorough efforts, it was not possible to detect any particulate structures. The 
gradient profile for the 3'F30 protein, although protein was present in the lower region of 
the gradient (fractions 8 on), showed none of the 'banding' effect in any region, as was 
observed for the wild-type particle purification. Rather, the protein content of each 
fraction was approximately equal. Analysis of two sets of pooled, concentrated fractions 
(10-13 and 14-17) by electron microscopy showed that no particles were present.
The conclusion from the results in this section was that core proteins with deletions 
of only 11 amino acids at two separate positions in this central region, are still incapable 
of assembling into stable core particles.
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Figure 3E3b: Purification of A81-121 5' fill-in proteins (continued with figure legend on the 
following page)
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Figure 3E3b: Purification of A81-121 5' fill-in proteins (continued)
A81-121 5' fill-in proteins with C-terminal pp65 epitope tags were expressed in E.coli 
BL21 (DE3)pLysS at 26°C after induction with 300|iM IPTG. Cellular extracts were 
prepared (ex) and after centrifugation at 35k rpm for 20min, soluble protein (s) was 
centrifuged through a 10-50% sucrose gradient. Fractions were collected from the top (1) 
to the bottom (13) of the gradient and any pelleted material was resuspended (P). 
Fractions were electrophoresed through 17.5% polyacrylamide gels along with aliquots 
of tagged full-length core protein (c) and tagged core deletion protein A81-121 (A). After 
Western blotting of the gels, membranes were incubated with anti-pp65 mAb 9220. 
Molecular weights of the markers used (M) are shown and the position of the tagged 
proteins is indicated by an arrow (*—).
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Figure 3E3c: Expression of A81-121 3' fill-in proteins
A81-121 3' fill-in proteins with a C-terminal pp65 epitope tag were expressed in Ecoli 
BL21(DE3)pLysS for 4 hours at 26°C after induction with 300|iM IPTG. Cellular extracts 
were prepared and aliquots electrophoresed through a 17.5% polyacrylamide gel 
alongside tagged full-length core protein (WTtag) and tagged A81-121 core deletion 
protein (A81-121tag). After Western blotting of the gel, the blot was incubated with anti- 
pp65 mAb 9220. Molecular weights of the markers used (M) are shown.
143
Chapter 3 Results
i 3‘F10tag
A ex s 1 M 10 M 1 9 P A
—  46
—  30
ii 3'F20tag
c  e x  s  1 M 10 1 9 P M c
Figure 3E3d: Purification of A81-121 3 'fill-in proteins (continued with figure legend on the 
following page)
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Figure 3E3d: Purification of A81-121 3' fill-in proteins (continued)
A81-121 3' fill-in proteins with C-terminal pp65 epitope tags were expressed in E.coli 
BL21 (DE3)pLysS at 26°C after induction with 300|iM IPTG. Cellular extracts were 
prepared (ex) and after centrifugation at 35k rpm for 20min, soluble protein (s) was 
centrifuged through a 10-50% sucrose gradient. Fractions were collected from the top (1) 
to the bottom (19) of the gradient and any pelleted material was resuspended (P). 
Fractions were electrophoresed through 17.5% polyacrylamide gels along with aliquots 
of tagged full-length core protein (c) and tagged core deletion protein A81-121 (A). After 
Western blotting of the gels, membranes were incubated with anti-pp65 mAb 9220. 
Molecular weights of the markers used (M) are shown and the position of the tagged 
proteins is indicated by an arrow (4— ).
3E4 D iscussion
The results from this section have shown that the central region of the core protein, 
amino acids 81-121, is very important for correct assembly of core particles. Neither 
alteration of the amino acid sequence in this region of the protein nor deletion of smaller 
sections of this region allowed the resulting proteins to assemble into particles, as was 
determined by sucrose gradient analysis.
The rationale behind these experiments came from the observations of the 'structural 
flexibility' of the core protein (see Section 1E5). Certain fusion protein derivatives of core 
protein described in Section 1E5 (Schodel et al., 1992) involve the removal of central core 
protein residues (amino acids 76-82) and replacement of these regions with foreign amino 
acid sequences. These core protein derivatives were able to assemble into core particles
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and suggest that not all core protein residues are required for particle assembly. However, 
from the results presented here, replacement of the larger region from amino acid 81-121 
did not allow particles to form. This region, or residues within it, is therefore important 
for particle formation. It was possible, however, that the region of the surface protein, 
used to replace the deleted core protein residues, contained amino acid sequences which 
would have inhibited core particle assembly. At the time of construction of the Acore- 
surface gene, the only detailed structural information available on core protein was the 
structure predicted by Argos and Fuller (1988). This predicted that the region between 
amino acids 81-121 included two (3-sheet structures (amino acids 89-95 and 99-115). 
However, the more recent biophysical analysis and high resolution structural data 
obtained for the core protein by electron cryomicroscopy (see Section 1E3) have shown 
that the previous predicted structure of core protein was incorrect. Instead, the region 
between amino acids 81-121 includes sections from two a-helices (helix 3: residues 82- 
110 and helix 4: residues 112-128). As the region from the surface protein inserted into 
the core protein deletion included six proline residues (see Figure 3C4a), these would 
have disrupted the a-helical nature of this region. Therefore, it is possible that the 
presence of these residues was responsible for the inability of this protein to assemble into 
core particles. In order to overcome this problem, another Acore hybrid protein could be 
constructed. This could either be the Acore-surface hybrid protein used in this section, but 
where the proline residues had been mutated to alternative residues, or a Acore hybrid 
protein where the region chosen to replace amino acids 81-121 possessed a similar 
hydropathy profile to amino acids 81-121 of core protein.
The results from the purifications of the 5' and 3' fill-in proteins, which contained 
deletions of decreasing size, showed that none of the proteins with a deletion in the central 
region were competent for particle assembly. The smallest deletions, in the 5'F30 and 
3'F30 proteins, were still sufficiently large to prevent particle assembly. The fact that both 
of these small deletions, which removed core protein regions with dissimilar amino acid 
sequences, were capable of preventing core particle assembly suggests that the size of the 
deletion was the critical factor. Therefore, further reducing the sizes of these deletions 
may have allowed particles to form.
Although the results from this section have identified the core protein region 
between amino acids 81-121 as important for core particle assembly, the N- and C- 
terminal limits of this functionally important region have not been precisely delineated. It 
may have been that small deletions, equal in size to the 5' and 3'30 deletions, made on 
either side of residues 81-121 would have actually allowed particle assembly to occur. 
One possible way to further define this region would be to construct a range of core 
protein deletion mutants, with overlapping deletions of a fixed size covering the entire 
core gene. Subsequent assaying of these proteins for particle assembly would allow 
identification of regions of the protein which were non-essential for this process. This
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type of experiment has been performed for the larger core protein from DHBV (Yang et 
al., 1994). In view of the results presented in this thesis, it was of interest that, although 
deletions were tolerated in the C-terminal region of the DHBV core protein, protein with 
N-terminal or central deletions did not assemble of core particles when expressed in 
E.coli..
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3F Studies o f co-assem bly between fu ll-length  and core deletion p ro te in s  
into core particles 
3F1 Introduction
As discussed in Section 1E6, in all but two reported cases of detection of core gene 
deletions from patients with chronic hepatitis investigators have, in addition, always been 
able to detect full-length core gene in these samples. However, because these results were 
all derived from the study of serum samples, the relationship between these two 
populations in the cellular context is still unclear. For example, it is not known whether 
both full-length core gene and core deletions can arise and co-exist in the same infected 
cell, or whether core deletions can represent the sole population in an infected cell. From 
the results in previous sections, where such core deletions have been shown to be 
incapable of forming stable core particles, it is unlikely that they would be able to sustain 
the viral infection themselves. Lacking the ability to produce functional core particles, 
which play important roles in the viral lifecycle, the virus could spread no further than its 
present host cell. However, if the alternative scenario in fact exists, where both virus with 
full-length core gene and that with core gene deletions occur in the same cell, then the 
possibility exists of novel core particles being assembled, containing both types of 
protein.
3F2 C o-expression o f fu ll-length and core deletion proteins
In order to investigate the possibility of co-assembly, it was decided to attempt to 
produce both proteins in the same bacterial cell and analyse the particles produced, to 
determine whether they contained both types of core protein. This necessitated 
modification of the existing bacterial expression system to introduce means of ensuring 
that cells were actually expressing both types of protein and means of specifically 
detecting each protein expressed. The full-length core gene was amplified by PCR using 
primer pair cp3/cd2 to give full-length core protein lacking the C-terminal pp65 epitope 
tag sequences. This gene was then cloned into the pET9a vector, which is identical to 
pET3a but with a kanamycin resistance gene instead of one conferring ampicillin 
resistance. pET3a plasmids containing the epitope tagged core deletion gene were as used 
previously. For the initial experiment the pET9a and pET3a (containing the gene encoding 
the A84-109 core deletion protein) recombinant plasmids were co-transformed into E.coli 
B L21 (DE3)pLysS and co-transformants selected for in the presence of ampicillin and 
kanamycin. After growth of single colonies and induction of protein expression, total 
cellular extracts and soluble protein extracts were made and analysed by Western blot. 
Anti-core mAb 42B 12 was used to detect core protein lacking the pp65 epitope tag and 
anti-pp65 mAb 9220 was used for the detection of the epitope-tagged core deletion 
proteins. The results of the co-expression of full-length core protein and the A84-109 core
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Figure 3F2a: Co-expression of full-length core protein and pp65 epitope-tagged core 
deletion protein A84-109
Full-length core protein and core protein deletion A84-109 were co-expressed in E.coli 
BL21 (DE3)pLysS at 26°C for 4 hr after induction with 300pM IPTG. Cellular extracts 
(ex) and soluble protein samples (s) were prepared from six clones and electrophoresed 
through 17.5% polyacrylamide gels. After Western blotting, the blots were incubated 
with anti-core mAb 42B12 (Panel A) or anti-pp65 mAb 9220 (Panel B). An aliquot of 
tagged Acore-surface hybrid protein (c) was included as a control. Molecular weights of 
the markers used (M) are shown and the position of each protein is indicated by an 
arrow («—).
c ex  s  ex s  ex  s  M ex s  ex  s  ex  s
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Figure 3F2b: Electron micrograph of core particles expressed using the pET system 
Core particles were purified from extracts of bacteria transformed with a pET9a plasmid 
containing full-length core gene, using a 10-50% sucrose gradient. Fractions containing 
the highest levels of core protein as identified by Western blot analysis, were pooled 
and concentrated using an Amicon 50 microconcentrator. An aliquot of the concentrated 
sample was negatively stained and examined by electron microscopy. Scale bar 
represents 50nm.
deletion protein are shown in Figure 3F2a. A protein of the correct predicted size for the 
core deletion protein A84-109 was specifically detected on the blot using mAb 9220. 
However the blot on which mAb 42B12 was used showed two major bands for all 
samples of approximately 23kDa and 27kDa. The smaller of these bands was the correct 
size for the full-length core protein, but the identity of the larger band was undetermined. 
This protein may have been translated due to read-through of the core gene stop codon. 
Cellular extracts from clones l, 2, 3 and 5 also contained a protein of approximately 
29kDa, which reacted with the anti-core mAb 42B12. In order to determine whether the 
presence of these extra proteins would affect core particle assembly, E.coli 
BL2 l(DE3)pLysS cells were transformed with the pET9a plasmid containing the 
untagged full-length core gene. Following sucrose gradient centrifugation of induced 
cellular extracts and Western blot analysis, fractions with the greatest amounts of core 
protein were pooled, concentrated and examined by electron microscopy. The results 
showed that the full-length core protein which had been expressed was able to assemble 
into morphologically normal core particles (see Figure 3F2b). The results from the
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experiments in this section showed that expression of both proteins in the same cell was 
possible.
3F3 Purification o f co-expressed full-length and A 84-109 core proteins
Proteins were expressed from bacteria which had been co-transformed with 
plasmids containing the full-length core and tagged core deletion protein A84-109, as 
described in the previous section. Cellular extracts were prepared and, after clarification, 
soluble protein was centrifuged through a 10-50% sucrose gradient. The results are 
shown in Figure 3F3. Full-length protein expressed from the pET9a plasmid was detected 
strongly in fractions 13-17, which corresponded well to the position of core particles 
from previous experiments (see Figure 3D2b). The tagged A84-109 protein was present 
in two peaks in the gradient: one in fractions 7-11 and the other in fractions 13-17. The 
co-existence of the A84-109 protein in fractions containing core particles suggested that 
both the full-length core protein and the core deletion protein were present within the same 
particles. Further evidence for this came from a comparison with the results obtained from 
the purification of the A84-109 protein alone (Figure 3D2d). These results showed that 
the A84-109 protein was detected in fractions 8-13. However, in the results shown here, 
the A84-109 protein was also present in the lower region of the gradient, in fractions 13- 
17. This position corresponded very well to that of the core particles produced in the same 
cells. In addition, the fact that the A84-109 protein was not distributed equally throughout 
fractions 7-17, but gave a distinct peak in fraction 13-17 suggested that it was associated 
with the core particles in these fractions.
3F4 Purification of co-expressed full-length and A 81-121 core proteins
It was decided to perform the same type of co-expression experiment for the core 
deletion protein A81-121 and full-length core protein, to determine if a similar result 
would be obtained. This protein was co-expressed with the full-length protein and the 
particles produced were purified (see Figure 3F4). The full-length protein was present in 
fractions 13-17, as before, and the A81-121 deletion protein was detected in two peaks: 
fractions 9-11 and fractions 14-17. Again the location of the A81-121 protein differed 
from the results obtained when this protein was expressed by itself and purified (Figure 
3D2d). These results showed that the A81-121 deletion protein migrated to fractions 8-19, 
with more protein present in fractions 8-14. These results differ markedly to the results 
presented in this section, where the A81-121 protein was detected in two distinct peaks. 
The position of the second peak corresponded well with the position of the core particles 
produced, which again led to the possibility that these two proteins had associated and 
formed novel 'mixed' core particles.
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Figure 3F3: Purification of co-expressed coreWT and A84-109tag
Full-length core protein and pp65 epitope-tagged core deletion protein A84-109 were co­
expressed in E.coli BL21 (DE3)pLysS at 26°C for 4 hours after induction with 300jiM 
IPTG. Cellular extracts were prepared (ex) and after centrifugation at 35k rpm for 20 min, 
soluble protein (s) was centrifuged through a 10-50% sucrose gradient. Fractions were 
collected from the top (1) to the bottom (19) of the gradient and any pelleted material was 
resuspended (P). Fractions were electrophoresed through 17.5% polyacrylamide gels 
along with tagged full-length core protein (c). After Western blotting of the gels, 
membranes were incubated with either anti-core mAb 42B12 (panel i) or anti-pp65 mAb 
9220 (panel ii). Molecular weights of the markers used (M) are shown and the position of 
the relevant protein is indicated by an arrow (<*—).
I Anti-core mAb 42B12
c e x s 1  M 1 0  1 9  P M  c
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Figure 3F4: Purification of co-expressed coreWT and A81-121tag
Full-length core protein and pp65 epitope-tagged core deletion protein A81-121 were co­
expressed in E.coli BL21 (DE3)pLysS at 26°C for 3 hours after induction with 300pM 
IPTG. Cellular extracts were prepared (ex) and after centrifugation at 35k rpm for 20 min, 
soluble protein (s) was centrifuged through a 10-50% sucrose gradient. Fractions were 
collected from the top (1) to the bottom (19) of the gradient and any pelleted material was 
resuspended (P). Fractions were electrophoresed through 17.5% polyacrylamide gels 
along with tagged full-length core protein (c). After Western blotting of the gels, 
membranes were incubated with either anti-core mAb 42B12 (panel A) or anti-pp65 mAb 
9220 (panel B). Molecular weights of the markers used (M) are shown and the position 
of the relevant protein is indicated by an arrow («— ).
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3F5 Purification of co-expressed full-length and 5'F30 core proteins
From the results of the previous two experiments it seemed possible that full-length 
core protein and core deletion proteins could co-assemble to form core particles. It was 
decided to see whether a more conclusive result could be obtained by using proteins with 
smaller deletions. The 5'F30 and 3'F30 fill-in proteins from Section 3E3 were 
consequently used in these co-expression experiments. When co-expression of full-length 
and 3'F30 proteins was attempted it was found that, although full-length protein was 
produced effectively, detection of the 3'F30 protein was not possible. The reasons for 
this were unknown and unable to be investigated further, due to time restraints. This 
problem did not occur for the 5'F30 protein and the particles produced from cells co­
expressing this protein and full-length core protein were able to be purified (see Figure 
3F5). As was observed in the previous experiments, the full-length protein banded in 
fractions 13-17, in the form of particles. The 5'F30 protein, however, was detected only 
in the lower region of the gradient, in fractions 15-19 and also in the pelleted material at 
the bottom of the centrifuge tube. Another lower molecular weight protein of 
approximately 17kDa, was detected in fractions 6-8. The location of the 5'F30 protein in 
this co-expression experiment differed from the results obtained when this protein was 
expressed by itself (Figure 3E3b). When expressed in isolation and purified on a sucrose 
gradient, the 5'F30 protein was present in fractions 6-9. These fractions correspond only 
with the fractions in which the 17kDa protein was detected in the co-expression 
experiment. Therefore this 17kDa protein may represent a degradation product of the 
5'F30 protein. The shift in location that was observed for the 5'F30 protein, upon co­
expression with the full-length protein, to a region further down the gradient appeared to 
suggest that these two proteins had associated to form particles. However, upon closer 
examination of the results it was concluded that this was not the case. The fractions 
containing full-length core protein (fractions 13-17) did not correlate exactly with those 
containing the 5’F30 protein (fractions 15-19). This is not the expected result if the two 
proteins are covalently linked to form a particulate structure.
3F6 D iscussion
The results in this section have shown the possibility that core protein and certain 
core deletion proteins could co-assemble to form novel core particles. Upon co­
expression with full-length protein, core deletion proteins A84-109 and A81-121 migrated 
to different regions of the sucrose gradient, compared to when either deletion protein was 
expressed alone and purified. These new regions coiresponded well to the Factions 
where purified core particles were observed. In this lower gradient region these proteins 
were also observed to be present in relatively few fractions, in a manner analogous to 
purified core particles. However, the results from the purification of co-expressed full- 
length core and 5'F30 proteins did not follow this same pattern. It was concluded that
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Figure 3F5: Purification of co-expressed coreWT and 5'F30tag
Full-length core protein and pp65 epitope-tagged A81-121 5'F30 were co-expressed in 
E.coli BL21 (DE3)pLysS at 26°C for 4 hours after induction with 300pM IPTG. Cellular 
extracts were prepared (ex) and after centrifugation at 35k rpm for 20 min, soluble protein 
(s) was centrifuged through a 10-50% sucrose gradient. Fractions were collected from 
the top (1) to the bottom (19) of the gradient and any pelleted material was resuspended 
(P). Fractions were electrophoresed through 17.5% polyacrylamide gels along with 
tagged full-length core protein (c). After Western blotting of the gels, membranes were 
incubated with either anti-core mAb 42B12 (panel i) or anti-pp65 mAb 9220 (panel ii). 
Molecular weights of the markers used (M) are shown and the position of the relevant 
protein is indicated by an arrow (i— ).
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these two proteins did not co-assemble into particles. This conclusion provided no 
obvious explanation for the shift in migration of the 5'F30 protein on sucrose gradients 
after being co-expressed with the full-length protein. It may have been that the presence of 
the two proteins in the same cell could have contributed to an increased aggregation of the 
5'F30 protein, with these larger aggregates migrating further down the gradient. The 
assembly of core particles was not interfered with presumably because this process is co­
operative, so leaving less time for other proteins to interfere with the rapid particle 
assembly.
The results from the co-expression of full-length core protein and core deletion 
proteins A84-109 and A81-121 only suggest that core deletion proteins co-assemble with 
the full-length protein to form novel core particles. It is possible that the core deletion 
protein was only associated with wild-type core particles in a non-integrated, peripheral 
manner. The core particles present could have been formed from full-length core protein 
alone, and the deletion protein associated with them only by non-covalent interactions. In 
order to provide more evidence for the occurrence of co-assembly, it would be necessary 
to demonstrate that both proteins were still present in samples of 'mixed' particles which 
had been previously incubated in buffers of increasing salt concentrations and then 
repurified on sucrose gradients. These increasingly stringent conditions should disrupt 
any non-covalent interactions, while leaving the disulphide-linked particle intact. A more 
direct detection method, such as immune-electron microscopy, would also have been 
useful. With this method, anti-core mAb 42B12 could be conjugated to a large diameter 
gold particle and anti-pp65 mAb 9220 conjugated with a gold particle of smaller diameter. 
Preparations of particles re-purified after being exposed to the above conditions would be 
incubated with both antibody-conjugates and examined by electron microscopy. The 
direct visualisation of both conjugated antibodies binding to the same particles would 
prove the presence of both proteins in the particle.
The formation of hybrid or mixed core particles has been demonstrated recently by 
Scaglioni et al. (1997). Mammalian cells were transiently co-transfected with a plasmid 
expressing-length core protein and one expressing an epitope-tagged p22 pre-core 
protein. When immunoprecipitation experiments were carried out on these transfected 
cells, both proteins were found to co-immunoprecipitate, with the conclusion that hybrid 
core particles had formed. In addition, purification of core particles from these transfected 
cells on sucrose gradients showed that both proteins were present in the same fractions, 
as detected by Western blot analysis. In similar immunoprecipitation experiments, an 
18kDacore protein containing ten C-terminal pre-core residues and truncated at P ro -144 
was also shown to be able to co-assemble with full-length core protein into mixed core 
particles.
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3G M odifications o f the core particle purification protocol 
3G1 Introduction
Throughout the course of these studies, the purification protocol for the core 
deletion proteins had been altered a number of times to take various factors into account. 
When these results were compared it was discovered that the method of preparation of 
cellular extracts and soluble proteins, prior to sucrose gradient centrifugation, could 
significantly affect the conclusion drawn from the experiment. In order to illustrate this 
the results obtained for each modification of the purification of core deletion protein A84- 
109 are shown in Figure 3G. For all these modifications the results obtained for 
purification of the full-length protein were identical to those presented in Section 3D.
3G2 M odification of the purification protocol for core deletion  p rotein  
A 84 -1 0 9
The initial extract preparation method consisted of overnight freezing of the induced 
E.coli BL21(DE3)pLysS cell pellet. After thawing of the pellet on ice, addition of TNE II 
buffer and DNase/RNase treatment, the extract was sonicated to disrupt any remaining 
cellular material. The extract was then clarified of cellular debris by a 4°C centrifugation 
step at 13k rpm for 20 minutes, prior to sucrose gradient purification. The results are 
shown in Figure 3G, Panel A.
The first modification to this protocol was to increase the centrifugation speed 
during the clarification step to 35k rpm. This was intended to ensure that only protein 
which was truly soluble was loaded onto the sucrose gradients, which would hopefully 
eliminate some of the bands detected in the lower region of the gradient. From the results 
which had accumulated at this stage in the study, it was already suspected that these bands 
represented aggregates of expressed protein, rather than particles. The results are shown 
in Figure 3G, Panel B.
Due to the extremely efficient lysis of the E.coli BL21(DE3)pLysS cells after the 
freezing stage, it was thought that the sonication step was no longer required and may, in 
fact, have caused damage to any particle-like structures which had formed. This was of 
obvious concern, especially if these particles were less stable than the wild-type particles. 
These results are shown in Figure 3G, Panel C.
The final modification was designed to cater for the possibility that, despite sucrose 
gradient fractions not being frozen at any stage, the freezing step required for lysis of the 
BL21(DE3)pLysS cells was responsible for disrupting any particles that had actually 
assembled inside these cells. This modification involved overnight storage of the induced 
cell pellet at 4°C, rather than -20°C, followed by lysis of the cells using lysozyme 
extraction buffer (see Figure 3G, Panel D). Although protein was detected in the gradient 
factions, this extraction protocol was not as efficient as the previous method. It was
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Figure 3G : Modifications to the core particle purification method (continued with figure 
legend on the following page)
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Figure 3G : Modifications to the core particle purification method (continued)
Core deletion protein A84-109 with a C-terminal pp65 epitope tag was expressed in 
E.coli BL21 (DE3)pLysS at 26°C for 4 hr after induction with 300|iM IPTG. Cellular 
extracts (ex) and soluble protein samples (s) were prepared as described in the text 
and according to the summary table below. Clarified extracts were centrifuged through 
10-50% sucrose gradients. Fractions were collected as normal and analysed b y  
Western blotting using anti-pp65 mAb 9220. Lanes marked 'c' contain tagged full-length 
core protein. Molecular weights of the markers used (M) are shown and the position of 
the tagged protein is indicated by an arrow («—).
Panel
Extract preparation
Extract clarification 
(rpm)
FfT 4°C s L 13k 35k
A X X X
B X X X
C X X
D X X X
F/T - overnight freezing at -20°C, followed by thawing on ice 
4°C - overnight storage at 4°C 
S - disruption by sonication 
L - extraction with lysozyme
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thought that this may have caused problems in the detection of proteins that had been 
expressed at comparatively lower levels.
3G 3 D iscu ssion
The results from this section have shown that the method employed for the 
preparation of cellular extracts and soluble protein extracts could greatly influence the 
results obtained from the subsequent sucrose gradient purification step. The final 
extraction method, using lysozyme extraction buffer (Panel D), was thought to be least 
likely to disrupt any potentially unstable particle-like structures formed. However, the 
decreased amounts of protein extracted using this protocol reduced the sensitivity of the 
protein detection. For this reason, the modification involving freeze/thaw of the bacterial 
cell pellet, followed by clarification at 35k rpm (Panel C), was chosen for routine use and 
yielded all the results shown in previous sections. Despite the freeze/thaw step involved in 
this protocol, which may have disrupted unstable particles, protein purified using this 
modification was detected in exactly the same fractions of the gradient as protein purified 
following lysozyme extraction. In addition, increased amounts of protein could be 
extracted from bacterial cells using this protocol, when compared with using the lysozyme 
extraction method. This aided detection of the proteins in the subsequent purification 
steps.
160
Chapter 3 Results
3H A garose gel assay for core particle form ation  
3H1 Introduction
During the last stage of the experimental work presented in this thesis we were 
made aware ot an additional method for the detection of core particles. This was described 
by Birnbaum and Nassal (1990) and involved electrophoresis of core particle samples 
through a 1% agarose gel. The particles were able to enter the gel, which was then first 
stained with ethidium bromide, to detect the RNA known to be incorporated into core 
particles. After destaining, the gel was stained with Coomassie blue to detect the position 
of the protein. It was decided to use this assay on the samples for which concentrated 
material remained after electron microscopic examination.
3H 2 R esults
The results for the selection of samples assayed are shown in Figure 3H. These 
results showed that wild-type core particles could be detected by this method. The 
position of the band after ethidium bromide staining of the gel (Panel A, lanes 1-4) 
corresponded exactly with the position of the band after Coomassie staining(Panel B, 
lanes 1-4). This indicated that core particles had formed and were capable of 
encapsidating nucleic acid. Investigation of the samples of concentrated fractions resulting 
from the purification of the core deletion proteins (Sections 3D and 3E), however, did not 
give equivalent results. Both nucleic acid and protein bands were observed at the same 
positions after ethidium bromide and Coomassie staining for core deletion protein A84- 
109 fractions 8-10 (lane 5) and also to a lesser extent for core deletion proteins A79-125 
fractions 9-12 (lane 9) and A60-117 fractions 9-12 (lane 1 1). However the earlier results 
for these samples, from examination by electron microscopy, showed that no particulate 
structures were detected. Furthermore, these assay results were not consistent when 
equivalent samples from duplicate purification experiments were tested, as can be seen 
from a comparison of the samples in lanes 6-8 with those in lanes 21-24.
The concentrated fractions from the purification of the 5' fill-in proteins did give 
results similar to those observed for the full-length protein, with bands visible at the same 
position after both staining procedures (lanes 13, 15 and 17). This suggested that 
particulate structures had formed and were able to encapsidate nucleic acid. H owever, 
again, these results did not concur with those obtained from the electron microscopic 
examination of these samples, where no particles were detected (Section 3E).
3H 3 D iscu ssion
The results obtained from this type of assay gave further evidence to the conclusion 
that the core deletion proteins examined in this study were unable to assemble into stable 
core particle-like structures. No bands were visible at the same positions when the gel
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Figure 3H: Agarose gel assay for core particle detection
Peak fractions from a number of sucrose gradient purifications were pooled and 
concentrated using a Centricon-50 microconcentrator. Samples were loaded onto a 1 % 
TAE agarose gel, according to the legend shown below, and electrophoresed. Panel A 
shows the gel after staining with ethidium bromide and panel B shows the same gel after 
destaining and subsequent staining with Coomassie blue.
Lane Sample Lane Sample
1 Wild-type core - lOpg 13 5'F10 fractions 12-14
2 Wild-type core - 3pg 14 5'F10 fractions 15-17
3 Wild-type core - 1pg 15 5'F20 fractions 12-14
4 Wild-type core (pET9a) - 1pg 16 5'F20 fractions 15-17
5 A84-109 fractions 8-10 17 5'F30 fractions 12-14
6 A84-109 fractions 15-17 18 5'F30 fractions 15-17
7 A81-121 fractions 8-11 19 Wild-type core fractions 9-12
8 A81-121 fractions 16-19 20 Wild-type core fractions 14-17
9 A79-125 fractions 9-12 21 A84-109 fractions 9-12
10 A79-125 fractions 15-18 22 A84-109 fractions 13-16
11 A60-117 fractions 9-12 23 A81-121 fractions 9-12
12 A60-117 fractions 16-19 24 A81-121 fractions 13-16
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was stained with ethidium bromide and subsequently with Coomassie blue. Again the 
possibility existed that any particles formed were either damaged during the purification 
process, or were so unstable as to be undetectable using the methods described in this 
thesis. The results for the 5' fill-in proteins did appear to show convincing evidence for 
the assembly of particles that possessed the ability to encapsidate nucleic acid. However, 
these putative particles were not observed by electron microscopy. For all non-particulate 
samples, large amounts of protein were detectable after Coomassie staining as a smear. 
This was of a different size to the band of core particles and agreed with the previous 
conclusion that large aggregates, rather than particles, were formed when these deletion 
proteins were expressed.
The ability of core particles to encapsidate RNA could have been exploited further 
as an assay for particle assembly by the core deletion proteins. Bacterial cells could have 
been grown in the presence of a 32P-UTP and protein expression induced. Following the 
preparation of cellular extracts, unprotected nucleic acids would be digested with DNase 
and RNase treatment of the extract. The clarified extract would be centrifuged through a 
sucrose gradient and fractions analysed by Western blot. Encapsidated RNA could be 
detected by exposure of a dried SDS PAGE gel of the gradient fractions to X-ray film or 
by scintillation counting of the gradient fractions. If RNA had been encapsidated within 
particulate structures formed from core deletion proteins, the peak gradient fractions 
containing core deletion protein should correspond with the peak a 32P-UTP-RNA- 
containing fractions.
It may be possible that RNA could be present within an aggregate of proteins due to 
interactions with the basic C-terminal region of the proteins. This may result in the RNA 
being protected from the nuclease treatment of cellular extracts. This would explain the 
correlation in the position of the bands for the 5'F10, 5'F20 and 5'F30 core deletion 
proteins after both staining procedures. However, if this was the case, similar results 
would be expected for other deletion proteins.
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3J Investigation  of the cellular localisation o f core deletion proteins  
3J1 Introduction
Core protein has been shown by a number of groups to localise to the nucleus, 
cytoplasm or both, in cells either infected with HBV or in cells transfected with the core 
gene alone (see Section 1E4). The signal directing nuclear localisation of core protein was 
contained in the C-terminal arginine-rich region of the protein and may be comprised of 
two distinct regions. This localisation has also been shown to be cell cycle stage- 
dependent (Yeh et al., 1993). Core protein localised to the nucleus in the Gq/G, phase of 
the cell cycle, with the amount localising increasing during G, phase. When cells were in 
S phase, however, the protein was undetectable in the nucleus and instead accumulated in 
the cytoplasm.
It was decided to examine the subcellular localisation of the core deletion proteins 
using immunofluorescence assays. The location of the protein can be determined at a 
specific stage in the cell cycle by the use of aphidicolin, which arrests cells at the Gj/S 
boundary (Pedrali-Noy et al., 1980). The epitope-tagged core gene deletions, along with 
a full-length tagged core gene, were amplified by PCR using primer pair cpk/Hintag. 
These primers included Eco RI and Hind III sites respectively, and primer Hintag also 
included the sequences for the pp65 epitope tag. The PCR products were digested and 
cloned into the vector pRK5 (see Section 2A1) such that the core genes were under the 
control of the CMV IE promoter. After transfection of aphidicolin-treated HepG2 cells 
with these plasmids, cells were fixed and labelled with either a Zymed anti-core 
polyclonal antibody or the anti-pp65 mAb 9220. Labelling was detected using FITC- 
conjugated second antibodies.
3J2 E xpression  o f core deletion proteins in m am m alian cells
An initial experiment was carried out to determine the correct expression of protein 
from this vector and detection by anti-pp65 mAb 9220. Plasmids were transfected into 
COS 7 cells and total cellular extracts prepared. These extracts were then analysed by 
Western blot using the anti-pp65 mAb 9220. The results are shown in Figure 3J2. No 
bands are visible in the lanes containing extracts from cells transfected with vector alone 
or untagged core protein (kindly provided by Ed Dornan - Institute of Virology). The core 
deletion proteins were all specifically detected, but were shown to be expressed at 
different levels, with the A79-125 protein expressed at the lowest level. An additional 
protein of approximately 44kDa was detected in the extract from cells transfected with the 
plasmid expressing epitope tagged full-length core protein. This may represent the dimeric 
form of this protein, as was examined in Section 3D3. Additional proteins of lower 
molecular weight were also detected in extracts from cells transfected with the plasmids
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46 —
3 0  —  
21  —
CoreWT 
A84- 109  
A81-121  
A79- 125  
A 6 0 - 1 1714  —
Figure 3J2: Expression of epitope-tagged core deletion proteins in transfected COS 7 
cells
COS 7 cells in 60mm dishes were transfected with 5pg of pRK5 plasmid expressing 
tagged full-length core protein (CoreWTtag), tagged core deletion proteins (Atag), 
untagged full-length core protein (CoreWT) or vector only (pRK), as a control. After a 
24hr incubation following replacement of the transfection medium, cells were scraped and 
pelleted by centrifugation. The cell pellet was washed twice with PBS, finally 
resuspended in SDS PAGE sample buffer and heat-denatured at 100°C for 5 min. 
Samples were electrophoresed through a 17.5% polyacrylamide gel and Western 
blotted. The blot was incubated with anti-pp65 mAb 9220. Molecular weights of the 
markers used (M) are shown.
expressing epitope tagged full-length core protein and core deletion protein A84-109, but 
these may have only been due to protein degradation during preparation of the extracts.
3J3 Im m un oflu orescen ce assays
Although the core protein has been shown to localise to the nucleus under the 
conditions used here, the results obtained in this section were found to differ (see Figure 
3J3). The full-length core protein did not localise exclusively to the nucleus, but was 
present in both nuclear and cytoplasmic regions of the cells, when examined with the anti- 
pp65 mAb 9220 (Panel A). The same localisation pattern was detected when the 
polyclonal antibody was used (Panel G). Upon closer examination of the amino acid 
sequence of this particular protein it was observed that a Gly>Cys mutation was present 
in the C-terminal region of the protein, at amino acid 153. As the nuclear localisation
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A) B)
C) D)
E) F)
Figure 3J3: Immunofluorescent labelling of cell-cycle arrested HepG2 cells transfected 
with pp65 epitope-tagged core genes (continued on following pages)
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j )
K) L)
Figure 3J3: Immunofluorescent labelling of cell-cycle arrested HepG2 cells transfected 
with pp65 epitope-tagged core genes (continued with legend on the following page)
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M )
F i g u r e  3 J 3 : I m m u n o f l u o r e s c e n t  l a b e l l i n g  o f  c e l l - c y c l e  a r r e s t e d  H e p G 2  c e l l s  t r a n s f e c t e d  
w i t h  p p 6 5  e p i t o p e - t a g g e d  c o r e  g e n e s
H e p G 2  c e l l s  a r r e s t e d  a t  t h e  G / S  b o u n d a r y  in t h e  p r e s e n c e  o f  a p h i d i c o l i n  w e r e  
t r a n s f e c t e d  w i t h  p l a s m i d  p R K 5  c o n t a i n i n g  e i t h e r  f u l l - l e n g t h  c o r e  g e n e  w i t h  a  C - t e r m i n a l  
e p i t o p e  t a g ,  e p i t o p e - t a g g e d  c o r e  d e l e t i o n  g e n e s  o r  n o  i n s e r t .  F o l l o w i n g  t r a n s f e c t i o n ,  c e l l s  
w e r e  i n c u b a t e d  w i t h  e i t h e r  a  1 : 3 0 0  d i l u t i o n  o f  a n t i - p p 6 5  m A b  9 2 2 0  o r  u n d i l u t e d  Z y m e d  
p o l y c l o n a l  a n t i b o d y .  A f t e r  w a s h i n g ,  c e l l s  w e r e  i n c u b a t e d  w i t h  e i t h e r  a  1 : 1 0 0  d i l u t i o n  o f  
F I T C - c o n j u g a t e d  g o a t  a n t i - m o u s e  a n t i b o d y ,  o r  a  1 : 6 0  d i l u t i o n  o f  g o a t  a n t i - r a b b i t  F I T C -  
c o n j u g a t e d  a n t i b o d y  t o  e n a b l e  d e t e c t i o n  o f  t h e  p p 6 5  s e q u e n c e  a n d  c o r e  p r o t e i n ,  
r e s p e c t i v e l y .
A) Full-length core protein - mAb 9220 G) Full-length core protein - Zymed pAb
B) A84-109 - mAb 9220 H) A84-109 - Zymed pAb
C) A81-121 - mAb 9220 I) A81-121 - Zymed pAb
D) A79-125 - mAb 9220 J) A79-125 - Zymed pAb
E) A60-117 - mAb 9220 K) A60-117 - Zymed pAb
F) pRK5 - mAb 9220 L) pRK5 - Zymed pAb
M) Untagged full-length core protein 
- Zymed pAb
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signal ot the core protein is located within this C-terminal region of the protein, the 
Gly 153Cys mutation may have affected the localisation of this protein.
The core deletion proteins were all detected effectively using mAb 9220 (Panels B-
E), but none were detected with the anti-core polyclonal antibody (Panels H-K). The 
localisation of all four core deletion proteins was found to be similar, with protein present 
in both the cytoplasm and the nucleus of the cells, in a manner similar to that observed for 
the epitope-tagged full-length protein used in these experiments. The C-terminal amino 
acid sequences of these proteins were examined for mutations, but none were detected. It 
was concluded that the core deletion proteins did not display the same subcellular 
localisations as wild-type core protein. Rather, the proteins showed a distribution that was 
both nuclear and cytoplasmic, even when cells were arrested at the G,/S boundary by 
incubation with aphidicolin. Cells transfected with plasmid alone showed minimal 
fluorescence with either antibody (Panels F and L). Panel M shows the nuclear 
fluorescence observed when untagged full-length core protein with no C-terminal amino 
acid mutations was expressed (this plasmid construct was kindly supplied by Ed Dornan - 
Institute of Virology). The core protein was detected using the Zymed polyclonal 
antibody.
3J4 D iscu ssion
The results from this section have shown that the core deletion proteins showed a 
subcellular distribution that was altered from that of full-length wild-type core protein. At 
the G,/S boundary of the cell cycle, all the deletion proteins were located in the cytoplasm 
in addition to the nucleus. This altered distribution may have been due to the presence of 
the C-terminal epitope tag sequences, which could interfere with the normal function of 
the core protein nuclear localisation signal. The more likely possibility was this signal was 
affected by the deletion of the upstream core protein residues, or by the new amino acid 
sequence formed as a result of the deletion. From the results of previous sections, where 
the core deletion proteins were shown to be incapable of forming as core particles, it may 
have been expected that they would not display other properties which characterise the 
full-length protein.
The epitope-tagged full-length core protein studied here, again in contrast to 
published reports, did not localise exclusively to the nucleus, but displayed a distribution 
throughout the nucleus and cytoplasm of the cell, similar to that observed for the core 
deletion proteins. This was thought to be due to a Gly 153Cys mutation in the C-terminal 
region o f the protein. A previous mutation (Argl51Thr) in this region was shown to 
inactivate the core protein nuclear localisation signal (Eckhardt et a l ,  1991).
The implications of core protein C-terminal mutations and the related alterations in 
subcellular localisation of the proteins are unclear at present. Recent results from our 
laboratory have suggested a correlation between core protein localisation in the cytoplasm
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and ongoing disease (Dornan et al., 1996). Sequential serum samples from e antigen 
positive patients, who subsequently seroconverted to anti-HBe antibody, and patients 
who were continually anti-HBe positive were analysed. The core gene was amplified by 
PCR (using an antisense primer which did not include the nucleotide sequences encoding 
the pp65 epitope tag) and cloned into pRK5. Following transfection of HepG2 cells the 
location ot the core protein was analysed in a manner identical to that used in this section, 
using the Zymed polyclonal antibody. Patients who seroconverted to anti-HBe antibody 
and went into clinical remission showed no change in the localisation of the core protein 
between sequential serum samples: all samples showed strong nuclear fluorescence for 
core protein. However, patients with ongoing disease after seroconversion to anti-HBe 
antibody showed increased cytoplasmic core protein in samples taken after 
seroconversion. Increased cytoplasmic core protein expression was also detected in later 
sequential samples from patients who were continually anti-HBe positive, but remained 
viremic and had episodic reactivations of hepatitis.
As the localisation of the core deletion proteins is both nuclear and cytoplasmic (for 
the particular samples tested), the disease observed in the patient from which these 
variants were isolated may be caused by a similar mechanism to that observed in the 
patients described above. Work is ongoing to attempt to further determine the possible 
details of such a mechanism.
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3K Sequence analysis of co-existing fu ll-length  core genes 
3K1 Introduction
For all but two cases where the existence of core gene deletions has been described, 
investigators have also been able to detect full-length core gene in the same samples. The 
relative proportions of the two populations has not been well-documented, but greater 
attention has been focused on the core deletion genes. The rationale behind this was that 
as the regions deleted in these genes corresponded approximately to antigenic regions of 
the protein, it was hypothesised that these deletion variants may have represented a form 
of immune escape from one or more arms of the immune response. By allowing the virus 
to persist in this way, these deletion variants may have contributed to the chronic nature of 
the disease which affected these patients. However this attention may have been wrongly 
focused, and it may have been that the co-existing virus was in fact responsible for the 
disease state, in a manner similar to chronic patients without core gene deletions.
With this hypothesis in view it was decided to isolate and sequence full-length core 
genes, including the pre-core region, from the serum of patients with core gene deletions. 
This was made possible by the very kind gift of an aliquot of serum from Dr. N . 
Naoumov, from the Kings College group in London. This serum came from an e antigen- 
positive Chinese patient with CAH, from whom the core gene deletions A81-121, A79- 
125 and A60-1 17 had been isolated. After extraction of DNA from the serum, the pre­
core/core region was amplified by PCR using primer pair C1/C2. When the products of 
this reaction were analysed by agarose gel electrophoresis, a broad band at approximately 
600bp could be detected, representing core gene deletions, with only a fainter smear 
visible at approximately 730bp, corresponding to full-length core gene. However, when 
both bands were excised, gene-cleaned and cloned into the PCR-cloning vector pT7-Blue, 
no full-length genes could be isolated from recombinant plasmids. It was then decided to 
gene-clean total PCR products and make them blunt-ended using Klenow polymerase. 
The products could then be cloned into Sma I-digested plasmid pTZ18R, full-length 
genes being identified by Eco RI/Hin d ill digests of recombinant plasmid mini-prep DNA 
which were subsequently sequenced.
3K 2 R esu lts
A total of 84 pre-core/core genes were analysed following cloning of the PCR 
products as described above. Restriction enzyme digest fragments that were smaller in 
size than approximately 800bp, as determined by agarose gel electrophoresis, were 
excluded from further study. The full-length genes of the remaining 33 clones were then 
completely sequenced. Upon closer sequence analysis, it was found that only 10 of the 33 
'full-length' genes actually represented complete genes. The remaining genes all had small
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Chapter 3 Results
deletions from 29-38bp between nucleotides 385 and 431 (inclusive) of the core gene. 
Among these clones, the predominant deletion was a 37bp deletion of nucleotides 387- 
423, inclusive. Mutations observed in the amino acid sequences derived from the full- 
length genes are shown in Table 3K.
From these results, the sequences can be separated into two groups: sequences with 
a pre-core stop mutation and those without. However there was no significant difference 
in the number of mutations between these two groups (x2 test; P<0.1). In addition several 
mutations were common to both groups: S26A, L60V, V85I, P130T, T147A, S155P and 
Q 182Stop. Frequent mutations were observed which were specific to either group, such 
as R158G and P5T, in addition to sporadic mutations at other positions. The observed 
mutations do not appear to cluster in any of the regions suggested by other groups (see 
Section 1D2), with the exception perhaps of the region between amino acids 130 and 156 
suggested by Ehata et al. (1992, 1993). Of the 46 mutations observed, 12 (26%) are 
located in this region, but as no functional or immunological significance it has been 
assigned to this portion of the protein the relevance of this is unclear. These results also 
contrast with those of Akarca and Lok (1995) who observed an absence of mutations in 
the C-terminus of the protein which overlapped with the polymerase reading frame.
It was of interest that no mutations occurred within the region between amino acids 
86-129, as this contains the hydrophobic heptad repeat motif required for correct particle 
assembly. Cysteine residues were also unaltered, with the exception of Cys-183, which 
was missing in clones 4, 5, 8, 16 and 43 due to the creation of a stop codon at residue 
182. However, as these residues are not essential for particle assembly their absence is 
not significant.
3K 3 D iscu ssion
The results presented in this section have attempted to analyse mutations occurring 
in full-length core genes from a patient with co-existing core gene deletions. However the 
low number of full-length clones isolated has made this type of analysis less effective than 
was possible; the remaining 23 clones all having small regions deleted. This does show 
that, at this time-point, viruses with core gene deletions are present at greater levels than 
those with full-length core genes (10 full-length:73 deletions). Further longitudinal 
analysis of this particular patient by the group at Kings College has shown that after 
seroconversion, viruses with core gene deletions were lost from the serum, in common 
with other patients having deletions (Patient WT; Marinos et a l ,  1996).
As the significance of mutations in the core gene remains undetermined, it is 
difficult to comment on the absence of any mutational clustering in the sequences from 
this section. It may be that examination of a greater number of clones would shed light on 
this and maybe reveal signilicant regions.
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In conclusion, the presence of full-length core genes containing no mutations which 
would be likely to disrupt the functional role played by the protein, provides the means 
for the propagation of viral genomes with core gene deletions. Further analysis of the 
relevance of core mutations, particularly in relation to the immune response, is required 
before their significance is determined.
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Hepatitis B viruses with deletions in the core gene can represent a large population 
of viral variants observed during chronic infections. As the significance of many HBV 
variants remains unclear, the work presented in this thesis has attempted to identify and 
characterise any possible functional roles for core gene deletions in the life cycle o f the 
virus or in the pathology of the disease.
4A Do core deletion proteins form  core particles?
An important initial question regarding the relevance of core gene deletions was 
whether or not the resulting proteins could assemble into core particle structures. That 
core protein can tolerate substantial deletions o f various regions as well as insertions of 
large heterologous sequences and still form core particles shows its tremendous structural 
flexibility. It was therefore hypothesised that proteins with central deletions would also 
retain this ability, especially those with smaller deletions.
The results from Sections 3C, 3D and 3H have shown that, under the conditions 
used, no core particle-like structures could be detected when core proteins containing 
naturally-occurring deletions were expressed and purified. Despite the fact that Western 
blot analysis of sucrose gradient fractions showed the presence of these proteins in 
fractions where particles would have been expected, none were visible by electron 
microscopic examination. Two possibilities exist: (i) that no particles, only large 
aggregates of protein, were formed or (ii) that particulate structures did actually form but, 
despite all precautions taken, they were insufficiently stable to allow detection by electron 
microscopic examination. The latter possibility seems likely for the A81-121 5'fill-in 
proteins, where particles with encapsidated nucleic acid were also suggested by the 
agarose gel assay (see Section 3H), but not visible by electron microscopy.
Other experimental strategies could have been pursued to address this possibility 
had time allowed. A cross-linking agent such as glutaraldehyde, added to the protein 
solution immediately after the sucrose gradient fractionation stage, may have stabilised 
any particulate structures. Another possibility was to immunoprecipitate proteins from the 
bacterial extract, but problems may have arisen as m ajor core protein epitopes were 
deleted (see Section 3B). It may have been possible to use the anti-pp65 mAb 9220 for 
these experiments, but unfortunately this antibody/epitope tag combination does not work 
well in such experiments (John McLauchlan, MRC Virology Unit - personal 
communication).
The most obvious reason for the failure of particle formation is that the missing 
regions completely disrupt the tertiary structure of the protein, making it impossible for 
the protein dimers to form particles. The observation that the core deletion proteins retain
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the ability to dimerise (see Section 3D3) does not guarantee that these dimers are in the 
correct conformation for the subsequent core particle assembly: the formation of 
disulphide bonds may only require cysteine residues to be in close proximity and exposed 
at the surface of the folded protein.
It is also now obvious that the central region of core protein does not form a 
separate, external, globular domain, which could have been removed with minimal 
disturbance to the remainder of the polypeptide chain. Even the smallest regions, which 
were deleted in the A81-121 5'F30 and 3'F30 proteins, do not seem to form separate 
domains. These particular regions must therefore be located within the main domain of 
the protein. This has now been shown experimentally by the structural studies of core 
particles published during the production of this thesis (Conway et al., 1997; Bottcher et 
al., 1997; see Section 1E5). These studies showed that four a-helices were formed by the 
polypeptide backbone of the core protein. Comparison of the polypeptide chain 
conformation obtained from these results with the locations of the natural core protein 
deletions studied in this thesis showed that the deletions removed at least the entire third 
helix (A84-109) and, in the case of A60-117, large sections of helices 2 and 4 were 
removed as well. As helices 2 and 3 form part of the novel four-helix bundle found in the 
core particle, central deletions destroy this structurally important region of the protein.
These structural studies also provide a possible explanation for the inability of the 
Acore-surface hybrid protein to form stable particles (see Section 3E2). Examination of 
the surface protein sequence used to replace core residues 81-121 showed that this region 
contained seven proline residues. It was previously thought that this region of the protein 
contained mainly (3-sheets (Argos and Fuller, 1988) and so would not be disrupted by the 
presence of these residues. However, their presence would certainly disrupt the third and 
fourth a-helices now known to be present in this region of the protein. These two helices 
are also affected by the two smallest deletions created, A81-121 5'F30 and 3'F30, with 
the N-terminal third of helix 3 and the N-terminal half of helix 4 removed, respectively. 
Disruption of these regions of secondary structure may be the primary factor in 
prohibiting particle assembly. The deletion reported by Valliammai et al. (1995) removed 
amino acids 41-51 which contain only a region of unstructured polypeptide and the N- 
terminal residue of helix 2 (according to the structure from Bottcher et al. (1997)). As the 
hydrophobic heptad repeat (see below) is also undisturbed by this deletion, this particular 
deletion protein may well be assembly-competent.
It may be of interest to create deletions which reduce the length of helices 2 and 3 
equally, by removing residues 75-85 for example and determine whether this would 
allow particle assembly. Deletion of this region should only reduce the length of the spike 
on the external surface of the particle and therefore may have an increased probability of 
assembling altered core particles. A logical mutagenesis approach such as this, based 
upon knowledge of the structure of the core protein, may have a greater chance of
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defining the residues required for particle assembly, rather than the more random manner 
in which the deletions were created in this thesis.
The identification of the hydrophobic heptad repeat motif in core protein (Yu et al., 
1996), published toward the end of the work in this thesis, provided an additional 
explanation for the inability of core deletion proteins to form particles. This important 
motif for particle assembly was disrupted by all four natural deletions, with at least two 
m otif residues missing or, in the case of A79-125, all four residues. When viewed in the 
light of the importance of this motif, such gross alterations as the observed deletions 
could only be expected to prohibit particle assembly. The two smallest created deletions, 
A 81-121 5'F30 and 3'F30, removed one or none of the motif residues, respectively, and 
would therefore not have interfered significantly with the function of this motif. The more 
general disruption to the tertiary structure of the core protein described above would 
however, still explain the absence of core particle assembly when these proteins were 
expressed (see Section 3E3).
If further work was to be carried out to address the ability of core deletion proteins 
to form particles, a change of experimental strategy would probably allow more definitive 
results to be generated. Although core particles can be assembled by expression of the 
core gene in heterologous systems, comparisons of the efficiency of this process and the 
equivalent process occurring during the infectious cycle have not been carried out. It is 
possible that the latter system operates at a higher level of efficiency due to the presence 
of additional interactions. For example, interactions between the core protein and the full- 
length pgRNA may catalyse the assembly of the core particle during the encapsidation 
process and perhaps act to stabilise its final structure. Although Birnbaum and Nassal 
(1990) showed that core particles assembled in E.coli could encapsidate RNA, the major 
RNA species present within the particles was only approximately 0.9kb, in contrast to the 
3.5kb pgRNA. The core protein may also interact with the polymerase protein, bound to 
the e sequence. This interaction may initiate the core particle assembly process. As these 
potential interactions are not all necessarily present in the bacterial systems commonly 
used, opting for an experimental system which closely mimics events occurring during 
infection would help increase the authenticity of the results obtained. Amplification of 
viral DNA from serum using the PCR method developed by Gunther et al. (1995) would 
allow the isolation of entire HBV genomes containing core gene deletions. Individual 
variant genomes could then be cloned and transfected into hepatocyte cell lines, in the 
absence of any other viral genomes, to allow viral DNA replication and virion production 
to occur. The advantage of this type of system is that all the cellular and viral components 
required in the lifecycle, subsequent to viral entry and uncoating, are present. If 
functionally normal core particles were produced from genomes containing in-frame core 
gene deletions, any resulting extracellular virions could be purified from the culture 
medium and the nucleic acid analysed to confirm the presence of the deletion. H owever,
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if transfection of these genomes failed to produce virions, intracellular contents could be 
examined for the presence of core particles, thus identifying whether core particle 
assembly or core particle envelopment was the end-point in virion assembly for these 
variants.
4B A re core deletion proteins incorporated into m ixed particles?
As viruses with core gene deletions co-exist with wild-type virus in the majority of 
reported cases, the core deletion proteins may co-assemble with the full-length core 
protein to form altered core particles. This assumes that both types of virus are present in 
the same hepatocyte, which has never formally been proven. However, the results 
discussed above coupled with the detection of these variants in the serum strongly 
suggest this is realistic.
As core particles can be composed of 90 or 120 dimer subunits, a certain degree of 
flexibility is probably permitted in the overall particle structure. For example, the presence 
of a small number of 'altered' subunits may be permitted, with the wild-type core protein 
dimers acting as a scaffold, maintaining the structure of the particle. As the N- and C- 
terminal regions of the protein form the shell of the particle, perhaps only these would be 
required in altered subunits, removing only the spike from the particle surface. Thus, it 
may be possible to include a significant proportion of altered subunits whilst still 
maintaining the structural integrity of the particle.
From the results of Section 3F, it appears that this scenario may exist for the two 
naturally-occurring core deletion proteins studied, A84-109 and A 81-121. However for 
a definitive conclusion to be reached, a more direct experimental approach should be 
employed, such as the immunoelectron microscopy discussed in the results section. 
Comparison with the results of the 5'F30 protein co-expression experiment also stresses 
the need for confirmation of the previous results, as this deletion is included in the A81- 
121 region yet does not appear to assemble into mixed particles. The extra polypeptide 
sequence in this protein compared to the A81-121 protein may alter the conformation so 
that it cannot fit into the subunit packing arrangement of the particle.
If the results for the naturally-occurring deletions are correct, the core particle 
would appear to be capable of tolerating a substantial proportion of altered subunits in its 
structure. In these cases, the original helix 2 may fold back on itself, forming a shorter 
spike but still supplying a sufficient length of polypeptide chain to form the domain 
interacting with the particle shell. In an analogous manner, it may again be of interest to 
determine whether or not a core deletion protein with only the upper region of the spike 
removed would form mixed particles. It is also unknown if mixed particles can 
encapsidate nucleic acid and be enveloped correctly.
If such mixed particles do assemble, encapsidate viral pgRNA and are enveloped 
during infection, what would their relevance be? As discussed previously, core gene
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deletion variants have been proposed to represent a viral subpopulation capable of 
escaping detection and elimination by the immune system. However, no mechanism has 
been proposed in any great detail to explain this hypothesis. Had core deletion proteins 
been able to assemble into particulate structures by themselves, these would have escaped 
recognition, or at best been poorly recognised, by B-cells. This would have reduced or 
eliminated the anti-core humoral response. The efficient initiation of a Th cell response 
would also have been affected in this scenario, as Th epitopes were either removed or 
disrupted by the deletions. In addition, a consequent decrease in the production of anti­
core protein and anti-surface protein antibodies would result. As the anti-core Th 
response is held to be the primary factor in determining the outcome of infection, the 
deletions could cause a higher incidence of chronic disease.
However, from the results mentioned previously, the only possibility appears to be 
the formation of mixed core particles. The relevance of these in the course of virus 
infection is more difficult to determine. In this scenario, full-length core protein remains 
present and accessible to all branches of the immune system, making 'immune escape' 
highly unlikely. This does not necessarily mean that the viral deletion variants are 
incapable of influencing the outcome of infection. It may be that the relative strength of 
the immune response is important, in contrast to the generation of an all-or-nothing 
response. In the former case, mixed particles would contain fewer epitopes for antibody 
and Th recognition, thus reducing these responses and their consequent effects.
4C Do core deletion proteins show altered subcellu lar localisations?
From the results of the immunofluorescence assays on transfected HepG2 cells in 
Section 3E4, it appears that core deletion proteins do not share the same subcellular 
distribution as the wild-type protein. Whereas full-length wild-type protein is reported to 
localise to the nucleus in the G, phase of the cell cycle, all four core deletion proteins 
were detected in both the cytoplasmic and nuclear compartments in this phase. This 
apparent lack of cell-cycle regulation of core deletion proteins was not caused by 
disruption of the NLS regions, as no mutations were present in the C-terminus of the core 
deletion proteins. However, other explanations exist: the presence of the epitope tag 
sequences or the absence of the deleted residues could both affect the NLS function.
Full-length epitope-tagged core protein, used as a control, also showed both nuclear 
and cytoplasmic distribution under cell-cycle arrest conditions. This suggested that the 
epitope tag sequences may have prevented cell cycle regulation of the location o f the 
protein, possibly by occluding NLS regions or phosphorylation sites. However, the 
particular full-length protein used in these experiments contained a Gly>Cys mutation at 
amino acid 153. Similar C-terminal point mutations within the NLS have been shown to 
be responsible for significantly altering the localisation pattern of the core protein (Ed 
Dornan, Division of Virology, University of Glasgow - unpublished results): core protein
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with a G in—>Lys mutation at amino acid 169 localised preferentially in the cytoplasm. 
After this single mutation was corrected by site-directed mutagenesis, the protein localised 
to the nucleus when expressed under identical conditions. Therefore, it seems probable 
that the unexpected core protein distribution observed in the results obtained for the full- 
length protein was due to the G lyl53Cys point mutation. In support of this conclusion, 
other full-length core proteins have been examined under identical conditions and have all 
been shown to localise to the cell nucleus (Ed Dornan - personal communication). The 
failure of the core deletion proteins to display the expected subcellular distribution is 
therefore likely to be due to the presence of the deletions.
A similar alteration in localisation caused by the deletion of residues separate from 
the NLS has previously been shown for the murine type IV c-ahl gene product (Van Etten 
et a i ,  1989). Removal of 53 amino acids in the N-terminal region of the protein, 
upstream from the NLS sequence, changed the localisation of the protein. The nuclear 
protein now located to the cytoplasm, with an apparent increased concentration at the cell 
membrane. In a separate experiment, insertion of a four amino acid linker at 
approximately the same position also resulted in this altered localisation. Deletion of the 
core protein residues upstream to the NLS could alter the tertiary structure of the protein 
so as to prevent protein kinases from phosphorylating target residues or inhibiting the 
interaction of the NLS with its nuclear targeting protein. As the precise role of the nuclear 
localisation of core protein and its regulation by the cell cycle are unclear, it is difficult to 
comment on the meaning of these results. Since the deletion proteins do not form particles 
they can play little, if any, role in genome delivery to the nucleus during infection, except 
perhaps in the form of mixed core particles.
4D Are core gene deletion variants an im portant factor in ch ron ic  
h ep atitis?
Large amounts of information have been generated from studies of the core protein 
and core particles over recent years. Studies in the contexts of such fields as 
immunology, structural biology and molecular biology, have allowed a more informed 
assessment of the relative importance of HBV core gene deletion variants to be made.
1) Do core gene deletion variants represent im m une escape?
A hypothesis exists which proposes that deletion of core gene regions which 
encode epitope sequences would prevent or decrease recognition of the protein by the 
immune system. The possibility that the chronic disease observed in patients is a 
consequence of the presence of these variants has been proposed by a number of groups 
(Wakita et al., 1991; Takayanagi et al., 1993; Ackrill et al., 1993; Liordalisi et al., 1994; 
Akarca and Lok, 1995b; Valliammai et al., 1995; Zoulim et al., 1996). However, other 
more thorough studies have cast significant doubt on this hypothesis.
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Gunther et al. (1995) detected core gene deletions in viral genomes cloned from a 
group of renal transplant patients. However, all patients from which deletion variants 
were isolated had been kept under continuous immunosuppressive treatment. Results 
from this study and a similar subsequent study (Gunther et al., 1996b) suggested that 
core gene deletions may be characteristic of this subgroup of HBV-infected patients. 
However, the continuous immunosuppressive therapy received by these patients makes 
immune-mediated selection an unlikely explanation for the emergence of core gene 
deletion variants. This possibility cannot be ruled out entirely, as some immune functions 
may have been retained by these patients.
A longitudinal analysis of changes in core gene deletion variants was carried out by 
Marinos et al. (1996) to determine the effects of both an enhanced immune response, in 
patients undergoing IFN a treatment, and seroconversion to anti-HBe antibody. The study 
showed that viruses containing core gene deletions were preferentially eliminated after 
either IFNa-induced or spontaneous seroconversion to anti-HBe. This failure to persist 
under enhanced immune pressure contrasts with the results obtained for viruses with full- 
length core genes and makes it unlikely that these deletion variants remain undetected by 
the immune system.
Another possibility does exist where core gene deletion variants need not 
completely evade the immune response, but could instead inhibit core-specific T cell 
responses in a manner analogous to that described by Bertoletti et al. (1994a, b). Rather 
than involving a wild-type T cell epitope and a variant epitope containing point mutations, 
the novel peptides formed as a result of juxtaposition of sequences external to the deletion 
may also act as inhibitors of the T-cell responses evoked by the wild-type peptide. 
Alternatively, competition for HLA-binding could occur between novel and wild-type 
peptides, or the novel peptides could render T cells anergic. However, examination of the 
novel sequences formed by the deletions shows they display no homology to T cell 
epitopes identified in core protein. Nevertheless, until tested experimentally, using a 
system similar to that of Bertoletti et al., this scenario cannot be discounted.
2) Are core gene deletion variants responsib le for increased d is e a s e  
sev er ity ?
As discussed previously (Section 1E6) in the majority of studies where viruses 
containing core gene deletions have been detected, patients have suffered from 
CAH/severe liver damage as opposed to being diagnosed as CPH or ASC cases. This 
correlation does suggest a role, as yet undefined, for this type of variant in augmenting 
disease severity.
An alternative explanation for this link is that, rather than representing immune 
escape, core deletion proteins may be directly cytopathic to the hepatocytes in which they 
are expressed. Core protein has previously been associated with such an effect when
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expressed in a HepG2 clone produced by transfection with cloned circular HBV DNA 
(Roingeard et al., 1990). This clone did not produce extracellular virions, despite 
expressing high levels of surface proteins and e antigen. This clone also displayed a high 
level of cell death, in contrast to an identical HBV-producer clone. The reason for this 
cytopathic effect was found to be an accumulation of core protein within the cells.
A similar scenario may exist for core deletion proteins: accumulation of the protein 
may occur, producing a cytopathic effect. Alternatively, the core deletion proteins could 
interfere with particle assembly from full-length protein, leading to an accumulation of 
protein due to its inability to be enveloped and secreted from the cell. Gunther et al. 
(1996b) showed that viruses with core gene deletions could persist and even increase 
with time, presumably leading to increased production and accumulation of core deletion 
proteins with the concomitant cytopathicity. However, such proteins cannot be highly 
cytotoxic as they are able to be transiently expressed in bacterial and mammalian cells 
with no visual evidence of cell death or growth inhibition. In addition, Gunther et al. 
observed only a limited increase in serum markers indicative of hepatocyte destruction, 
again suggesting only a weak cytopathic effect.
From these observations the likelihood of a link between the presence of core 
deletion proteins and disease severity is possible. However, it is unlikely to fully explain 
the increased severity observed in these patients. In addition, other studies of disease state 
in patients with core gene deletions have found no correlation (Okamoto et al., 1987b; 
Akarca and Lok, 1995b).
3) Do core gene deletion variants represent defective interfering particles?
Defective interfering particles (DIPs) are replication-defective viral deletion mutants 
and are associated with most RNA viruses and some DNA viruses (Holland, 1990). DIPs 
can interfere with the growth of homologous wild-type virus by a number of possible 
mechanisms and it has been suggested that they may play a role in several viral infections 
(Holland, 1990). The presence of DIPs may affect viral replication due to the 
modification of viral proteins in the DI genome (dePolo et al., 1987); by alteration of the 
host immune response (Chattopadhyay et al., 1989; Morgan and Dimmock, 1992); or by 
alteration of the expression of viral genes due to novel regulatory proteins being encoded 
by the DI genome (Sai'b et a l,  1993). It is possible that hepadnaviral deletion variants can 
act as DIPs, affecting the wild-type virus with which they co-exist. Experiments 
involving co-transfection of full-length DHBV genomes and defective genomes into 
Huh7 cells have shown that the presence of the defective genome can suppress the 
production of wild-type virions (Horwich et al., 1990). Defective genomes encoding 
either C-terminally truncated polymerase and surface proteins or C-terminally truncated 
polymerase, surface and core proteins were able to reduce the production of virions from 
transfected cells, after co-transfection. This reduction was approximately thirty-fold for
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the latter defective genome and was thought to be due to disruption of the virion assembly 
process by the truncated proteins. It is important that similar experiments are performed 
tor the naturally-occurring HBV deletion variants in order to assess the likelihood that 
they produce DIPs.
The possible effects that core deletion proteins have on the immune responses 
occurring during HBV infection also need to be examined. Core protein can inhibit the 
production of IFNp (see Section 1C3) and has also recently been implicated in the 
decreased expression of the type I interferon-inducible MxA protein observed in Huh7 
cells stably transfected with a defective 2.2kb viral genome (Rosmorduc et al., 1996). 
Core deletion proteins may have increased inhibitory effects on the expression of these 
important immune system proteins or may reduce the responsiveness of infected cells to 
the host immune response. These alterations may be an important factor in determining 
the outcome of HBV infection.
4) Do core gene deletions have effects on other viral genes?
The possibility exists that the deletions originally attributed to the core gene actually 
primarily affect other viral genes. This seems a likely explanation, especially as the 
deletions cluster around the region encoding the core protein hydrophobic heptad repeat 
motif, which is essential to the function of the core protein. However, the central 
clustering of the deletions avoids the polymerase gene. Were the core gene deletions to 
extend much farther in the 3' direction, 5' regions of the polymerase gene would also be 
removed. Instead, studies of two different patient groups have proposed a different 
explanation for the observed clustering. This involves the J- and C2-AUG codons 
(nucleotides 2163-2165 and 2177-2179, respectively), located 5' to the authentic 
polymerase AUG codon as described by Fouillot et al. (1993).
Deletions clustering in the central region of the core gene remove sequences 
encoding both of these AUG codons, but do not affect the authentic polymerase start 
codon. Deletion analysis of this region showed that removing the J and C2 codons 
allowed increased polymerase translation from the downstream ORF. Therefore, in 
viruses with core gene deletions which remove this region, increased polymerase 
expression probably occurs. Due to the requirement for polymerase in the encapsidation 
process, its predicted increased expression in these viruses may explain the high viremia, 
the preferential encapsidation and accumulation of this type of viral variant in renal 
transplant patients (Gunther et a l ,  1995, 1996b). This enhanced expression also provides 
a possible explanation for a selection process for these variants that is independent of 
immune system involvement.
However, Marinos et al. (1996) found that patients with core gene deletions had 
only low levels of viremia, in contrast to the results from the renal transplant patients. 
This was despite the fact that all the core gene deletions had also removed the J- and C2-
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AUG codons. In this case the core deletion proteins were proposed to interfere with core 
particle assembly by full-length core protein dimers. This may have occurred by the 
deletion proteins preventing dimerisation of the full-length protein or preventing full- 
length protein dimers from multimerising. Due to the ds-preferential nature of core 
protein dimerisation, full-length core proteinxore deletion protein dimers are unlikely to 
form, and results from this thesis suggest that the latter possibility may also be unable to 
explain the prevention of particle assembly. Direct interactions between the polymerase 
and core deletion proteins, leading to the inhibition of polymerase function, may instead 
explain the reduced DNA levels. Such interactions may also interfere with the 
encapsidation process, causing further reductions.
Increased presentation of polymerase-specific T cell epitopes may be an additional 
consequence of higher polymerase expression caused by core gene deletions. As this 
protein contains several CTL epitopes, increased levels of CTL activity will occur with a 
resulting increase in hepatocyte lysis and liver damage. This secondary effect o f the 
deletions may alone explain the more severe form of disease suffered by these patients, 
and also the preferential elimination of cells harbouring these variants.
5) Is the co -ex isting  w ild-type virus population  responsib le for the  
d isease state?
Perhaps the most unsatisfactory answer to the question concerning the relevance of 
core gene deletion viruses is that they have no significant role to play in causing the 
disease state observed. This is so unsatisfactory because it consigns this class of variant 
to the same group as all other core gene variants: it is possible to isolate and describe 
them, but their significance remains unknown, as does any possible mechanism linking 
them to chronic hepatitis.
Sequencing of the limited number of full-length genomes revealed no promising 
clues to explain the disease state. It is clear that more detailed studies of this 
subpopulation are required. Such studies should include HLA-typing, in order to refine 
the analysis of mutations; studies of mutations in relevant epitopes for immunological 
differences; assessment of core particle assembly by individual variants; an assessment of 
the stability of particles formed; and quantification of the efficiency of pgRNA 
encapsidation and envelopment by these same variants.
4E M echanism  of generation of core gene deletions
Despite the many reported observations of deletions in the HBV core gene, no 
mechanism for their generation has been discovered. At least two mechanisms are 
possible: splicing of pgRNA and, by analogy to the generation of deletions in a retroviral 
vector-based system (Pathak and Temin, 1990; Pulsinelli and Temin, 1991), a 
mechanism involving errors in plus-strand viral DNA synthesis.
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Splicing of the pgRNA has been discussed previously in Sections 1B3.1 and 
1E6 (2). The intron boundaries contain the consensus 5' GT/C and 3' AG donor and 
acceptor sites. However, examination of the boundaries of the other observed core gene 
deletions shows that neither site is consistently present at these positions. Therefore, 
splicing can only explain the generation of HBV core gene deletion variants if non­
consensus donor and acceptor sites can be recognised by the splicing machinery. As 
introns with highly conserved, but non-consensus sequences at both splice sites are 
present in genes from a variety of species (Tarn and Steitz, 1997), splicing of pgRNA 
may be the mechanism whereby deletions in the core gene are generated. However, if this 
is the case, deletions might be expected to occur throughout the genome, which has not 
been observed (Ackrill et al., 1993).
The mechanism of HBV DNA replication may provide an alternative explanation for 
the generation of the core gene deletion variants observed. As reverse transcriptase is an 
error-prone enzyme, base-pair substitutions, insertions and deletions can all occur during 
a single round of replication (Roberts et al., 1989; Pathak and Temin; 1990). Detailed 
characterisation of deletions and other mutations which occurred in a spleen necrosis 
virus-based vector allowed the elucidation of the mechanisms whereby these mutations 
were generated (Pulsinelli and Temin, 1991). Two classes of deletion mutant were 
generated by a mechanism which may be applicable to the generation of HBV core gene 
deletion variants. The first class of retroviral-based vector deletions arose due to a 
misalignment of the 3' terminus of the plus-strand strong stop DNA as it was being 
extended by the reverse transcriptase (see Figure 4A, steps 9 and 10). Sequences at the 3 ' 
terminus of this strand hybridised to sequences which were homologous to those being 
copied, but which were located further downstream in the minus-strand DNA. As 
extension of the plus-strand DNA continued at this new site, a stretch of intervening 
minus-strand nucleotide sequence was deleted. In some cases the homology between the 
sequence being copied and the misalignment site was only two nucleotides. The second 
class of retroviral vector deletions arose due to late termination of the strong stop plus- 
strand DNA (see Figure 4A, step 7). This resulted in the inclusion of additional 
nucleotide sequence at the 3' terminus of the plus-strand DNA. This sequence was 
complementary to the tRNA molecule used as a primer for minus-strand DNA synthesis. 
Following transfer of the plus-strand DNA to the 3' terminus of the minus-strand DNA, 
the tRNA sequences at its 3' terminus could not hybridise to nucleotides adjacent to the 
primer binding site (PBS). Instead, these tRNA sequences hybridised to nucleotides 
further 3' than the PBS, with the deletion of intervening minus-strand DNA sequences.
The deletions described using this experimental system are of interest for two 
reasons: (i) they are generated during a replication cycle which is similar to that of HBV 
and (ii) the deletions are positioned in a region which is the genomic homologue of the 
core gene: 3' to the binding site for the primer of plus-strand DNA synthesis.
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Figure 4A: Summary diagram of retroviral reverse transcription and DNA replication 
(1) Retroviral plus-strand RNA (dashed line) is the template for the synthesis of minus- 
strand strong stop DNA (hatched rectangle). (2) This process occurs by reverse 
transcription and utilises a tRNA primer. (3) Removal of the bound RNA from the minus-
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strand strong stop DNA by RNase H. (4) Minus-strand strong stop DNA transfer. (5) 
Minus-strand DNA synthesis by reverse transcriptase. (6) Nicking of RNA at the 
polypurine tract (ppt) and removal of 3' sequence by RNase H. (7) Minus-strand DNA 
synthesis continues and plus-strand strong stop DNA (clear rectangle) synthesis is 
initiated using the RNA primer. (8) Removal of RNA by RNase H. (9) Plus-strand strong 
stop DNA transfer. (10) Completion of minus-strand and plus-strand DNA synthesis. 
(Adapted from Pulsinelli and Temin, 1991)
However, the mechanism of generation of the second class of retroviral-based vector 
deletion mutants may not be relevant to the generation of the HBV core gene deletions. 
This is due to the differences that exist between the strategies for DNA replication 
employed by HBV and the retroviruses. In the second class of retroviral-based vector 
deletion mutants, the plus-strand strong stop DNA contained tRNA sequences at its 3 ' 
terminus. As a result, the DNA sequences 3' to the PBS sequence were missing in the 
final double-stranded retroviral DNA and the additional tRNA sequences included in their 
place. However, in HBV DNA replication, the inclusion of extra nucleotides at the 3 ' 
terminus of the primer for plus-strand DNA would be impossible. This is because the 
primer for synthesis of HBV minus-strand DNA is a protein molecule (pol/RTase), rather 
than a nucleic acid. As a result, extra nucleotides complementary to this primer cannot be 
added to the primer for plus-strand DNA synthesis. Also, no additional nucleotides are 
inserted in place of the deleted regions in the HBV core gene deletions. The locations of 
the deletions in this second class of retroviral-based vector deletion mutants also makes 
their mechanism of generation less relevant to the HBV core gene deletions. The retroviral 
deletions were immediately adjacent to the PBS sequence. This removed the E sequence, 
a positional and functional homologue of the e sequence of HBV. As £ sequences are 
present in all HBV core gene deletions, a different mechanism must exist for their 
generation.
The mechanism of generation of the first class of retroviral-based vector deletions 
may be similar to that used to generate HBV core gene deletions: while the 3' terminus of 
the plus-strand DNA primer is being extended, it could misalign with downstream 
sequences similar to those being copied. This would delete the intervening regions of the 
core gene and leave the e sequences intact. However, a closer examination of the 
sequences surrounding the 5' and 3' limits of the core gene deletions shows that this 
mechanism cannot explain the observed deletions. Even the two nucleotide homology 
between the 3’ end of the plus-strand strong stop DNA and the location of the 
misalignment observed for a retroviral-based vector deletion was not present for the 
equivalent sequences in the HBV core gene deletions. Unless the site of misalignment of
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the HBV plus-strand DNA primer is entirely random, with no requirement for nucleotide 
homology, a novel mechanism must exist for the generation of the HBV core gene 
deletions.
As chronic carriers of HBV represent a significant proportion of the population it is 
important that both the viral and host factor/s which determine the outcome of HBV 
infection are more fully investigated. Despite the number of reports of patients with core 
gene deletion variants, no investigations to date have examined possible functions they 
may have, or the effects they may have on the co-existing wild-type viral population. The 
results presented in this thesis have shown that the core deletion proteins encoded by 
these variants cannot functionally substitute for the wild-type protein. Therefore, further 
studies should concentrate on the effects of the interactions between the two types of core 
protein and any consequences these may have on the respective viral populations. The 
possibility that the deletions affect other genes, in particular the polymerase gene, also 
deserves further investigation.
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